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In eukaryotes, the genetic material, DNA, is highly compacted with histone 
proteins to form chromatin in interphase nuclei.  Both the higher levels of chromatin 
folding and the spatial organization of the chromatin, referred to as large-scale chromatin 
organization, have been shown to correlate with transcriptional activity.  One example 
suggesting transcriptional regulation by large-scale chromatin organization is position 
effects and position effect variegations observed in transgene expressions, which, as well 
as other epigenetic silencing mechanisms, have been obstacles to achieving predictable 
and stable transgene expression.  Molecular dissections of the determinants regulating 
large-scale chromatin organization would help to elucidate the real relationship between 
large-scale chromatin organization and transcriptional regulation, yet are difficult due to 
the complexity of the mammalian genome.  Bacterial artificial chromosomes (BACs), 
containing 100-300 kb mammalian genomic regions have been shown to recapitulate the 
expression level and nuclear localization of the corresponding genomic regions, and to 
protect embedded reporter mini-genes from epigenetic silencing.  
Here in Chapter 2 we show that BACs could provide a versatile platform for 
achieving reproducible, stable simultaneous expression of multiple transgenes maintained 
either as episomes or stably integrated copies.  Moreover, in Chapter 3 we show that 
BACs could be used as a powerful model system for dissecting mechanisms regulating 
large-scale chromatin organization, by demonstrating distinctive large-scale chromatin 
conformations formed by BAC transgene arrays and results indicating separation of 
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CHAPTER 1: INTRODUCTION 
 
TRANSGENE EXPRESSION 
Transgene expression is a fundamental technique in both basic biological research 
and biotechnology.  Yet most of the widely used transgene expression systems, such 
plasmids, lentiviruses and transposons , still suffer from various degrees of transgene 
silencing.  The integration site of the transgene has a great effect on its expression, 
known as chromosome position effects (Akhtar et al., 2013; Chen et al., 2013). 
Transgenes integrated into inactive chromatin regions tend to express at low levels or 
have variegated expression (position effect variegation, PEV) (Robertson et al., 1995; 
Ramunas et al., 2007; Girton and Johansen, 2008).  However, integration into active 
chromatin regions is not sufficient for high level of expression, as prokaryotic and viral 
sequences, as well as transgene concatemers can become targets for epigenetic silencing 
(Dorer and Henikoff, 1997; Hong, Sherley and Lauffenburger, 2001; Chen et al., 2004)  
Thus, it usually takes tedious screening to get clones with desired levels of transgene 
expression.  However, transgene expression could deteriorate with increasing number of 
passages or freezes, or when the cell clones get differentiated. 
A conventional way to protect the transgene from silencing is to include certain 
cis-elements in the expression cassette.  Various cis-elements have been shown to 
alleviate transgene silencing.  Examples include insulators (Pikaart, Recillas-Targa and 
Felsenfeld, 1998; Emery et al., 2000), locus control regions (LCRs) (Grosveld et al., 
1987; Guy et al., 1996), scaffold/matrix attachment regions (S/MARs) (Phi-Van et al., 
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1990; Kim et al., 2004), ubiquitous chromatin opening elements (UCOEs) (Williams et 
al., 2005; Müller-Kuller et al., 2015) and anti-repressors (Kwaks et al., 2003). 
Recently, bacterial artificial chromosomes (BACs) have been shown to be more 
effective than the conventional cis-elements for achieving sustained high-level transgene 
expressions (Blaas et al., 2009; Bian and Belmont, 2010).  BACs usually contain 100-300 
kb mammalian genomic regions and can integrate into mammalian genomes as tandem 
repeats.  It is hypothesized that the large BAC transgene array could shield the embedded 
mini-genes from influences from the chromosomal integration sites and that the mini-
gene expression is determined by the properties of the genomic region contained within 
the BACs.  Based on this hypothesis, a study explored different promoter and BAC 
combinations for high level production of recombinant proteins (Zboray et al., 2015). 
 
 
EPISOMAL TRANSGENE EXPRESSION SYSTEMS 
In some transgene expression applications, it is desirable for the transgenes to 
persist in the host cell nuclei as extrachromosomal DNA, instead of integrating into the 
host chromosomes, to avoid possible disruption of host genes, and/or to eventually 
eliminate these transgenes from the cells.  Various episomal vectors have been developed 
(Van Craenenbroeck, Vanhoenacker and Haegeman, 2000; Conese, Auriche and 
Ascenzioni, 2004; Ehrhardt et al., 2008; Lufino, Edser and Wade-Martins, 2008).  Viral 
sequence based episomal vectors rely on viral proteins and a viral replication origin for 
replication and partitioning into daughter cells (Milanesi et al., 1984; Rawlins et al., 
1985; Yates, Warren and Sugden, 1985; Piirsoo et al., 1996).  Epstein Barr virus (EBV) 
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derived episomal vectors are lost at a low rate without selection (Nanbo, Sugden and 
Sugden, 2007) and have been used to produce transgene-free iPS cells (Yu et al., 2009).  
The main disadvantage of viral based vectors is the requirement for the viral proteins, 
which could lead to transformation of the transfected cells (Frappier, 2012).  None viral 
episomal vectors have two key components: a S/MAR sequence from the human b-
interferon gene cluster, and a upstream transcription going through the S/MAR 
(Piechaczek et al., 1999; Baiker et al., 2000; Jenke et al., 2004).  S/MAR based episomal 
plasmids are maintained at low copy number and are mitotically stable without selection 
(Piechaczek et al., 1999; Baiker et al., 2000; Jenke et al., 2004; Stehle et al., 2007; 
Argyros et al., 2008).   
Human artificial chromosomes (HACs) are a high capacity episomal vector 
system.  They are usually 1-10 Mb in size, and contain centromeric repeat sequences for 
episomal status maintenance (Harrington et al., 1997; Mills et al., 1999; Kazuki and 
Oshimura, 2011; Kouprina et al., 2013).  Most HACs are constructed by either “top 
down” or “bottom up” approaches.  In the “top down” approach, a natural chromosome is 
fragmented by a targeting vector containing a terminal telomere segment, a selectable 
marker, and sometimes a region of homology to the target chromosome, generating an 
engineered mini-chromosome.  In the “bottom up” approach, cloned centromeric DNA 
and genomic DNA, or engineered BACs, PACs, or YACs containing centromeric DNA 
are introduced into cells to form de novo chromosomes.  Telomeric DNA is not 
necessary, as the de novo chromosomes formed are usually circular DNA (Mejía et al., 
2001; Ebersole, 2002; Conese, Auriche and Ascenzioni, 2004).  Both the “top down” and 
the “bottom up” approaches require specific cell lines, and the transfer of the HACs from 
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the donor cells into the recipient cells is even more difficult (Fournier and Ruddle, 1977; 
Liskovykh et al., 2016).  HACs have shown great potential in a wide range of 
applications, such as recombinant protein production, drug selection and gene therapy 
(Kazuki et al., 2010; Takahashi et al., 2010; Hiratsuka et al., 2011; Kim et al., 2011).   
 
 
DOMAIN ORGANIZATION OF THE INTERPHASE CHROMATIN 
The position effects and position effect variegations suggest regulation of 
transcription at the chromatin level.  An interesting hypothesis is that besides 
transcription factors, an additional level of gene expression regulation exists that acts 
over 100s-1000s kb sized chromosomal domains.  A study reporter showed constructs 
integrated at 90 different chromosomal positions obtain expression levels that correspond 
to the activity of the domains of integration (Gierman et al., 2007).  Such domains were 
identified by testing various window sizes to find the highest correlation between reporter 
gene expression and domain transcriptional activity (Gierman et al., 2007).  More studies 
are needed to verify the hypothesis. 
Both microscopy and genomic mapping studies have suggested domain 
organization of the interphase chromatin.  Transmission electron microscopy (TEM) 
studies with DNA specific stains (Belmont et al., 1989; Bohrmann and Kellenberger, 
1994; Bazett-Jones and Hendzel, 1999), as well as recently developed ChromEMT (Ou et 
al., 2017), have shown most nuclear DNA is present in large-scale, frequently fiber-like 
structures consisting of ~Mbp size segments with a range of diameters.  Moreover, DNA 
FISH and light microscopy based experiments have shown that each chromosome 
5 
 
occupies a distinct territory, termed chromosome territories (Cremer and Cremer, 2001; 
Parada et al., 2002). 
Such domain organization is consistent with recent discoveries from genome-
wide mapping studies.  For example, the A/T content of the mammalian genomes form 
long DNA stretches (>100 kb) termed isochores, with A/T-poor regions roughly 
corresponding to high gene density regions along the genome (Caron et al., 2001; 
Costantini, 2006).   
Enrichment of certain histone modifications also form 10s-100s kb of domains.  
H3K27me3 modifications have been shown to form 10s of kb BLOCs (broad local 
enrichments) over silent genes and intergenic regions in mouse embryonic fibroblast 
(MEF) cell lines (Pauler et al., 2009).  H3K9me2 has also been found to form 10s kb 
sized domains, along the genome in mouse cells and tissues, which are termed large 
organized chromatin K9 modifications (LOCKs), and together cover up to 45% of the 
genome, depending on the cell type (Wen et al., 2009).  Analyzing a set of histone 
modifications over 100s kb-Mb sized intervals have categorized five chromatin states 
(Zhu et al., 2013).    
Moreover, genomic mapping studies have also identified 100 kb-10 Mb nuclear 
lamina associating domains (LADs), which are generally low in transcriptional activity, 
and are enriched with repressive histone modifications (Guelen et al., 2008; Peric-
Hupkes et al., 2010).   
Recent development of genome-wide chromosome conformation capture 
techniques (3C, 4C, 5C, and Hi-C) has shown that chromatin interactions are spatially 
restricted into repeated chromatin domains (Dixon et al., 2012; Dixon, Gorkin and Ren, 
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2016), termed topologically associated domains (TADs).  TADs have been found to 
associated with distinct patterns of histone marks and can be segregate into six 
subcompartments (Rao et al., 2014). 
In spite of the chromatin domains discovered by both TEM and genomic mapping 
studies, how are these domains established and how do they regulate each other has not 
been established.  A study (Boettiger et al., 2016) showed that 100s kb sized genomic 
domains with active histone modifications have more “open” chromatin conformation 
than genomic regions with repressive histone modifications, and genomic regions with 
neither active or repressive histone modifications have chromatin conformation in 
between with DNA FISH and super-resolution light microscopy, indicating possible 
regulation of large-scale chromatin compaction by epigenetic modifications.  Moreover, 
using a multiplexed FISH method to sequentially image many genomic regions a study 
traced several TADs in human cells and found that TADs are largely organized into two 
compartments spatially arranged in a polarized manner in individual chromosomes 
(Wang et al., 2016).  Interestingly, a 4.3-Mb region on mouse chromosome 14 that 
contains four clusters of genes separated by gene “deserts” was shown to form 
nonrandom “higher order” structures, where the gene clusters and gene deserts regions 
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CHAPTER 2: VERSATILE MULTI-TRANSGENE EXPRESSION USING 




Achieving reproducible, stable, and high-level transgene expression in 
mammalian cells remains problematic. Previously, we attained copy-number-dependent, 
chromosome-position-independent expression of reporter minigenes by embedding them 
within a BAC containing the mouse Msh3-Dhfr locus (DHFR BAC). Here we extend this 
“BAC TG-EMBED” approach. First, we report a toolkit of endogenous promoters 
capable of driving transgene expression over a 0.01-5 fold expression range relative to 
the CMV promoter, allowing fine-tuning of relative expression levels of multiple reporter 
genes expressed on a single BAC. Second, we show small variability in both the 
expression level and long-term expression stability of a reporter gene embedded in BACs 
containing either transcriptionally active or inactive genomic regions, making choice of 
BACs more flexible. Third, we describe an intriguing phenomenon in which BAC 
transgenes are maintained as episomes in a large fraction of stably selected clones. 
Finally, we demonstrate the utility of BAC TG-EMBED by simultaneously labeling three 
nuclear compartments in 94% of stable clones using a multi-reporter DHFR BAC, 
constructed with a combination of synthetic biology and BAC recombineering tools. Our 
extended BAC TG-EMBED method provides a versatile platform for achieving 
reproducible, stable simultaneous expression of multiple transgenes maintained either as 
episomes or stably integrated copies. 
 14 
INTRODUCTION 
Transgene expression has been widely used in both basic research and 
biotechnology. Applications of transgene expression range from the elucidation of gene 
function by ectopic expression of selected transgenes, to the expression of transgenes for 
gene therapy, and to the overexpression of genes for production of biopharmaceuticals 
(Wurm, 2004; Glover, Lipps and Jans, 2005; Prelich, 2012; Zhu, 2012; Walsh, 2018). 
Examples of such applications include the expression of multiple fluorescent proteins for 
live-cell imaging (Rizzo, Davidson and Piston, 2009), the expression of the four or more 
Yamanaka transcription factors for efficient generation of induced pluripotent stem (iPS) 
cells (Takahashi and Yamanaka, 2006), and the expression of multiple proteins for 
reconstitution of protein complexes (Machida et al., 2012). 
Despite the currently widespread use of transgene expression, most transgene 
expression systems still suffer from serious experimental limitations.  Plasmid-, 
lentivirus- and transposon- based systems, all still show varying degrees of chromosome 
position effects (Akhtar et al., 2013; Chen et al., 2013) and position effect variegation 
(PEV) (Karpen, 1994; Robertson et al., 1995; Ramunas et al., 2007; Girton and Johansen, 
2008; Tchasovnikarova et al., 2015). Moreover, foreign sequences by themselves are 
targets for epigenetic silencing (Scrable and Stambrook, 1999; He, Yang and Chang, 
2005; Suzuki, Kasai and Saeki, 2006; Minoguchi and Iba, 2008), and transgene 
concatamers can induce the formation of heterochromatin (Dorer and Henikoff, 1997; 
Garrick et al., 1998). Together these transgene silencing mechanisms result in 
unpredictable transgene expression levels that do not correlate with copy number and are 
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unstable with long-term culture or changes in the cell physiological or differentiated state 
(Laker et al., 1998; Hotta and Ellis, 2008; Herbst et al., 2012).  
Such limitations are compounded when the simultaneous and reproducible 
expression of multiple transgenes is required. For example, a common application in the 
emerging field of synthetic biology is the design of novel gene circuits, involving the 
expression of multiple proteins, in many cases at precise relative levels (Brophy and 
Voigt, 2014).  While this approach has worked well in prokaryotes and yeast, it has been 
difficult to implement in mammalian cells due to the lack of suitable multi-transgene 
expression methods which overcome chromosome position effects and allow expression 
of different transgenes at reproducible relative levels. 
A commonly used approach to countering this transgene-silencing phenomenon 
has been through the inclusion of cis-elements. These include insulators (Pikaart, 
Recillas-Targa and Felsenfeld, 1998; Emery et al., 2000), locus control regions (LCRs) 
(Grosveld et al., 1987; Guy et al., 1996), scaffold/matrix attachment regions (S/MARs) 
(Phi-Van et al., 1990; Kim et al., 2004), ubiquitous chromatin opening elements 
(UCOEs) (Williams et al., 2005; Müller-Kuller et al., 2015) and anti-repressors (Kwaks 
et al., 2003); some of these regulatory elements have context-dependent and/or vector 
dependent activity. While these cis-elements improve transgene expression to varying 
degrees, they are insufficient for chromosome-position independent, copy-number-
dependent transgene expression (Guy et al., 1996; Bharadwaj et al., 2003; Truffinet et 
al., 2005; Grandchamp et al., 2011). 
Additionally, in some transgene expression applications the ability to avoid 
transgene chromosomal integration and eventually eliminate these transgenes from the 
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cells is highly desirable. Both viral-sequence based and non-viral, pEPI based episomal 
vectors have been developed (Van Craenenbroeck, Vanhoenacker and Haegeman, 2000; 
Conese, Auriche and Ascenzioni, 2004; Ehrhardt et al., 2008; Lufino, Edser and Wade-
Martins, 2008). Viral-based vectors have the potential of causing transformation of the 
transfected cells (Frappier, 2012), while pEPI-like vectors, containing a S/MAR sequence 
immediately downstream of an active transcription unit, are mitotically stable without 
selection (Piechaczek et al., 1999; Baiker et al., 2000; Jenke et al., 2004; Stehle et al., 
2007; Argyros et al., 2008), and thus cannot be removed from the cells. Moreover, 
transgenes on these episomal vectors are still subject to silencing (Tessadori et al., 2010), 
possibly due to the prokaryotic or viral sequences on these vectors (Chen et al., 2004; Riu 
et al., 2007).  
Bacterial artificial chromosomes (BACs) carrying ~100-200 kb mammalian 
genomic DNA inserts harbor most of the cis-regulatory sequences required for expression 
of the endogenous genes contained within these genomic inserts. Previously we 
demonstrated how embedding minigene constructs at different locations within the 
DHFR BAC provided reproducible expression of single or multiple reporter genes 
independent of the chromosome integration site (Bian and Belmont, 2010). Similar 
approaches were used by other labs for high-level recombinant protein production (Blaas 
et al., 2009; Zboray et al., 2015). Recently, our lab demonstrated stable transgene 
expression after cell-cycle arrest or after terminal cell differentiation, using the BAC-TG 
EMBED approach (Chaturvedi et al., 2018). All of these studies tested only BACs 
containing actively transcribed regions, based on the hypothesis that the expression level 
of the transgenes inserted into the BACs was determined by the chromatin environments 
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reconstituted by the genomic inserts within the BACs. Indeed, because of this 
assumption, previous studies have specifically targeted the inserted transgenes to 
transcription units and even exons (Blaas et al., 2009; Bian and Belmont, 2010; Zboray et 
al., 2015). 
However, this hypothesis has not been tested. Moreover, overexpression from the 
genes on the BAC genomic inserts might change the properties of the transfected cells, or 
interfere with other assays of a study. Thus, BACs with no transcription units would be 
more desirable. Another improvement over our previous BAC TG-EMBED system (Bian 
and Belmont, 2010; Chaturvedi et al., 2018) would be a toolkit of endogenous promoters 
capable of driving transgene expression over a wide range of expression levels. Viral 
promoters, including the CMV promoter we used previously, are known to be prone to 
epigenetic silencing (Fitzsimons, Bland and During, 2002; Brooks et al., 2004), while 
most previously used endogenous and synthetic promoters were selected for their 
strength (Hong et al., 2007; Qin et al., 2010; Chen et al., 2011; Zboray et al., 2015). 
While high-level transgene expression is preferable in applications calling for 
overexpression, a low or near-physiological expression is important for many other 
applications, including gene therapy. Additionally, multiple transgenes may need to be 
expressed simultaneously but at reproducible differential levels.  
Here we describe further extensions to the BAC TG-EMBED method that 
together provide a more versatile BC TG-EMBED toolkit for a range of future potential 
applications. First, we describe a toolkit of endogenous promoters that can drive 
transgene expression at reproducible relative levels over a 500-fold range. Second, we 
show that multiple BAC scaffolds can be used to drive sustained high-level transgene 
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expression driven by the UBC promoter without selection for up to 12 weeks, including 
BAC scaffolds containing no active transcription units. Third, we describe an episomal 
version of BAC TG-EMBED, where BAC transgenes form circular, ~1 Mb episomes and 
can be eliminated from the cells by removing selection. Fourth, we developed a “BAC-
MAGIC” (BAC-Modular Assembly of Genomic loci Interspersed Cassettes) to more 
rapidly assemble BACs containing multiple transgene expression cassettes. Finally, as a 
proof-of-principle demonstration of our new, more versatile BAC TG-EMBED toolkit, 
we demonstrate simultaneous expression of fluorescently tagged proteins labeling three 
different nuclear compartments, achieving >90% optimally labeled cell clones after a 




Overview of BAC TG-EMBED toolkit development  
We previously demonstrated the feasibility of the BAC TG-EMBED approach 
using both the DHFR BAC (Bian and Belmont, 2010) and a BAC containing the human 
GAPDH gene locus (GAPDH BAC) (Chaturvedi et al., 2018). We set out to extend this 
BAC TG-EMBED methodology in two new directions (Figure 2.1). 
First, to better control transgene expression and to be able to express multiple 
transgenes at reproducible expression ratios, we explored a set of constitutive promoters 
with various strengths for transgene expression. Testing each promoter with each BAC 
scaffold would have generated too large a number of possible combinations. We 
therefore decided to test a number of different promoters with the original DHFR BAC.  
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Second, we used one specific reporter gene construct to survey the effect of 
different BAC scaffolds on reporter gene expression. Previous applications of BAC TG-
EMBED used BAC scaffolds containing multiple endogenous genes which would also be 
expressed in addition to added transgenes. Here we compared BAC scaffolds containing 
expressed genes with BAC scaffolds from gene deserts or regions containing silenced 
genes. We assayed the level, stability, and reproducibility of the embedded reporter gene 
expression when inserted into different BAC scaffolds to identify optimal BAC scaffolds 
for the BAC TG-EMBED system. 
 
A toolset of 7 endogenous promoters for tuning relative transgene expression levels 
We selected 7 endogenous promoters to test, either because of their known ability 
and use to drive transgene expression in a range of cell types (EEF1α, UBC) (Mizushima 
and Nagata, 1990; Schorpp et al., 1996; Lois et al., 2002; Hong et al., 2007), or because 
these promoters were from housekeeping genes (RPL32, PPIA, B2M, RPS3A, GUSB) 
known to be expressed uniformly across a wide range of tissue types (de Jonge et al., 
2007; Hong Cai et al., 2007; Zhu et al., 2008; She et al., 2009). We amplified 1-3 kb of 
regulatory regions upstream of the transcription start sites of these genes using either 
human genomic DNA as a template or, for the UBC promoter, using the pUGG plasmid 
(Chaturvedi et al., 2018).  
To assay relative promoter strength, we used the two-minigene reporter system 
developed in our previous study in which we compared expression of CMV-driven EGFP 
and mRFP minigenes inserted in the same mouse DHFR BAC scaffold (Bian and 
Belmont, 2010). We previously showed that the mRFP minigene reporter expression 
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varied less than or equal to 2.4-fold when the mRFP reporter was inserted at 6 different 
positions ranging 3-80 kb away from the EGFP reporter gene location on the same BAC 
(Bian and Belmont, 2010). To compare relative promoter strengths, we fixed the insertion 
positions of mRFP and EGFP, and measured the relative fluorescence levels of mRFP 
and EGFP when they were both driven by the CMV promoter versus when the mRFP 
reporter was driven by an endogenous promoter (Figure 2.1). Thus our assay measured 
the strength of different endogenous promoters relative to the viral CMV promoter.  
For this assay, the EGFP reporter minigene was inserted 26kb downstream of the 
Msh3 transcription start site (Bian and Belmont, 2010) (Figure 2.2a). PCR-amplified 
promoters from 7 different housekeeping genes were cloned upstream of the mRFP 
expression cassette (Figure 2.2b), and then this mRFP expression cassette was introduced 
121 kb downstream of the Msh3 transcription start site by BAC recombineering (Figure 
2.2a), generating the dual reporter DHFR BAC. As a control, we used the dual reporter 
BAC previously constructed (Bian and Belmont, 2010) in which the same mRFP cassette 
driven by the CMV promoter was inserted at this same location 121 kb downstream of 
the Msh3 start site.  
Mouse NIH 3T3 fibroblasts were then stably transfected with these modified 
BAC constructs. After dual selection with G418 and Zeocin for two weeks, mixed 
populations of stable clones carrying the BAC transgenes were analyzed by flow 
cytometry to measure the relative expression ratio of mRFP and EGFP (Figure 2.2c). 
Fluorescent beads were used as an invariant fluorescence standard to calibrate the flow 
cytometer intensity outputs. The ratio of mRFP to EGFP expression was then normalized 
by the ratio observed with the original dual-reporter BAC construct in which both 
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reporters were driven by CMV promoter, providing the endogenous promoter strength 
relative to the CMV promoter.  
We observed an overall variation in promoter strength of over 500-fold, ranging 
from the 4-5 fold relative promoter strength of the RPL32 and EEF1α promoters to the 
0.01-fold relative promoter strength for the GUSB promoter as compared to the CMV 
promoter (Figure 2.2d).  
 
Reporter gene expression as a function of transcriptionally active and inactive BAC 
scaffolds 
To find the best BAC scaffold for the BAC TG-EMBED system, we tested BAC 
scaffolds from both actively transcribed regions and regions containing silenced genes or 
no genes. Specifically, we measured the expression as a function of copy number of one 
specific reporter gene construct inserted into these BAC scaffolds. Previous applications 
of BAC TG-EMBED showed a linear relationship between copy number and expression 
level, largely independent of the chromosome integration site, demonstrating copy-
number dependent, position independent transgene expression (Bian and Belmont, 2010; 
Chaturvedi et al., 2018). For active chromosomal regions, we chose the RP11-138I1 
BAC containing the human ubiquitin B gene locus (UBB BAC), the RP23-401D9 BAC 
containing the “safe-haven” mouse Rosa26 genetrap locus (ROSA BAC) (Zambrowicz et 
al., 1997), and the CITB-057L22 BAC carrying the mouse Dhfr gene locus (DHFR 
BAC). For inactive chromosomal regions, we chose the CTD-2207K13 BAC (2207K13 
BAC) that contains no known gene or regulatory element from a gene-desert region from 
the human genome, and the CTD-2643I7 (HBB BAC) containing the human HBB gene 
 22 
locus and multiple olfactory genes, all of which are transcriptionally silenced in 
fibroblasts (Bertulat et al., 2012).  
We selected the UBC promoter for this reporter gene cassette as this promoter had 
previously been shown to drive high expression across multiple cell types (Lois et al., 
2002); in our dual reporter system the UBC promoter was 2.6-fold stronger than the 
CMV promoter (Figure 2.2d). Moreover, to eliminate any possible transcriptional 
interference from closely spaced reporter and selectable marker minigenes and to 
minimize any epigenetic silencing arising from DNA methylation of this reporter gene-
selectable marker construct, we used a commercially available GFP-ZeoR fusion protein 
gene construct in which all CpG dinucleotides had been removed and replaced by 
synonymous codons (Figure 2.3a).  
We inserted this UBC-GFP-ZeoR reporter gene construct into different BAC 
scaffolds by BAC recombineering, using galK for positive/negative selection (Warming 
et al., 2005; Khanna et al., 2013). To eliminate potential artifacts caused by proximity to 
active promoters, transcriptional start sites (TSS), or miRNA sequences, we chose 
insertion sites flanked on both sides by at least 5 kb free of such sequence elements 
(Figure 2.3b). The UBB, HBB, 2207K13, ROSA, DHFR BACs with the UBC-GFP-ZeoR 
reporter gene insertion were named as UBB-UG, HBB-UG, 2207K13-UG, ROSA-UG 
and DHFR-UG. 
After transfection, multiple cell clones (n=20-40) carrying stably integrated BAC 
arrays were selected for Zeocin resistance and analyzed for reporter gene expression by 
flow cytometry, using untransfected NIH 3T3 cells to determine background, 
autofluorescence levels. For each cell clone, we used flow cytometry to measure the 
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mean GFP reporter expression and qPCR to measure reporter gene copy number. These 
cell clones showed GFP fluorescence mean levels ranging from 10-1000 fold higher than 
the background autofluorescence.  
Our original working hypothesis predicted that the BAC TG-EMBED reporter 
expression should be uniform in all cells of the same clone. Also, we expected to see a 
linear relationship between mean reporter gene fluorescence and number of BAC copies, 
signifying a copy-number-dependent, position independent expression. Furthermore, we 
expected that the slope of this linear relationship would be higher for BAC scaffolds 
expected to reconstitute an active chromatin environment permissive for transgene 
expression as compared to BAC scaffolds expected to reconstitute a more condensed, 
inactive chromatin environment (Figure 2.1). In contrast, we expected that the reporter 
gene cassette transfected without any BAC scaffold would show clonal expression levels 
that poorly correlated with reporter gene copy number (copy-number-independent 
expression). 
Unexpectedly, the stable cell clones we isolated showed two distinct types of 
population expression profiles- uniform versus heterogeneous. Uniform clones showed 
single, relatively narrow expression peaks in the flow cytometry histograms, with more 
than 90% of the cells showing GFP fluorescence varying only over a 10-fold intensity 
range (Figure 2.3c, left). Heterogeneous clones instead showed two peaks with a range of 
GFP expression varying ~1000-fold, with the lower GFP intensity peak overlapping with 
the autofluorescence distribution of control cells (Figure 2.3c, right). We had not 
previously observed such heterogeneous expression profile using our original DHFR 
BAC containing the CMV-driven mRFP alone or both the CMV-driven EGFP and CMV-
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driven mRFP reporter genes (Bian and Belmont, 2010). However, we had observed 
~80% uniform clones for a GAPDH BAC scaffold with the UBC-GFP-ZeoR reporter 
gene inserted (Chaturvedi et al., 2018). The percentage of clones showing such 
heterogeneous expression varied from 58% to 83% for the 5 BAC scaffolds surveyed 
here (Table 2.1). No similar heterogeneous expression profile was observed when the 
reporter gene construct was transfected by itself (Table 2.1). 
As expected, the control transfection of the reporter gene cassette by itself 
resulted in copy-number-independent expression of the reporter gene (Figure 2.3d, 
R2=0.09), while the reporter gene embedded within the BACs yielded a linear 
relationship between reporter gene fluorescence for both uniform (black) and 
heterogeneous (red) BAC transgene clones (Figure 2.3d, R2=0.561 to 0.914).  
Surprisingly, we observed no more than a 4-fold variation in expression per copy 
number among the 5 different BAC scaffolds tested, with no obvious relationship 
between the observed slope and the type of BAC scaffold (Figure 2.3d). Although the 
transcriptionally active DHFR BAC produced the highest slope, the transcriptionally 
inactive HBB BAC and the 2207K13 BAC containing DNA from a gene desert produced 
the second and third highest slopes, while the BAC containing DNA from the “safe 
haven” mouse Rosa26 locus produced the lowest slope.  
Overall, these results show that for this UBC-GFP-ZeoR reporter gene, high-
level, copy-number-dependent transgene expression using the BAC TG-EMBED method 
does not require BACs containing active, housekeeping genomic regions, but can also be 
obtained from a wide range of BAC genomic DNA inserts, including gene-desert regions. 
This means BAC TG-EMBED can be used to drive expression of only the transgenes 
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added to the BAC scaffold, without overexpression of the genes contained within the 
BAC scaffold. 
 
Temporal stability of BAC-embedded reporter gene expression in uniform cell clones 
We previously showed that the BAC TG-EMBED method provided long-term 
stability of transgene expression in the presence of continued drug selection (Bian and 
Belmont, 2010). However, in the absence of drug selection we observed a 30-80% drop 
in expression over several months of cell passaging without any apparent drop in the 
integrated BAC copy number (Bian and Belmont, 2010).  
Here we determined the long-term stability of the UBC-GFP-ZeoR reporter gene 
expression for both uniform and heterogeneous clones for four different BAC scaffolds. 
Individual clones for each BAC scaffold (3 uniform and 2 heterogeneous for ROSA-UG 
BAC, 7 uniform and 4 heterogeneous for 2207K13-UG BAC, 8 uniform and 3 
heterogeneous for UBB-UG BAC, and 3 uniform and 3 heterogeneous for DHFR-UG 
BAC) were passaged up to three months in the absence or presence of drug selection and 
analyzed for reporter gene fluorescence at regular intervals after removal of drug 
selection.  
With the exception of a small number of apparent fluctuations possibly related to 
transient changes in culture conditions, clones with uniform reporter gene expression 
showed no significant change either in the mean fluorescence values (Figure 2.4a) or in 
the distribution of fluorescence among the same clones (Figure 2.4b and Figure A.1) over 
time in the absence of selection for all four BAC scaffolds tested. In the presence of 
continued selection, uniform clones containing DHFR-UG or ROSA-UG BACs showed 
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no significant reporter gene expression change, while an ~50% or 100% increase was 
observed for the UBB-UG or 2207K13-UG BAC clones, respectively (Figure 2.4a). No 
changes in estimated BAC copy number based on qPCR measurement were observed for 
any of these clones during this time series. This suggests that epigenetic changes driven 
by selection pressure may be responsible for these small increases in reporter gene 
expression. 
Notably, in the absence of selection, heterogeneous clones for all tested BAC 
scaffolds showed a significant and progressive loss of reporter gene expression over time. 
This led to a significant fraction of cells showing autofluorescence levels of fluorescence 
by the end of the experiment (Figure 2.4a). Reporter gene expression-level became 
progressively more homogenous, but at lower fluorescence levels (Figure 2.4b and Figure 
A.1). With selection, UBB-UG and DHFR-UG BAC heterogeneous clones showed a 1.6 
to 3-fold increase in reporter gene expression, respectively, while the other BAC scaffold 
heterogeneous clones showed no significant changes (Figure 2.4a). 
 
BAC transgenes are maintained as episomes in heterogeneous clones 
In our previous work, all stable cell clones obtained after BAC transfection and 
drug selection contained single BAC copies or multi-copy BAC arrays that had integrated 
into endogenous chromosomes (Hu et al., 2009; Bian and Belmont, 2010; Hu, Plutz and 
Belmont, 2010; Sinclair et al., 2010; Bian et al., 2013) consistent with similar results 
from numerous laboratories. Thus, we initially assumed that the broad distribution of 
reporter gene fluorescence observed in heterogeneous cell clones was due to position 
effect variegation (PEV) of the BAC TG-EMBED reporter genes. We hypothesized that 
 27 
integrations into some chromosome integration sites led to uniformly-expressing clones, 
while integration into other chromosome sites prone to PEV led to heterogeneous clones 
with variegated transgene expression. 
However, the observation of a progressive loss over time of reporter gene 
expression for all heterogeneous clones led us to question the genome stability of the 
BAC transgenes in these clones. To test the relationship between changes in reporter gene 
expression and BAC copy number, we first sorted cells from the heterogeneous DHFR-
UG-s3 cell clone by fluorescence-activated cell sorting (FACS), using a narrow sorting-
window centered around the GFP peak fluorescence level (Figure 2.5a). After cell-
sorting, with drug selection the original heterogeneous reporter gene expression 
distribution reestablished itself within one week of culture (Figure 2.5b). We then 
resorted cells showing different levels of GFP fluorescence using four narrow 
fluorescence windows P1, P2, P3, and P4 (Figure 2.5b), and then used qPCR to measure 
the BAC copy number in cells from each of these sorting windows. Plotting mean cell 
fluorescence intensity levels versus copy number for these clonal subpopulations yielded 
a strikingly linear relationship (R2=0.99) (Figure 2.5c). Thus, the variable reporter gene 
expression level in this heterogeneous cell clone is the result of loss of BAC transgenes 
rather than chromosome PEV. 
To identify the source of this BAC copy-number instability, we next used DNA 
FISH to visualize BAC transgenes within interphase nuclei and mitotic chromosome 
spreads. We compared the distribution of BAC transgenes within the heterogeneous 
clone, DHFR-UG-s3, versus a uniform clone, DHFR-UG-f3-15. 
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DNA FISH suggested that whereas the uniform clone contained cells with an 
integrated DHFR BAC array, the heterogeneous clone contained cells in which the 
DHFR BAC was present as episomes. Specifically, interphase FISH against the DHFR 
BAC in the heterogeneous clone revealed multiple, noncontiguous, small spots 
distributed randomly throughout the nuclei (Figure 2.5d). The number of these spots was 
highly variable in different cell nuclei, suggesting unequal segregation of BAC 
transgenes. In contrast, most cells from the uniform clone showed just one large, fiber-
like FISH spot per nucleus (Figure 2.5e). Moreover, FISH spots in mitotic spreads from 
the heterogeneous clone were either touching or spatially separated from the 
chromosomes (Figure 2.5f), whereas FISH spots in mitotic spreads from the uniform 
clone were always located within the chromosome (Figure 2.5g). The number of FISH 
spots per mitotic spread was highly variable in the heterogeneous clone, with each spot 
much smaller than the single FISH spot visualized within the mitotic chromosome from 
the uniform clone. Interestingly, the FISH spots in the heterogeneous clone mitotic 
spreads had weak DAPI staining, varying from slightly elevated over background to no 
difference from background (Figure 2.5h), suggesting these structures are much smaller 
than previously described double minute chromosomes (DMs) generated by gene 
amplification (Carroll et al., 1988; Schwab and Amler, 1990; L’Abbate et al., 2014). 
Using DNA FISH of both interphase nuclei and mitotic spreads, we confirmed 
this finding of integrated BACs in uniformly expressing clones versus episomal BACs in 
heterogeneously expressing clones in additional cell clones carrying BAC transgenes 
based on three different BAC scaffolds (FigureA.2 and data not shown- 3 heterogeneous 
and >3 uniform clones for both DHFR and HBB BAC scaffolds).  
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Unequal segregation of these BAC episomes during cell division would explain 
the heterogeneity of BAC transgene copy number in the cell population of heterogeneous 
clones, leading to variability of reporter gene expression. Indeed, telophase cells from 
heterogeneous clones showed unequal numbers of FISH spots in the two daughter nuclei 
(Figure 2.5i). In the absence of continued drug selection, we would expect cells that have 
lost BAC transgenes will accumulate if there is any selective growth advantage for cells 
with fewer BAC copies. 
 
BAC episomes are circular and ~1 Mb in size 
We analyzed the average amount of DNA per BAC episome, using two 
independent methods- light microscopy and pulsed-field gel electrophoresis (PFGE). 
Both methods produced a similar estimate of ~800-1000 kb per BAC episome. 
Using light microscopy, we measured the average DHFR BAC episome DAPI 
integrated staining intensity in mitotic spreads from cell clone DHFR-UG-s3 relative to 
the smallest mouse chromosome (chr19) with known DNA content of 61.4 Mbp (Figure 
2.6a).  This comparison produced an estimated mean episome size of 770 kb in this 
DHFR-UG-s3 clone.  
Using PFGE, we observed that the BAC episomes were circular and estimated the 
modal BAC episome size to be ~900 kb and 1 Mbp for DHFR-UG and HBB-UG BAC 
episomes in cell clones DHFR-UG-s3 and HBB-UG-100d3, respectively. Two different 
cell clones, DHFR-UG-f3-1 and HBB-UG-fD2, were used as negative controls as they 
contained the same DHFR-UG or HBB-UG BAC DNA as the cell clones with episomes 
but the BAC DNA was integrated within endogenous mouse chromosomes.  E. coli 
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strains containing the DHFR or HBB BACs were used as positive controls for detection 
of circular episomes.  
Pulsed-field gels were analyzed by Southern blotting using pooled BAC DNA 
PCR products as the hybridization probes. Linear but not circular DNAs migrate in 
pulsed-field gels. Similar to the E. coli controls containing circular BACs, the Southern 
blot signals for the BAC DNA from the two clones containing episomes did not migrate 
out of the wells (Figure 2.6b and FigureA.3a-b), consistent with circular rather than linear 
BAC episomes.  
To validate that the BAC episomes are really circular, and to estimate their size, 
the agarose-embedded DNA was digested using the ssDNA specific Nuclease S1 prior to 
PFGE and Southern blot hybridization. After removal of proteins, circular DNA 
episomes in both bacteria and mammalian cells are typically negatively supercoiled. This 
supercoiling generates torsional stress which is relieved by local formation of single-
stranded regions. Thus, S1 nuclease has been used to cut these single-stranded regions 
and linearize circular DNA episomes (Barton, Harding and Zuccarelli, 1995; Walker, 
LeBlanc and Sikorska, 1997; Marasini and Fakhr, 2014).  After S1 digestion, DNA from 
the cell clones carrying BAC episomes now showed DNA smears with peak intensities of 
~900 kb and 1 Mb for the DHFR-UG-s3 and HBB-UG-100d3 cell lines, respectively 
(Figure 2.6b and Figure A.3a-b). In contrast, after S1 nuclease digestion, DNA from the 
integrated BAC clones showed signals within the wells and above 2 Mb, overlapping the 
smears of fragmented genomic DNA (Figure 2.6b and Figure A.3a-b). DNA of E. coli 
containing DHFR BAC and HBB BAC episomes produced bands at ~200-300 kb, in 
addition to signals in the wells (Figure 2.6b and Figure A.3a-b) after S1 nuclease 
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digestion. These estimated BAC sizes measured slightly larger than the actual BAC sizes 
(~200 kb), indicating there might be a slight overestimation of episome sizes using our 
PFGE running conditions.  
 
BAC episomes contain no detectable host DNA as revealed by CNV analysis 
The propagation of BAC transgenes as episomes was unexpected. A major 
question is whether these episomes consist solely of BAC DNA, or whether host DNA is 
also included and possibly required for episome propagation.  
We first compared the estimated episome DNA content size with estimates of 
BAC copies per episome. BAC episome sizes estimated by either light microscopy or 
PFGE were approximately twice as large as predicted from qPCR BAC copy number 
estimates (Table 2). The estimated average BAC content per episome was 445 kb in 
DHFR-UG-s3 and 716 kb in HBB-UG-100d3. 
The difference in the estimated BAC DNA content per episome and the average 
episome size is at most a few hundred kb, and may be accounted for by inaccuracies of 
the qPCR copy number, PFGE size estimation, and possible variation in sequence 
representation within the BAC episomes due to shearing of DNA and/or recombination 
during the transfection and creation of the BAC episomes.  
Alternatively, this difference in episome size versus qPCR estimation of BAC 
copies per episome could also be caused by presence of host cell genomic DNA on the 
episomes. To search with higher sensitivity for the possible presence of host DNA within 
the episome, we performed Whole Genome Sequencing (WGS) based copy number 
variation (CNV) analysis of the two clones, DHFR-UG-s3 and HBB-UG-100d3. 
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Genomic regions present on the episomes would appear amplified in cells containing 
episomes (test sample), comparing to cells with no episomes (reference sample). Thus the 
ratio in the number of reads for a given bin between the test sample and the reference 
sample was calculated. To reduce noise, bins were merged into segments based on the 
log2(ratio), using a circular binary segmentation (CBS) algorithm (Olshen et al., 2004; 
Venkatraman and Olshen, 2007). The mean log2(ratio) of each segment was used to 
estimate the CNV of this segment in the test sample relative to the reference sample. 
Mouse 3T3 cells show genomic instability; therefore we anticipated CNV 
between the parental cell line and individual clones. To reduce false-positives derived 
from CNV between different 3T3 clones, independent of episome content, we used cells 
with low reporter gene fluorescence sorted from the cell clone containing the episomal 
BAC transgenes (region L, Figure 2.6c-d, and Figure A.4a) as the reference sample. To 
further reduce false positives, we also imposed constraints that copy number increase for 
true positive regions should be reproducible between experimental replicates and 
correlate with episomal copy number. We calculated the estimated CNV in cells sorted 
with high (H2) reporter gene expression, using sorted cells with low (L) expression as the 
reference sample (H2, L, Figure 2.6c-d, and Figure A.4a). We also compared the 
estimated CNV in cells sorted with high reporter gene expression in an independent 
experiment (H1, Figure 2.6c-d, and Figure A.4a) with the estimated CNV from the first 
experiment. All samples were sequenced to ~2x coverage.  
We used 3 and 30 kb bin sizes for analysis. To reduce noise, we excluded all bins 
in the test sample with zero reads (5.5% of total bins for 3 kb bin analysis and 3.5% for 
30 kb bin analysis) plus extreme outlier bins, defined by the lower quantile minus 4 times 
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the interquantile distance, with unusually low read count (~0.5% of total bins for 3 kb bin 
analysis and 2.5% for 30 kb bin analysis) in the test sample before calculating ratios. 
As a test of our analysis method, we compared the mean segment log2(ratio) of 
the BAC regions in H1 and H2, generated by the above analysis method, to the fold 
increase of BAC regions in H1 and H2 relative to L measured by qPCR. As expected, the 
results from the CNV and qPCR analysis were very similar (Figure A.5). 
We were interested in asking whether a specific host DNA element was present 
on each episome copy present within a cell clone. We estimated that on average the 
sorted cells with high reporter gene expression had 15-20 episome copies per cell, 
depending on the cell clone, based on qPCR of BAC DNA sequences and the estimated 
number of BACs per episome (Table 2.3). 
We estimated theoretical minimum copy number increase for episome-localizing 
host DNA (minimum increase) in the H1 and H2, based on BAC copy number measured 
by qPCR, and assuming the NIH 3T3 to be tetraploid and each episome to have the same 
host cell genomic DNA (Table 2.3). Segments with mean log2(ratio) equal to or greater 
than log2(minimum increase) in both H1 and H2 samples were selected as candidates for 
being on the episomes (Figure 2.6e).  
Interestingly, all candidate segments identified belonged to the BAC regions, 
including the UBC-GFP-ZeoR and the BAC vector (Figure 2.6f-g, Figure A.4b-c and 
Figure A.6), and no other mouse genomic sequence satisfied all of the above conditions.  
In conclusion, we could not detect host cell DNA reproducibly present on all 
episomal copies using bin sizes of either 3 or 30 kb. We therefore conclude BAC DNA 
itself is sufficient for the creation and propagation of these BAC episomes. We cannot 
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exclude the possibilities, however, that an unmappable, repetitive host DNA sequence is 
present on the episomes and confers their ability to propagate or that different host DNA 
sequences are present on each episome present within a single cell clone. 
 
Multiple promoters added to BACs support formation of episomal BAC transgenes 
but only in certain cell lines 
Because we did not observe episomal BAC transgenes in our original BAC-TG 
EMBED work using the CMV-mRFP-SV40-ZeoR reporter gene (Bian and Belmont, 
2010), we hypothesized that addition of the UBC-GFP-ZeoR reporter gene might be 
responsible for BAC episome formation. Our dual-reporter assay showed that the UBC 
promoter was much stronger than the CMV promoter; therefore, we further hypothesized 
that promoter strength might correlate with the frequency of BAC episome formation.  
To test this hypothesis, we isolated clones stably transfected with the dual-
reporter DHFR BAC transgenes and examined reporter gene expression patterns in these 
clones by flow cytometry (Figure A.7a). As expected, no heterogeneously GFP/RFP 
expressing clones where observed when the mRFP reporter gene was driven by CMV 
promoter (n=13) or B2M promoter (n=6). In contrast, we observed ~70% or ~30% 
heterogeneously GFP/RFP expressing clones when the mRFP was driven by the EEF1a 
promoter (12/18) or the RPL32 promoter (10/29), respectively (Figure A.7a-b). We 
confirmed that BAC transgenes in these heterogeneously expressing clones were 
episomal using DNA FISH (Figure A.7c).  
These results using human promoter sequences added to the BACs, did show a 
rough correlation of promoter strength with the frequency of clones containing episomes. 
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However, when we examined a series of DHFR BAC constructs, we instead observed 
clones with episomes using BAC transgenes containing the dual reporter, selectable 
marker CMV-mRFP-SV40-ZeoR reporter cassette. This included the identical DHFR 
BAC construct used in our previous BAC-TG EMBED work (Bian and Belmont, 2010), 
as well as various DHFR BAC deletions (Figure A.8a). All the DHFR BAC constructs 
contain LacO repeats, and a NIH 3T3 derived clone expressing EGFP-LacI was used for 
transfection, so that BAC transgenes could be observed directly in fixed cells. Although 
all clones showed a unimodal flow cytometry expression pattern, explaining why we did 
not observe this phenomenon previously, a large fraction (DHFR-c27: 1/2, DHFR-c27d2: 
2/10, DHFR-c27d3crz: 2/16, DHFR-c27d4: 7/10) of clones showed episomal BAC 
transgenes (Figure A.8b-c).  
Thus, the promoter used to drive reporter and/or selectable markers appears to 
determine not whether episomal BAC transgenes are established but rather whether a 
unimodal versus bimodal distribution is observed in cells containing these episomal BAC 
transgenes. The presence of strong promoters (UBC, EEF1a and RPL32) appears to allow 
the formation of bimodal distributions of reporter gene expression, possibly related to the 
balance between the degradation rate of the initially high levels of selectable marker 
versus the rate of loss of BAC transgene episomes during cell division. 
Next, we tested whether BACs can form episomes in a different cell line other 
than mouse NIH 3T3 fibroblasts. Previously, we observed cell clones containing only 
integrated BAC transgenes in CHO (Hu et al., 2009; Hu, Plutz and Belmont, 2010) and 
mouse ES cells (Sinclair et al., 2010; Chaturvedi et al., 2018). Reasoning that cancer 
cells with some level of genomic instability might be more prone to formation of BAC 
 36 
episomes, we tested the human colorectal carcinoma epithelial cell line, HCT116, using 
the 2207K13-UG BAC which produced 79% episome clones in NIH 3T3 cells.  
Four out of 32 stable clones showed a heterogeneous GFP distribution similar to 
that observed in NIH 3T3 episome clones, with a broad high fluorescent peak and a 
tail/secondary peak near the auto-fluorescence level (Figure A.9). However, none of these 
four clones showed episomal BAC transgenes by DNA FISH (Figure A.10a). Instead, 
most cells in each clone showed the same number (one or two) of spots, but these spots 
varied in size from cell to cell. Therefore, it appears that the broad GFP peaks in these 
four clones are due to some form of genomic instability leading to CNV of integrated 
transgene arrays. Interestingly, one clone, HCT116-k13_06, out of the 32, which had a 
single GFP peak, showed a small fraction of cells of with episomal BAC transgenes, in 
contrast to the vast majority of cells which contained integrated BAC transgenes (Figure 
A.10b). One out of 24 subclones of this HCT116-k13_06 clone, HCT116-k13_06-10, 
showed a similar mixed population with either integrated BACs or episomal BACs, 
similar to the parent clone HCT116-k13_06 (Figure A.10c). The low frequency of clones 
with episomal BACs, the variable size of the integrated BAC transgene arrays, and the 
co-existence of integrated and episomal BAC transgenes in the same cells and from the 
same clone suggests these episomes might arise from the well-known phenomenon of 
gene amplification (Carroll et al., 1988; Schwab and Amler, 1990; L’Abbate et al., 
2014).  
Similarly, a small percentage of clones carrying the GAPDH BAC in stable 
mouse ES cell colonies showed broad GFP expression peaks by flow cytometry, but 
FISH revealed this was due to variable size, integrated BAC transgene arrays (Appendix 
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B), due presumably to some type of CNV induced by genomic instability of these 
transgene arrays.  
In conclusion, the high frequency establishment of BAC transgene episomes seen 
in mouse 3T3 cells does not appear to occur in either HCT116 or mouse ES cells, or at 
detectable frequency in CHO cells (Hu et al., 2009; Hu, Plutz and Belmont, 2010; 
Sinclair et al., 2010; Chaturvedi et al., 2018).  
 
Expression of multiple-reporters by BAC-MAGIC 
As a proof-of-principle application of our improved toolkit for BAC TG-EMBED, 
we created a multi-transgene BAC to label simultaneously the nuclear lamina, nucleoli, 
and nuclear speckles with a single stable transfection. The original DHFR BAC was used 
for this multi-transgene expression. A SNAP-tagged Lamin B1 reporter mini-gene was 
used to label the nuclear lamina, a SNAP-tagged Fibrillarin the nucleoli, and an mCherry-
Magoh the nuclear speckles. We used the RPL32 promoter to drive the expression of the 
SNAP-tagged Lamin B1, and a promoter of intermediate strength, PPIA, for the SNAP-
tagged Fibrillarin and the mCherry-tagged Magoh, which are both abundant proteins.  
Previously, we used random Tn5 transposition to introduce expression cassettes 
into BAC scaffolds (50), but this approach is limited in the number of serial insertions 
that can be made due to the remobilization of existing transposons, its requirement for 
multiple selectable markers, and the randomness of the insertion sites. Alternatively, 
BAC recombineering using antibiotic resistance genes as positive selectable markers 
have been used to insert expression cassettes into precise locations on the BACs. 
However, like transposition, this method relies on the availability of multiple selectable 
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markers and introduces unwanted selectable markers into the BACs. An alternative BAC 
recombineering scheme using cycles of galK-based positive selection to insert sequences 
followed by negative selection to remove galK have been used to make multiple BAC 
modifications without addition of unwanted selectable markers. However, the low 
efficiency of negative selection, due to a high background of competing, spontaneous 
deletions of mammalian DNA with its high repetitive DNA content, makes this approach 
quite time and labor intensive. Typically, one month is required for each cycle of 
insertion of DNA by positive selection, removal of the selectable marker by negative 
selection, and subsequent screening and testing of DNA from colonies that survive the 
negative selection to identify the small fraction of colonies containing the desired 
homology-driven, specific deletion of just the selectable marker. 
To accelerate creation of BACs containing multiple transgene, we created a new 
BAC assembly approach, BAC MAGIC (BAC-Modular Assembly of Genomic loci 
Interspersed Cassettes). BAC MAGIC combines the DNA assembler method in yeast 
(Shao, Zhao and Zhao, 2009; Shao and Zhao, 2012) and/or Gibson assembly (Gibson et 
al., 2009) with traditional cloning methods to create a number of BAC recombination 
modules followed by sequential rounds of BAC recombineering in which one fragment is 
inserted using one selectable marker followed by addition of a new fragment overlapping 
the previous fragment using a second positive selectable marker which replaces the first 
(Richardson et al., 2017). Each round of fragment insertion only requires ~ 1 week for 
transformation and screening of clones. In this way, 45 kb of the DHFR BAC was 
effectively reconstructed such that DHFR sequences remained but 3 fluorescent mini-
gene expression cassettes were added, each spaced by ~10 kb of DHFR sequence (Figure 
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2.7a-b, Figure A.11). The large homologous sequences flanking each expression cassette 
reduces recombination between similar sequences in other expression cassettes already 
inserted into the BAC, increasing the efficiency of this overall approach.  
We began the process using a DHFR BAC. After six rounds of BAC 
recombineering, we had created a BAC with four expression cassettes (Figure 2.7b): a 
SNAP-tagged Lamin B1 minigene, a SNAP-tagged Fibrillarin minigene, a mCherry-
Magoh minigene, and a ZeoR selectable marker. 
We tested simultaneous expression of the three reporters in 17 independent NIH 
3T3 cell clones transfected with the multi-reporter BAC by examining fluorescence in 
fixed cells under a microscope (SNAP-tagged proteins were labeled with a Fluorescein 
conjugated SNAP tag substrate before fixation). We observed uniform expression of all 
the three reporters in 16/17 clones. The loss of SNAP-Lamin B1 expression in one of the 
clone (Cl#16) may be due to random breakage of the BAC during transfection, as PCR 
revealed the absence of this minigene from the cell clone. Similarly, 12/14 U2OS human 
osteosarcoma cell clones showed both SNAP-Lamin B1 and SNAP-Fibrillarin expression 
after transfection of a BAC containing only these two expression cassettes (data not 
shown).  
Within individual cells, a linear correlation was observed between the integrated 
fluorescence intensity per cell of SNAP-tagged proteins Lamin B1 and Fibrillarin versus 
mCherry-Magoh in 4/4 representative NIH 3T3 clones (04, 08, 13 and 14, Figure 2.7c). 
Moreover, these fluorescently tagged proteins showed uniform rather than variegating 
expression in different cell nuclei of the same clone observed under the microscope 
(Figure 2.7d).  
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DISCUSSION 
We previously demonstrated the utility of the BAC TG-EMBED method to 
achieve position-independent, copy-number-dependent, one-step transgene expression in 
mammalian cells (Bian and Belmont, 2010; Chaturvedi et al., 2018). Here, we have 
extended the BAC TG-EMBED methodology through four new advances and provided a 
proof-of-principle demonstration of this new methodology by efficiently creating cell 
lines stably expressing uniform levels of three different fluorescently tagged proteins- 
Lamin B1, Fibrillarin, and Magoh in a single stable transfection. 
First, we describe a toolkit of endogenous promoters providing an ~500-fold 
range in promoter strength varying from ~5 fold higher to ~100-fold weaker than the 
commonly used viral CMV promoter. As these promoters are from human genes shown 
to be expressed in a wide range of cell lines and tissues (Mizushima and Nagata, 1990; 
Schorpp et al., 1996; Lois et al., 2002; de Jonge et al., 2007; Hong Cai et al., 2007; Hong 
et al., 2007; Zhu et al., 2008; She et al., 2009), we expect them to support transgene 
expression in most cell types and independent of cell proliferation or differentiation state. 
While most of the previous studies on transgene promoters focused on conventional, 
strong promoters (Hong et al., 2007; Qin et al., 2010; Chen et al., 2011; Zboray et al., 
2015), we included weak promoters and promoters that have not been widely used in our 
survey. The weak promoters we identified, such as GUSB and RPS3A, could possibly 
replace the commonly used minimal promoters or prokaryotic inducible promoters where 
a sustained low-level of transgene expression is needed. Moreover, this wide range of 
promoter strengths allows reproducible expression of multiple transgenes over a wide 
range of relative expression levels from a single BAC scaffold.  
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Second, we show that with the UBC-GFP-ZeoR reporter gene, our BAC-TG 
EMBED system achieved stable reporter gene expression of integrated BAC transgenes 
for several months in the absence of drug selection. This is an improvement over the 30-
80% drop in expression observed originally with the CMV-mRFP-SV40-ZeoR reporter 
gene (Bian and Belmont, 2010). Both the UBC promoter and the CpG free GFP-ZeoR 
gene body could be contributing to this improvement. 
Third, we show that at least with the UBC-GFP-ZeoR expression cassette, our 
BAC TG-EMBED system is not dependent on BAC scaffolds containing active DNA 
genomic regions but also works with BAC scaffolds containing silenced DNA genomic 
regions as well as gene deserts. UBC may represent a member of a class of active, house-
keeping gene promoters that is relatively insensitive to chromosome position effects. This 
allows choice of a BAC scaffold for the BAC TG-EMBED method that will not co-
express any genes other than the introduced transgene cassettes. In contrast, both our 
previous BAC TG-EMBED studies (Bian and Belmont, 2010; Chaturvedi et al., 2018) 
and similar work from other laboratories (Blaas et al., 2009; Zboray et al., 2015), used 
only BACs containing highly-transcribed house-keeping genes, due to the assumption 
that either an active chromatin region or active 5’ cis-regulatory regions would be 
required for creating a transcriptionally permissive environment for transgene expression. 
Integration of the UBC-GFP-ZeoR reporter gene into the BAC was required for position-
independent, copy-number dependent expression, as its expression was copy-number 
independent when the same UBC-GFP-ZeoR reporter gene was stably transfected by 
itself into cells. The expression levels of this UBC-GFP-ZeoR were similar, per copy 
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number, in cell clones with episomal BAC transgenes to levels in clones with integrated 
BACs.  
Fourth, we describe an episome version of our BAC-TG EMBED system. In a 
single experiment, clones containing either stably integrated or extrachromosomally 
maintained BAC transgenes can be isolated. Most of the widely used episomal vectors 
are either based on viral sequences or derived from the non-viral pEPI plasmid (Van 
Craenenbroeck, Vanhoenacker and Haegeman, 2000; Conese, Auriche and Ascenzioni, 
2004; Ehrhardt et al., 2008; Lufino, Edser and Wade-Martins, 2008). A notable feature of 
the episomes generated by our BAC TG-EMBED system is that they are lost rapidly in 
the absence of drug selection, whereas both of the other two systems show selection-
independent mechanisms for stable episome maintenance (Piechaczek et al., 1999; Baiker 
et al., 2000; Jenke et al., 2004; Nanbo, Sugden and Sugden, 2007; Stehle et al., 2007; 
Argyros et al., 2008). While episome stability is valuable for certain applications, in other 
cases one would like to be able to easily eliminate the episomes as needed. Moreover, in 
contrast to the low copy number of episomes per cell produced using the other two 
methods, the BAC TG-EMBED method yields tens of BAC copies per cell allowing for 
much higher transgene expression levels. Additionally, the sizes of the episomes 
generated by the BAC TG-EMBED method are much larger than those generated by the 
other two methods. In the two clones we examined, the episomes were ~1 Mb and 
containing several copies of the BACs per episome and no detectable host DNA.  
The high frequency creation and simple composition of these BAC episomes 
contrasts with human artificial chromosomes (HACs), which are special episomes, 
usually 1-10 Mb in size containing centromeric repeat sequences, mitotically stable, and 
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maintained at low copy number (Harrington et al., 1997; Mills et al., 1999; Kazuki and 
Oshimura, 2011; Kouprina et al., 2013). Capable of introducing large DNA sequences 
into recipient cells, HACs have shown great potential in a wide range of applications, 
such as recombinant protein production, drug selection and gene therapy (Kazuki et al., 
2010; Takahashi et al., 2010; Hiratsuka et al., 2011; Kim et al., 2011). However, the 
construction of HACs remains non-trivial: it requires cloning of either telomere 
sequences and/or alphoid DNA, the formation of HACs occurs at very low frequency and 
only in certain cell lines (Larin and Mejía, 2002), and the transfer of HACs from donor 
cells into recipient cells is difficult (Fournier and Ruddle, 1977; Liskovykh et al., 2016). 
Moreover, the presence of large telomere sequences and/or alphoid DNA on the HACs, 
and the heterchromatic state associated with these repeats, increases the likelihood of 
transgene silencing.  
In contrast, with our BAC-TG EMBED system, 10s-100s of stable cell clones 
containing multiple copies of ~Mb-size episomes, likely containing only BAC DNA, can 
be obtained from a single transfection. Cells containing high copy numbers of these BAC 
episomes can be enriched by flow sorting, while cells from these clones containing no 
BAC episomes can be recovered after removal of drug selection and/or flow sorting. We 
anticipate that with additional engineering, these BAC episomes might possibly become a 
high-capacity episome system complementary to HACs, assuming they can be isolated 
from one cell line and then introduced and propagated in other cell lines.  
It remains unclear how these BAC episomes form in NIH 3T3 cells and why they 
do not do so in other cell lines. In the two clones we studied, the episomes were circular 
DNA and composed of several BAC copies. Interestingly, previous studies have shown 
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that plasmids containing a MAR that is also a replication initiation region (IR) could 
initiate gene amplification in certain primary cancer cells, forming homogenously 
staining regions (HSRs), integrating into existing double minutes (DMs) or forming DMs 
de novo in cells without DMs (Shimizu et al., 2001, 2003). It is believed that the IR/MAR 
plasmids are initially replicated as extrachromosomal circles, and then they multimerize 
into larger circular molecules. These amplified circles further multimerize to form DMs, 
recombine with pre-existing DMs or integrate into chromosomes and initiate HSR 
formation (Shimizu, Shingaki and Kaneko-sasaguri, 2005; Shimizu, 2009). This model is 
very similar to the episome model of gene amplification, where instead of the IR/MAR 
plasmids, small extrachromosomal circular DNAs, which are several hundred kb in size 
and are possibly produced by small chromosome deletions, initiates DM and HSR 
formation (Carroll et al., 1988; Schoenlein et al., 1992; L’Abbate et al., 2014).  
Given that both the MAR and IR sequences are ubiquitous in the mammalian 
genome, it is likely that the BACs used in this study also contain MAR and/or IR 
sequences. However, unlike the MAR/IR plasmids, these BACs did not generate typical 
HSRs when integrated into the chromosomes, and the episomes were much smaller than 
DMs in NIH 3T3 cells. One possible explanation is that the BACs undergo initial steps of 
gene amplification to form the episomes in NIH 3T3 cells, but the cells have mechanisms 
to stop the episomes from further multimerization or amplification. As gene amplification 
happens only in cancer cells, perhaps BACs can only form episomes in certain cell lines. 
As shown here, BAC transgene formed episomes in a small fraction of HCT116 cells, 
which could not be stably maintained even with drug selection. Further study of this BAC 
episome phenomenon may provide new insights into the process of gene amplification.  
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Alternatively, the formation of BAC transgene episomes in NIH 3T3 cells might 
occur through a process completely unrelated to gene amplification. Future work will be 
needed to determine the actual mechanism of this BAC episomal formation in mouse 3T3 
cells. 
To facilitate the assembly of BACs expressing multiple mini-genes, we developed 
BAC-MAGIC, allowing creation of a multi-transgene expressing BAC in several weeks, 
rather than the 4-5 months which would have been required by multiple rounds of DNA 
insertion using conventional BAC recombineering. Initial attempts to reassemble large, 
~50kb regions of DHFR using yeast DNA assembly failed, apparently due to 
recombination between repetitive elements within the DHFR BAC sequence as well as 
the expression cassettes. In contrast, assembly of 10-15 kb modules from several DNA 
fragments using yeast DNA assembly worked with high efficiency. BAC-MAGIC 
exploits Gibson and yeast DNA assembly to build smaller modules with efficient serial 
BAC recombineering to reconstruct large BAC constructs containing multiple mini-gene 
expression cassettes. More generally, BAC-MAGIC should provide a tool for 
reconstruction of large eukaryotic DNA sequences containing high numbers of repetitive 
elements. 
Finally, as a demonstration of our new version of BAC TG-EMBED system, we 
created cell lines expressing three different fluorescently tagged proteins in a single stable 
transfection step requiring just several weeks to isolate and expand cell clones. Most cell 
clones expressed all three tagged proteins at uniform levels and at reproducible relative 
levels of expression. This contrasts with the 6-12 months we have devoted in previous 
studies to create similar cell lines expressing multiple tagged proteins (Khanna, Hu and 
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Belmont, 2014) through a series of individual transfections followed by extensive 
screening of colonies to identify the small fraction expressing suitable levels of tagged 
proteins with minimal variegation and/or progressive long-term transgene silencing over 
time. 
We anticipate that our expanded BAC TG-EMBED toolkit similarly will facilitate 
a wide range of applications requiring simultaneous expression of multiple transgenes.  
 
 
MATERIALS AND METHODS 
PCR amplification of endogenous promoters 
Primers (Data A.1) were designed using Primer3 (Rozen and Skaletsky, 2000) or 
NCBI primer blast (Ye et al., 2012) to amplify 1-3 kb promoter regions which included 
either the entire or part of the 5’ UTRs upstream of the first exons of target genes. We 
used human genomic DNA extracted from BJ-hTERT cells as the template for PCR. 
However, the UBC promoter, including a partially synthetic intron, was amplified from 
plasmid pUGG (Chaturvedi et al., 2018). 
 
Construction of dual reporter DHFR BACs 
The original dual reporter BAC, DHFR-HB1-GN-HB2-RZ (Bian and Belmont, 
2010), was derived from the CITB-057L22 BAC (DHFR BAC) containing mouse 
chr13:92992156-93161185 (mm9). DHFR-HB1-GN-HB2-RZ has an EGFP expression 
cassette inserted 26 kb downstream of the Msh3 transcription start site, and a mRFP 
expression cassette inserted at 121 kb downstream of the Msh3 transcription start site. 
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The EGFP expression cassette contains a CMV promoter-driven EGFP gene and a SV40 
promoter-driven Kanamycin/Neomycin resistance gene, while the mRFP expression 
cassette has a CMV promoter-driven mRFP gene and a SV40-driven Zeocin resistance 
gene. New dual reporter DHFR BACs were created using a similar strategy to that used 
to create DHFR-HB1-GN-HB2-RZ, except that new mRFP expression cassettes were 
used, where the CMV promoter was replaced with alternative, human endogenous 
promoters. The intermediate DHFR BAC containing only the EGFP expression cassette, 
DHFR-HB1-GN (Bian and Belmont, 2010), was used to insert these new mRFP 
expression cassettes using l Red-mediated homologous recombination (Warming et al., 
2005; Khanna et al., 2013). 
Plasmid p[MOD-HB2-CRZ] (Bian and Belmont, 2010) contains a CMV driven 
mRFP and a SV40 driven Zeocin resistance gene, flanked by two ~500 bp regions 
homologous to the DHFR BAC target site. Plasmid p[MOD-HB2-RCS-Zeo] was created 
by replacing the CMV-mRFP fragment between NotI and NheI sites of p[MOD-HB2-
CRZ] with a synthetic DNA fragment “RCS” containing multiple rare restriction sites 
(Table A.1). The mRFP fragment generated by digesting p[MOD-HB2-CRZ] with NheI 
was then inserted into the NheI site of p[MOD-HB2-RCS-Zeo], yielding plasmid 
p[MOD-HB2-RCS-RZ]. The PCR-amplified endogenous promoters were then inserted 
into the RCS, generating plasmids p[MOD-HB2-promoter name-RZ]. Promoter 
functionality was tested by transient transfection of NIH 3T3 cells with these plasmids. 
To insert the new mRFP expression cassettes into the DHFR-HB1-GN BAC, one 
round of l Red-mediated recombination, using Zeocin resistance as positive selection, 
was performed according to a published protocol (Khanna et al., 2013). DNA fragments 
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containing the new mRFP expression cassettes with a given promoter with flanking 
homologous arms were excised from p[MOD-HB2-promoter name-RZ] plasmids by 
PmeI. SW102, a derivative strain of Escherichia coli (E. coli), was used for 
recombination. Recombinants were selected on low-salt LB plates containing 25 µg/ml 
Zeocin and 12.5 µg/ml Kanamycin at 32°C for ~20 hours. Recombinant colonies were 
screened by PCR amplification of sequences flanking the site of insertion (primers listed 
in Data A.1). The integrity of BAC constructs was verified by restriction enzyme 
fingerprinting, where observed band patterns on agarose gels were compared with 
predicted ones.  
 
Construction of BACs containing the UBC-GFP-ZeoR cassette 
Construction of pUGG containing the UBC-GFP-ZeoR-FRT-GalK-FRT cassette 
was described previously (Chaturvedi et al., 2018). Human BACs RP11-138I1 (UBB 
BAC), CTD-2643I7 (HBB BAC), CTD-2207K13 (2207K13 BAC) and mouse BAC 
RP23-401D9 (ROSA BAC) were obtained from Thermo Fisher Scientific. Mouse BAC 
CITB-057L22 (DHFR BAC) was a gift from Edith Heard (Curie Institute, Paris, France).  
The UBC-GFP-ZeoR reporter gene insertion positions (mm9 or hg19) are 
chr17:16,301,887-16,301,888 in the UBB BAC, chr6:113,043,332-113,043,333 in the 
ROSA BAC, chr13:93,099,101-93,099,102 in the DHFR BAC, chr1:79,224,725-
79,224,726 in the 2207K13 BAC, and chr11:5,390,233-5,390,244 in the HBB BAC.  
l Red-mediated BAC recombineering (Warming et al., 2005; Khanna et al., 
2013) using a galK-based dual-selection scheme was used to introduce the UBC-GFP-
ZeoR reporter cassette onto the BACs according to published protocols (Khanna et al., 
 49 
2013). DNA fragments with homology ends for recombineering were prepared by PCR 
using primers (Data A.1) with 74-bp homology sequences plus 16-bp sequences 
(forward, 5’- acagcagagatccagt-3’; reverse, 5’-tgttggctagtgcgt-3’) that amplify the UBC-
GFP-ZeoR-FRT-GalK-FRT cassette from plasmid pUGG. E. coli strain SW105 was used 
for BAC recombineering. Recombinants containing the UBC-GFP-ZeoR-FRT-GalK-
FRT cassette were selected for galK insertion at 32°C on minimal medium in which D-
galactose was supplied as the only carbon source. Recombinant colonies were screened 
using PCR with BAC specific primers flanking the target regions (Data A.1). 
Subsequently, FLP recombinase-mediated removal of galK from selected recombinant 
clones was done by inducing actively growing SW105 cells with 0.1% (w/v) L-arabinose. 
Negative selection against galK used minimal medium containing 2-deoxy-galactose; 
deletion of galK in recombinants was again verified using BAC specific primers (Data 
A.1). The integrity of BAC constructs was verified by restriction enzyme fingerprinting.  
The UBB, HBB, 2207K13, ROSA, DHFR BACs with the UBC-GFP-ZeoR 
reporter gene inserted were named UBB-UG, HBB-UG, 2207K13-UG, ROSA-UG and 
DHFR-UG, respectively.  
 
Cell culture and establishment of BAC cell lines 
Mouse NIH 3T3 fibroblasts (ATCC CRL-1658TM) were grown in Dulbecco’s 
modified Eagle medium (DMEM, with 4.5 g/l D-glucose, 4 mM L-glutamine, 1 mM 
sodium pyruvate and 3.7 g/l NaHCO3) supplemented with 10% HyClone Bovine Growth 
Serum (GE Healthcare Life Sciences, Cat. # SH30541.03). Human HCT116 cells (ATCC 
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CCL-247TM) were grown in McCoy's 5A medium supplemented with 10% Fetal Bovine 
Serum (Seradigm, Cat. # 1500-500H). 
BAC DNA for transfection of mammalian cells was prepared with the QIAGEN 
Large Construct Kit (QIAGEN, Cat. # 12462) as per the manufacturer’s instructions. All 
BACs except DHFR BAC derived BACs were linearized before transfection: 2207K13-
UG BAC with SgrAI (New England Biolabs, Cat. # R0603S), HBB-UG BAC with NotI 
(New England Biolabs, Cat. # R3189S) and all other BACs with the PI-SceI (New 
England Biolabs, Cat. # R0696S). Lipofectamine 2000 (Thermo Fisher Scientific, Cat. # 
11668019) was used to transfect the cells with the BACs according to the manufacturer’s 
directions. The dual reporter DHFR BACs and the BACs containing the UBC-GFP-ZeoR 
reporter gene were transfected into NIH 3T3. The 2207K13-UG BAC was also 
transfected into HCT116. The DHFR BACs containing the Lac operator repeats were 
transfected into an NIH 3T3 cell clone 3T3_LG_C29 stably expressing the EGFP-dimer 
LacI-NLS fusion protein (EGFP-LacI) (Bian et al., 2013). Mixed clonal populations of 
stable transformants were obtained after ~2 weeks of selection (75 µg/ml Zeocin and 500 
µg/ml G418 for NIH 3T3 cells transfected with the dual reporter DHFR BACs; 75 µg/ml 
or 200 µg/ml Zeocin for NIH 3T3 or HCT116 cells, respectively, transfected with the 
BACs containing the UBC-GFP-ZeoR reporter gene; 75 µg/ml Zeocin and 200 µg/ml 
Hygromycin B for 3T3_LG_C29 transfected with the DHFR BACs); individual cell 
clones were obtained by serial dilution or colony picking using filter discs (Strukov and 
Belmont, 2008).  
To analyze the stability of reporter gene expression in NIH 3T3 cells, individual 
cell clones were grown continuously with or without Zeocin (75 µg/ml) selection for 96 
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days. We used the following clones (Figure 4 and Figure A.1): DHFR-UG BAC- f1-7, f3-
13, f3-15 (uniform), f1-6, f2-1, f2-3 (heterogeneous); ROSA-UG BAC- 2D6- 3C11, 3D7 
(uniform), 2C12, 3A1 (heterogeneous); UBB-UG BAC- 1C2, 1F1, 1F12, 2F5, 2G4, 4D3, 
5C1, 5C7 (uniform), 1A8, 1D5, 6H2 (heterogeneous); 2207K13-UG BAC- 3E3, 5C8, 
5E1, 6B9, 6E12, 6F4, 7B2 (uniform), 1E3, 6A2, 6C10, 7B9 (heterogeneous).  
 
Flow cytometry 
For analysis of reporter gene expression, cells were grown to ~40%-80% 
confluence, trypsinized, and resuspended in growth media at ~0.5-1 million/ml. For 
analysis of the expression of mRFP and EGFP, or mRFP alone, cell suspensions were run 
on a BD FACS AriaII (BD Biosciences) or a BD LSR Fortessa (BD Biosciences), using 
the PE channel (561 nm laser and 582/15 nm bandpass filter) for mRFP, and the FITC 
channel (488 nm laser, 505 longpass dichroic mirror and 530/30 nm bandpass filter) for 
EGFP. For analysis of GFP expression alone, the cell suspensions were run on a BD 
FACS Canto II Flow Cytometry Analyzer (BD Biosciences), using the FITC/Alexa 
Fluor-488 channel (488nm laser, 502 longpass dichroic mirror and 530/30 bandpass 
filter). Rainbow fluorescent beads (Spherotech, Cat. # RFP-30-5A) were used as 
fluorescence intensity standards. Each sample was run for 1-2 min or until the number of 
events after gating reached 10-20 thousand. 
For cell sorting, cells were resuspended at ~10 million/ml in growth media and 
run on a BD FACS AriaII for up to 30-40 minutes. Sorting windows are shown in the 
main and supplementary figures (Appendix A). 
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Estimation of relative promoter strength 
The red and green fluorescence of the mixed-clonal populations stably transfected 
with the dual-reporter DHFR BACs was measured by flow cytometry. The mean 
florescence values of all gated cells were divided by the bead intensity values for 
normalization. The ratio of normalized mRFP to normalized EGFP was calculated as a 
measure of promoter strength (Equation 2.1). All promoter strengths were then 
normalized with the CMV promoter strength (comparing the CMV-driven mRFP to the 
CMV-driven EGFP expression) to calculate the relative promoter strength (Equation 2.2) 











Genomic DNA extraction 
Genomic DNA was isolated by phenol/chloroform extraction (Sambrook and 
Russell, 2006b). Cultured cells were harvested and washed with 1x Cell Culture Phosphate 
Buffered Saline (PBS, Corning, Cat. # 21040CV). Sorted cells were pelleted. Up to ~2 
million cells were resuspended in 100 μl High-TE buffer (10 mM Tris-Cl, pH 8, 10 mM 
EDTA, 25-100 μg/ml RNase A (QIAGEN, Cat. # 19101)) and lysed by adding 2.5 μl 20% 
SDS. After incubation at 37°C for several hours, the lysate was digested by ~0.2 mg/ml 
Proteinase K (New England Biolabs, Cat. # P8102 or P8107S) at 55°C for ~1 day. 1 M 




the total volume to ~600 μl and final concentrations of Tris-Cl to ~0.1 M and NaCl to ~0.2 
M. The lysate was then extracted once with an equal volume of phenol/chloroform/isoamyl 
alcohol (25:24:1 mixture, Fisher Scientific, Cat. # BP1752I-400) and once with an equal 
volume of chloroform/isoamyl alcohol (24:1 mixture, MilliporeSigma, Cat. # C0549). 
DNA was precipitated by adding 2.5 volumes of 100% ethanol, washed with 70% ethanol 
and resuspended in EB (10mM Tris-Cl, pH 8.5). 
 
Estimation of transgene copy number  
BAC or plasmid transgene copy number within individual cell clones or sorted 
cells was measured by real-time quantitative PCR (qPCR), using purified genomic DNA, 
iTaq universal SYBR Green Supermix (Bio-Rad Laboratories, Cat. # 1725121) and a 
StepOnePlus (Applied Biosystems). Relative quantitation methods were used for copy 
number calculation. Primers used for qPCR are listed in Data A.1. Mouse genes Sgk1 and 
Hprt1 were used as endogenous controls, assuming four copies of each gene per cell in 
NIH 3T3. For Figure 3d and Figure 2.5c, a primer pair (Zeo-GFP2for/rev) that binds to 
the UBC-GFP-ZeoR region was used to estimate transgene copy number. For Table 2.2, 
Table 2.3 and Figure A.5, in addition to Zeo-GFP2for/rev, 4 primer pairs binding to the 
DHFR BAC or 6 primer pairs binding to the HBB BAC were used to estimate the copy 
number of DHFR-UG or HBB-UG BAC, respectively. The DCT method (Equation 2.3 
and 2.4) was used to estimate the copy numbers of the PCR amplification regions on the 
UBC-GFP-ZeoR reporter gene or on the HBB BAC, and DDCT method (Equation 2.5 and 
2.6) was used to estimate the copy numbers of the PCR amplification regions on the 
DHFR BAC. When multiple primer pairs were used for a region, the mean copy number 
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of all PCR amplification regions was calculated as the copy number of that region. 
Equation 2.3 and 2.7 were used to calculate the fold increase of BAC copy numbers in 
H1 and H2 samples relative to L. 
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Correlation of reporter gene expression and reporter gene copy number 
Mean fluorescence intensity (in arbitrary units) of individual clones were 
measured by flow cytometry and normalized by fluorescent bead intensity to be used as a 
measure of reporter gene expression. To ensure uniform normalization for all samples, 
fluorescent beads from the same batch were used for all measurements. Untransfected 
cells were used to establish background fluorescence levels. Linear correlations of GFP 
expression level versus transgene copy number for each group of cell clones were 
calculated using the linear trend line tool in Microsoft Excel with the y-intercept fixed to 
0 (autofluorescence normalized by beads was almost 0). 
 
DNA FISH probes 
Biotin or digoxigenin labeled DNA FISH probes were made from BAC DNA, 







HaeIII, MseI, MspI, RsaI (New England Biolabs, Cat. # R0137S, R0176S, R0108S, 
R0525S, R0106S, R0167S, respectively) and CutSmart Buffer (New England Biolabs); 
Terminal Deoxynucleotidyl Transferase and reaction buffer (Thermo Fisher Scientific, 
Cat. # EP0161); dATP (New England Biolabs, Cat. # N0446S) and Biotin-14-dATP 
(Thermo Fisher Scientific, Cat. # 19524016) for biotin labelling, or dTTP (New England 
Biolabs, Cat. # N0446S) and Digoxigenin-11-dUTP (MilliporeSigma, Cat. # 
11093088910) for digoxigenin labelling.  
 
3D DNA FISH 
DNA FISH of interphase nuclei used published protocols (Cremer et al., 2008; 
Solovei and Cremer, 2010) with small modifications. Cells grown on coverslips (12 mm 
diameter) were fixed with 3-4% paraformaldehyde in Dulbecco's phosphate buffered 
saline (DPBS, 8 g/l NaCl, 0.2 g/l KCl, 2.16 g/l Na2HPO4-7H2O, 0.2 g/l KH2PO4) for 10 
min, followed by permeabilization with 0.5% Triton X-100 (Thermo Fisher Scientific, 
Cat. # 28314) in DPBS for 10-15 min. Cells were subjected to six freeze-thaw cycles 
using liquid nitrogen, immersed in 0.1M HCl for 10-15 min, and then washed 3x with 2x 
saline-sodium citrate (SSC). Freeze-thaw cycles sometimes were skipped with no 
noticeable difference in FISH signals. Cells were incubated in 50% deionized formamide 
(MilliporeSigma, Cat. # S4117)/2x SSC for 30 min at room temperature (RT), and stored 
for up to 1 month at 4°C. Each coverslip used ~4 μl hybridization mixture, consisted of 5-
20 ng/µl probes, 10x of mouse (for NIH 3T3 cells) or human (for HCT116 cells) Cot-1 
DNA (Thermo Fisher Scientific Cat. # 18440016 or 15279011,) per ng probe, 50% 
deionized formamide, 10% dextran sulfate (MilliporeSigma, Cat. # D8906) and 2x SSC. 
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Cells and probes were denatured together on a heat block at ~76°C for 2-3 min and 
hybridized at 37°C for 16 hrs-3 days. After hybridization, cells were washed 3 x 5 min in 
2x SSC at RT, and for 3 x 5 min in 0.1x SSC at 60°C, and then rinsed with SSCT (4x 
SSC with 0.2% TWEEN 20) at RT. FISH signals were detected by incubation with Alexa 
Fluor 647 conjugated Strepavidin (1:200; Jackson ImmunoResearch, Cat. # 016-600-084) 
or Alexa 594 conjugated Strepavidin (1:200; Life Technology, Cat. # S11227) for biotin-
labeled probes, or Alexa Fluor 647 conjugated IgG fraction monoclonal mouse anti-
digoxin (1:200; Jackson ImmunoResearch, Cat. # 200-602-156) for digoxigenin labeled 
probes, diluted in SSCT with 1% Bovine Serum Albumin (MilliporeSigma, Cat. # 
A7906), for 40 min-2 hrs at RT. Coverslips were washed in SSCT for 4 × 5 min, rinsed 
with 4x SSC and mounted.  
 
Mitotic FISH 
Metaphase spreads were prepared according to a published protocol (Beatty and 
Scherer, 2002) with small modifications. Cells grown to 70-80% confluence were 
incubated with 0.1 μg/ml Colcemid (Thermo Fisher Scientific, Cat. # 15212012) in 
growth media for ~1 hr. Cells were then harvested and swollen by incubation in 0.075 M 
KCl for 10-20 min at 37°C, followed by fixation with freshly prepared Carnoy’s fixative 
(3:1 v/v ratio of methanol/acetic acid). Chromosomal spreads were made by dropping the 
fixed swollen cells onto cold wet glass slides. DNA FISH of mitotic spreads was 




Microscopy and image analysis 
For examining EGFP-LacI signals cells were grown on coverslips and fixed with 
3-4% paraformaldehyde in DPBS before mounting. For examining the expression of the 
three reporter minigenes, SNAP tagged-Lamin B1, SNAP-tagged Fibrillarin and 
mCherry-Magoh, the cells were first labeled with cell-permeable substrate SNAP-Cell 
Fluorescein (New England Biolabs, Cat. # S9107S) overnight at 240 nM concentrations. 
To reduce background of unreacted SNAP-tag substrate, cells were incubated 3x 30 mins 
with media in the incubator, washed with PBS, and fixed with freshly prepared 4% 
paraformaldehyde in PBS for 15 min at RT. All samples- including fixed cells expressing 
fluorescently tagged transgenes, 3D DNA FISH, and mitotic FISH sample- were mounted 
with a Mowiol-DABCO anti-fade medium (‘Mowiol mounting medium’, 2006) 
containing ~3 μg/ml DAPI (MilliporeSigma, Cat. # D9542). 
3D z-stack images were acquired using a Deltavision wide-field microscope (GE 
Healthcare), equipped with a Xenon lamp, 60X, 1.4 NA oil immersion objective 
(Olympus) and CoolSNAP HQ CCD camera (Roper Scientific) or a V4 OMX (GE 
healthcare) microscope, equipped with a 100X, 1.4 NA oil immersion objective 
(Olympus) and two Evolve EMCCDs (Photometrics).  Images were deconvolved using 
the deconvolution algorithm (‘Mowiol mounting medium’, 2006) provided by the 
softWoRx software (GE Healthcare). Gamma = 0.5 was applied to green channels in 
Figure 2.5e, Figure A.8 and Figure A.10 for proper display of spots with relatively low 
signals. All image analysis and preparation were done using Fiji (Schindelin et al., 2012). 
Images were assembled using Illustrator (Adobe), Photoshop (Adobe), or GIMP. 
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For estimation of episome size, the z-sections containing focused episome images 
for the DAPI and FISH channels were selected manually from the deconvolved z-stack 
image. Chromosomes and FISH spots were segmented by applying the k-mean clustering 
algorithm (number of clusters = 3, cluster center tolerance = 0.0001, randomization seed 
= 48) from the IJ Plugins Toolkit (http://ij-plugins.sourceforge.net/plugins/toolkit.html). 
The smallest chromosome was identified by manually searching for the chromosome 
with the smallest area. Segmented FISH spots overlapping or touching chromosomes 
were removed manually. Integrated DAPI intensities of the smallest chromosome and of 
the FISH spots not overlapping or touching chromosomes were calculated by Equation 
2.8 (Mean gray value and Area were measured by Fiji). Average episome size was 
calculated by Equation 2.9 (n is the number of FISH spots, chro is the smallest 
chromosome found in the field, 61.4 Mb is the size of chr19 in mm10). 
 







Comparison of reporter gene expression levels in for NIH 3T3 cell clones (Figure 
2.7c) was done by projecting deconvolved images stacks and then measuring the 
integrated intensity within individual nuclei after subtracting background intensity levels 
measured in the cytoplasm. Regions of interest circumscribing individual nuclei were 
drawn manually based on the SNAP-lamin B1 signal. Linear correlations of the 
integrated intensities of the nuclear SNAP-tag and mCherry signals were calculated using 




A non-linear Gamma correction (0.7) to reduce the grey-scale dynamic range 
followed by a maximum intensity projection of 3-4 z-sections was used to better visualize 
both lamin and nucleolar staining simultaneously (Figure 2.7d).  
 
Agarose embedded DNA preparation and S1 Nuclease digestion 
Agarose embedded DNA was prepared according to published protocols 
(Sambrook and Russell, 2006a; Khan and Kuzminov, 2017) with modifications. To 
prepare mammalian cell suspensions, cells were grown without selection for 3-4 days 
after passaging, reaching 80%-90% confluence. Cells were trypsinized, resuspended in 
cell media, washed with PBS, and resuspended in PBS at a concentration of ~8 x 106 
cells / 100 µl. To prepare E. coli cell suspensions, ~0.1 ml of overnight culture was 
diluted in 15 ml fresh LB and grown to an OD600 of ~1. Cells were washed with L Buffer 
(10 mM Tris-Cl pH7.6, 20 mM NaCl, 100 mM EDTA) once and resuspended in L Buffer 
at a concentration of ~109/100 µl, assuming a cell concentration of ~8 x 107/100 µl at an 
OD600 of 1. 
2% certified low melt agarose (Bio-Rad Laboratories, Cat. # 1613111) was 
prepared with L Buffer and kept at 75°C. Equal volumes of the cell suspension (RT) and 
the agarose solution (75°C) were mixed and immediately transferred to plug molds (Bio-
Rad Laboratories, Cat. # 1703713), ~100 µl mixture per plug. The agarose plugs were 
incubated in L Buffer with 1% Sarcosyl (MilliporeSigma, Cat. # L5125) and 0.5 mg/ml 
proteinase K at 55°C for 1-2 days. The agarose plugs were washed with W Buffer (20 
mM Tris-Cl, pH7.6, 50 mM EDTA) for 2 x 15 min, incubated in 1 mM PMSF in W 
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Buffer for 30 min, and washed with W Buffer again. Prepared agarose plugs were stored 
in 0.5 M EDTA at 4°C before use. 
For S1 Nuclease (Promega, Cat. # M5761) digestion, agarose plugs were first 
washed in TE (10 mM Tris-Cl, 1 mM EDTA, pH 7.6) for 3 x 10 min and in 1x S1 
Nuclease Buffer for 20 min on ice. The agarose plugs were then digested with 1-16 U/0.4 
ml S1 Nuclease in 1x S1 Nuclease Buffer at 37°C for 45 min. The reaction was stopped 
by washing the agarose plugs with 0.5 M EDTA or W Buffer. 
 
Pulsed Field Gel Electrophoresis (PFGE) 
PFGE was performed using a CHEF-DR III (Bio-Rad Laboratories) according to 
the manufacturer’s manual using a 1% certified megabase agarose (Bio-Rad 
Laboratories, Cat. # 1613108) gel in 0.5x Tris-borate-EDTA buffer (TBE), a 0.5x TBE 
running buffer, and the following parameters: voltage = 6 V/cm, angle = 120°, pulse = 
60-120 sec, temperature = 14 °C, run time = 20 or 24 hrs (stopped at 18-20 hrs). Yeast 
chromosomes (Bio-Rad Laboratories, Cat. # 170-3605) were used as DNA size markers. 
 
Southern hybridization probes 
Southern hybridization probes were created and labeled with digoxigenin by PCR 
using primers listed in Data A.1. Set 1 contains a 620bp and a 615 bp fragment amplified 
from the GFP-ZeoR region; Set 2 contains 525 bp, 534 bp, and 504bp fragments 
amplified from the BAC vector region; Set 3 contains 446 bp, 681 bp, and 424 bp 
fragments amplified from the HBB BAC. Pooled Set 1 and Set 2 fragments were used for 
detecting the DHFR BAC, and pooled Set 1 and Set 3 for detecting the HBB BAC. PCR 
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was done using Taq DNA polymerase (New England Biolabs, Cat. # M0267L) with the 
following recipe: 1x ThermoPol Buffer, 0.2 mM dATP/dCTP/dGTP (New England 
Biolabs, Cat. # N0446S), 0.165 mM dTTP (New England Biolabs, Cat. # N0446S), 0.035 
mM Digoxigenin-11-dUTP, 0.5 ng HBB BAC, 1.25 U Taq DNA polymerase, 0.5 µM 
forward/reverse primers, 50 µl total reaction volume. PCR products were column 
(QIAGEN, Cat. # 28104) purified. Pooled probes were denatured in nuclease free water, 
at ~100°C for ~10 min and snap-chilled on ice before use. 
 
Southern hybridization 
Southern blotting used a published protocol (Kimura et al., 2010) with 
modifications. After ethidium bromide staining and imaging, the gel was depurinated in 
0.25 M HCl for 2x 30 min, denatured in 0.4 M NaOH for 2x 25 min, neutralized in 0.5 M 
Tris-Cl/1.5 M NaCl (pH 7.6) for 2x 20 min and washed in 2x SSC for 2x 20 min. DNA 
was transferred to Zeta-Probe membranes (Bio-Rad Laboratories, Cat. # 1620165) using 
a Model 785 Vacuum Blotter (Bio-Rad Laboratories), with 2x SSC as transfer buffer, ~5 
inches Hg pressure, and ~16 hrs transfer time. A Stratalinker (Strategene) was used to 
cross-link DNA to the membrane.  
Hybridization used a standard protocol (Sambrook and Russell, 2006c) with 
modifications. The hybridization buffer was composed of 1:1 volumes of 1 M Na2HPO4 
(pH 7.2) and 14% (w/v) SDS. Total concentration of pooled probes was ~100 ng/ml. 
Hybridization was carried out at 65°C for ~16 hrs. After hybridization, the membrane 
was washed with 2x SSC/0.1% SDS for 2 x 5 min at room temperature, and with 1x 
SSC/0.1% SDS for 2 x 10 min at 65°C and rinsed with 2x SSC. Signals were detected 
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using the DIG Nucleic Acid Detection Kit (MilliporeSigma, Cat. # 
000000011175041910) according to the manufacturer’ manual, except that in the final 
step, CDP-Star (MilliporeSigma, Cat. # 11685627001) was used instead of NBT/BCIP, 
and the membrane was imaged by an iBright system (Thermo Fisher Scientific). 
 
Estimation of average BAC DNA content per episome 
To estimate the average BAC DNA content per episome of clone DHFR-UG-s3 
and clone HBB-UG-100d3, cells at the same passage were seeded on glass coverslips for 
DNA FISH using BAC probes, and in different plates for genomic DNA extraction 
followed by qPCR. The mean number of FISH spots per nucleus, counted from z-stack 
projected images, provided the average episome copy number per cell. For the DHFR-
UG clone, 3 was subtracted from the mean number of FISH spots, as the parental NIH 
3T3 cells had ~3 FISH spots, corresponding to the endogenous DHFR loci, using FISH 
probes prepared from the DHFR BAC. qPCR estimation of BAC copy number per cell 
was described in section “Estimation of transgene copy number”. BAC DNA content per 







Whole genome sequencing 
Clone DHFR-UG-s3 and clone HBB-UG-100d3 were sorted by flow cytometry 
using the H1, H2 and L sorting windows shown in Figure 2.6c and Figure A.4a. Cells 
from the H2 and L regions were sorted in the same experiment, while cells from the H1 
<latexit sha1_base64="68GBh1SJtl8jtDFh3HhYGQMc0aA="></latexit>
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regions were sorted in another experiment. 100-200 thousand cells were collected from 
each window. Genomic DNA from sorted cells was isolated by phenol-chloroform 
extraction. To prepare sequencing libraries, genomic DNA was first fragmented to 100-
500 bp by sonication using a Bioruptor Pico (Diagenode), with the following conditions: 
4 ng/µl DNA in 120 µl EB, 1.5 ml tube, 10-11 cycles of 30 secs on and 30 secs off. Next, 
indexed adaptors was attached to the fragmented DNA using True-Seq ChIP Sample 
Preparation kit (Illumina, Cat. # IP-202-1012) according to the manufacturer’s 
instructions with the following modifications: after the fragmented DNA was end 
repaired, 3’ end adenylated, and ligated to indexed adaptors without size selection, the 
ligation products were PCR amplified for 7~9 cycles. Libraries were quality checked on a 
Fragment Analyzer (Agilent) and quantitated by qPCR. Every 6 libraries were pooled at 
equal molar ratios and sequenced on one lane using a HiSeq 4000 for 101 cycles from 
one end of the fragments using a HiSeq 4000 sequencing kit version 1. Fastq files were 
generated and de-multiplexed with the bcl2fastq v2.20 Conversion Software (Illumina). 
Library quality checking, quantitation and sequencing, and fastq file generation and de-
multiplexing were done by the DNA services lab, Roy J. Carver Biotechnology Center, 
UIUC. 59-65 million reads with quality score >30 were obtained for each library.  
 
Sequencing reads processing and copy number variation analysis 
Low quality bases and adaptor sequences were trimmed from raw reads using 
cutadapt 1.14 with Python 2.7.13 with the following parameters: -a 
AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC -q 20,20 -m 20, resulting in 
~0.2% bp being trimmed. Reads were then aligned to a reference genome (mm10 plus 
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HBB BAC (CTD-2643I7, sequence from hg38), the BAC vector (pBelo11, GenBank 
Accession #: U51113) and UBC-GFP-ZeoR, each as an individual chromosome) using 
Bowtie2 (version 2.3.2) with default parameters. Overall alignment rate of each sample 
was ~98%-99%. Finally, PCR duplicates were removed by SAMtools rmdup (version 
1.7) with default parameters, resulting in 42-48 million total mapped reads in each 
sample.  
For reads binning, each chromosome of the reference genome was divided into 
non-overlapping 3 kb or 30 kb bins; the number of alignments with centers falling into 
each bin (binned reads) was counted and then divided by the mean read count (Equation 
2.11), generating normalized binned reads (normalized reads, Equation 2.12), and finally 
the normalized binned reads of the test sample (H1 or H2 cells) were divided by that of 
the reference sample (L cells), generating the ratio of normalized binned reads (ratio, 
Equation 2.13). The mean read count was ~50 or ~500 for 3 kb or 30 kb bin size, 
respectively. To reduce noise caused by extremely low read counts, a threshold for 
determining outliers was calculated based on the quantile range (Equation 2.14). Bins 
with log2(reads) smaller than the threshold in the test sample were removed from further 
analysis. The excluded bins took up ~6.0% of total bins for both 3 kb and 30 kb bin sizes, 
including zero read count bins, which took up ~5.5% or ~3.5% of total bins for 3 kb or 30 
kb bin size, respectively. The maximum number of reads of the excluded bins were ~7 or 
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A circular binary segmentation algorithm (Olshen et al., 2004; Venkatraman and 
Olshen, 2007) from the R-package DNAcopy (version 1.52.0) was used to merge bins 
with similar log2(ratio) into segments, with the following parameters for the segment 
function: verbose = 1, undo.splits="sdundo", undo.SD=1. The mean log2(ratio) of each 
segment was calculated for identifying episome-localizing regions. 
To identify possible episome-localizing regions, we first measured BAC 
transgene copy numbers in the H1, H2 and L samples by qPCR and then calculated the 
theoretical episome copy numbers using the estimated BAC copy number per episome of 
unsorted cells (Table 2.2). The minimum copy number increase of episome-localizing 
host DNA (minimum increase) was then calculated assuming NIH 3T3 to be tetraploid 
and each episome to have the same host DNA sequence (Equation 2.15). Segments with 
mean log2(ratio) equal to or greater than log2(minimum increase) in both H1 and H2 













Construction of DHFR BAC deletions 
We tested several DHFR BAC deletions- made for other purposes- for their ability 
to produce episomes. The DHFR-c27 BAC (Bian and Belmont, 2010) containing a 256-
mer Lac operator (LacO) repeats and a CMV-mRFP-SV40-ZeoR expression cassette was 
derived from the DHFR BAC, and was used for making the DHFR BAC deletions. DHFR-
c27d2 contains a ~70 kb deletion of the 3’ part of the Msh3 gene. DHFR-c27d3-crz contains 
a ~80 kb deletion of the whole Dhfr gene and the 5’ part of the Msh3 gene, including the 
CMV-mRFP-SV40-ZeoR expression cassette inserted in the Msh3 gene, and contains a 
new CMV-mRFP-SV40-ZeoR expression cassette introduced at the remaining part of 
Msh3 gene. DHFR-c27d4 contains a ~20 kb deletion around the divergent promoter region. 
l Red-mediated BAC recombineering with a galK-based dual-selection scheme was used 
to create the deletion BACs from the DHFR-c27 BAC, as described in “Construction of 
dual reporter DHFR BACs” and “Construction of BACs containing the UBC-GFP-ZeoR 
cassette”. DNA fragments containing either GalK or FRT-GalK-FRT and homology ends 
were produced by PCR using either pGalK or pUGG as templates. For DHFR-c27d2, the 
GalK cassette was introduced by the first round of recombination and was subsequently 
removed by another round of recombination using a DNA fragment created by a pair of 
partially overlapping primers. For DHFR-c27d3 and DHFR-c27d4, the FRT-GalK-FRT 
cassette was introduced in the first round instead and was subsequently removed by 
inducing FLP recombinase as described in “Construction of BACs containing the UBC-
GFP-ZeoR cassette”. To create DHFR-c27d3crz, the CMV-mRFP-SV40-ZeoR cassette 
was introduced into DHFR-c27d3 by one round of recombination using Zeocin resistance 
as positive selection as described in “Construction of dual reporter DHFR BACs”. Each 
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round of recombination was validated by PCR and restriction enzyme fingerprinting. All 
primers are listed in Data A.1. 
 
Construction of multi-reporter DHFR BAC by BAC-MAGIC 
Overview: Construction of the 3-reporter BAC was done by serially inserting 
~10-15 kb DNA cassettes into the DHFR BAC scaffold by BAC recombineering. These 
DNA cassettes were constructed from two different DNA plasmid module types: reporter 
modules and intervening DHFR sequence modules. DNA cassettes were inserted 
sequentially into the DHFR BAC using multiple rounds of BAC recombineering and 
positive selection with one of two different positive selectable markers. After insertion of 
the first DNA cassette, each subsequent insertion of the next DNA cassette removed the 
preceding positive selectable located at the 3’ end of the preceding cassette while 
inserting the alternative selectable marker located at the 3’ end of the new cassette. Three 
reporter gene modules (Rep Mod 01, 02, 03) plus three intervening DHFR sequence 
modules (DHFR 02, 03, 04) were constructed and then inserted into the DHFR BAC 
using 6 sequential rounds of BAC recombineering. In this way, 45 kb of the original 
DHFR BAC effectively was reconstructed such that the original DHFR sequences were 
retained but the 3 reporter mini-genes were inserted into this BAC region with each 
reporter minigene spaced by ~10 kb of DHFR sequence. We call this overall construction 
approach BAC-MAGIC (BAC-Modular Assembly of Genomic loci Interspersed 
Cassettes). 
Each DNA cassette was constructed using traditional cloning methods, Gibson 
assembly (Gibson et al., 2009), and/or DNA Assembler (Shao, Zhao and Zhao, 2009; 
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Shao and Zhao, 2012). Three reporter recipient modules (pRM01-Spec, pRM02-Spec, 
and pRM03-Spec) were designed to incorporate a rare AgeI restriction site for insertion 
of reporter expression cassettes of choice, in order to create the final reporter modules for 
BAC recombineering. Unless mentioned specifically all the enzymes were procured from 
New England Biolabs. All primers and oligos are listed in Data A.1. Gibson assembly 
used Gibson assembly cloning kit (New England Biolabs, Cat. # E5510S) as per the 
manufacturer’s instructions.  
DNA Assembler used Saccharomyces cerevisiae (S. cerevisiae) strain VL6-48N 
(MATα, his3-Δ200, trp1-Δ1, ura3-Δ1, lys2, ade2-101, met14, cir°), transformed with 43 
fmol pRS413 vector backbone and 130 fmol of all other fragments using the LiAc/SS 
carrier DNA/PEG method (Gietz and Schiestl, 2007). The S. cerevisiae single-copy 
shuttle vector pRS413 contains CEN6/ARS autonomously replicating sequence, 
auxotrophic selection marker HIS3 for propagation in yeast, and pMB1 origin of 
replication and bla (ApR) marker for selection with ampicillin in E. coli. The 3.8 kb 
pRS413 vector backbone was PCR amplified from plasmid pRS413 (New England 
Biolabs) using primer pair RS413-Fw/RS413-Rev for all yeast assembly reactions. The 
vector backbone and all other fragments made by PCR were digested with DpnI to 
remove template DNA. Transformants were selected on SC selection media plates 
lacking histidine [0.17% Bacto-yeast nitrogen base without amino acids (MilliporeSigma, 
Cat. # Y1251-100G), 0.5% ammonium sulfate, 2% D-glucose, 0.2% Dropout mix 
(MilliporeSigma, Cat. # Y2001-20G), 2% agar, 80 mg/l uracil, 80 mg/l L-tryptophan, and 
240 mg/l L-leucine] at 30°C for 3-4 days. Plasmid DNA were prepared using QIAprep 
Spin Miniprep Kit (Qiagen, Cat. # 27104) and screened by restriction enzyme 
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fingerprinting. Plasmid DNA from selected yeast colonies was introduced into E. coli 
strain DH5a and isolated plasmid DNA then further validated by additional restriction 
enzyme fingerprinting. 
Below we describe construction of each reporter and intervening spacer modules 
and BAC recombineering assembly of these modules to create the 3-reporter BAC.  
Construction of plasmid pRM01-RSLB1-Spec (Reporter module 01): Plasmid 
pRM01 was made by sequential addition of two DHFR homology regions to plasmid 
pEGFP-C1 (Clontech). First, the 2.1 kb DHFR homology region (M1F4) was PCR 
amplified from the DHFR BAC using primer pair M1F4-BamHIfor/M1F4-AgeIrev, 
double digested with BamHI/AgeI, and ligated with the BamHI/AgeI digested pEGFP-C1 
to generate intermediate plasmid pEG-Rep-Module-1a. Next, the 2.0 kb DHFR homology 
region (M2F12) was PCR amplified from the DHFR BAC using primer pair M2F12-
AgeIFor/M2F12-PshRev, double digested with AgeI/PshAI and ligated with the 
AgeI/SnaBI digested plasmid pEG-Rep-Module-1a to produce plasmid pRM01.  
To create plasmid pRM01-Spec (Reporter recipient module 01), a 1.6 kb 
Spectinomycin resistance gene expression cassette (SpecR), derived from plasmid 
pYES1L (Thermo Fisher Scientific), was inserted into pRM01, 400 bp upstream of the 3’ 
end of the M2F12 DHFR homology region by two-fragment Gibson Assembly (Gibson et 
al., 2009). The two fragments for Gibson assembly were PCR amplified from pRM01 
using primer pair GA-RM01-Spec-For/ GA-RM01-Spec-Rev (PCR product size: 7.8 kb), 
or from pYES1L using primer pair Specfor/SpecRev (PCR product size: 1.6 kb) 
respectively.  
 70 
The pRSLB1 (hRPL32-SNAP-Lamin B1) plasmid harboring SNAP-tagged 
Lamin B1 reporter expression cassette (RSLB1) was constructed by three-fragment 
Gibson assembly. pEGFP-Lamin B1 plasmid vector backbone 5.3 kb fragment was 
prepared by AseI/BsrGI double digestion. The hRPL32 promoter (2.2 kb) and SNAP tag 
(561 bp) fragments were PCR amplified using primer pairs GA-hRPL32-fwd/GA-
hRPL32-rev (template plasmid pMOD-HB2-hRPL32-RZ, made in this study), and GA-
SNAP-fwd/GA-SNAP-rev (template plasmid pSNAPf, New England Biolabs). 
pRM01-Spec was linearized by AgeI and simultaneously dephosphorylated by 
Shrimp Alkaline Phosphatase (New England Biolabs, Cat. # M0371S). The RSLB1 
expression cassette was PCR amplified from plasmid pRSLB1 using primer pair 
R32CerLBAgeIfor/newPCFAgeIrev (PCR product size: 4.9 kb) and double digested with 
DpnI/AgeI. The linearized pRM01-Spec and the digested RSLB1 PCR product were 
ligated to produce plasmid pRM01-RSLB1-Spec, which was digested with AseI to 
produce the final BAC recombineering 10.3 kb targeting construct. 
Construction of plasmid pRM02-PSF-Spec (Reporter module 02): Plasmid 
pRM02 was made using similar cloning steps used to produce pRM01 except two 
different DHFR homology regions were added to pEGFP-C1:  2.0 kb PCR product M2F4 
(primer pair M2F4-BamHIfor/M2F4-AgeIrev) replaced M1F4 and 2.0 kb PCR product 
M3F1 (primer pair M3F1-AgeIFor/M3F1-PshRev) replaced M2F12. Plasmid pRM02-
Spec was made the same way as pRM01-Spec except that fragment 1 for Gibson 
assembly was PCR amplified from plasmid pRM02 using primer pair GA-RM02-Spec-
For/GA-RM02-Spec-Rev (PCR product size: 7.8 kb). The final plasmid pRM02-Spec 
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(pRep-module 02-Spec) is Reporter recipient module 02 for the SNAP-tagged Fibrillarin 
reporter expression cassette (PSF).  
To create plasmid pPSF (pPPIA-SNAP-Fibrillarin), the GFP cassette between 
KpnI/HpaI restriction sites of plasmid GFP-Fibrillarin was replaced with a 730 bp 
Cerulean cassette PCR amplified from plasmid pCerulean-N1 (New England Biolabs) 
using primer pair ForCerFib/RevCerFib, resulting in an intermediate plasmid pPCF. 
Next, the CMV promoter between SnaBI/HindIII sites of pPCF was replaced with the 2.8 
kb PPIA promoter PCR amplified from plasmid p[MOD-HB2-PPIA-RZ] (made in this 
study) using primer pair PPIACerFibFor/ PPIACerFibRev, resulting in plasmid pPPIA-
Cer-Fib. Finally, the 720 bp Cerulean cassette between the AgeI/HpaI sites of pPPIA-
Cer-Fib was replaced with a 560 bp SNAP tag fragment PCR amplified from plasmid 
pSNAPf (New England Biolabs) using primer pair Snap-XmaI-For/Snap-HpaI-Fib-Rev 
and double digested with XmaI/HpaI, producing pPSF. 
pRM02-Spec was linearized by AgeI and simultaneously dephosphorylated by 
Shrimp Alkaline Phosphatase (New England Biolabs, Cat. # M0371S). The 4.6 kb PSF 
expression cassette was PCR amplified from pPSF using primer pair PSF-AgeI-For/ PSF-
AgeI-Rev and double digested with DpnI/AgeI. Their ligation produced plasmid pRM02-
PSF-Spec, which provided the 10.4 kb BAC recombineering targeting construct after 
BamHI/AatII/RsrII triple digestion of pRM02-PSF-Spec.  
Construction of plasmid pRM03-PCM-Spec (Reporter module 03): Plasmid 
pRM03 was made using similar cloning steps used to produce pRM01 except two 
different DHFR homology regions were added to pEGFP-C1: 2.1 kb PCR fragment 
M3F4 (primer pair M3F4-BamHIfor/M3F4-AgeIrev) replaced M1F4 and 2.1 PCR 
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fragment M4F1 (primer pair M4F1-AgeIFor/M4F1-PshRev) replaced M2F12. Plasmid 
pRM03-Spec was made the same way as pRM01-Spec except that fragment 1 for Gibson 
assembly was PCR amplified from plasmid pRM03 using using primer pair GA-RM03-
Spec-For/ GA-RM03-Spec-Rev (PCR product size: 7.8 kb). The final plasmid pRM03-
Spec (pRep-module 03-Spec) is Reporter recipient module 03 for the mCherry-tagged 
Magoh reporter expression cassette (PCM).  
Plasmid pPCM (pPPIA-mCherry-Magoh) was created in two steps. First, the 
CMV promoter between the NdeI/NheI sites of plasmid pmRFP-Magoh was replaced 
with the PPIA promoter (2.8 kb), PCR amplified from plasmid pMOD-HB2-PPIA-RZ 
using primer pair PPIA-Magohfor/ PPIA-MagohRev and double digested with 
NdeI/NheI, resulting in intermediate plasmid pPMM. Next, the mRFP tag between the 
NheI/HindIII sites of pPMM was replaced with a 720 bp mCherry tag PCR amplified 
from plasmid pQCXIN-TetR-mCherry using primer pair mCherry-NheI-Magoh-
For/mCherry-H3-Magoh-Rev, resulting in plasmid pPCM. 
To create plasmid pRM03-PCM-Spec (Reporter module 03), plasmid pRM03-
Spec was linearized by AgeI and simultaneously dephosphorylated by Shrimp Alkaline 
Phosphatase (New England Biolabs, Cat. # M0371S). A 4.2 kb PCM expression cassette 
was PCR amplified form plasmid pPCM using primer pair MMorCF-
AgeIfor/newPCFAgeIrev and double digested with DpnI/AgeI. pRM03-Spec and the 
PCM PCR product were ligated, producing plasmid pRM03-PCM-Spec, which was used 
as a template for PCR amplification using primer pair M3F4-PCR-Fw/M4F1-PCR-Rev to 
produce the 9.9 kb BAC recombineering target. After PCR, any remaining template 
plasmid was digested with DpnI. 
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Construction of plasmid pRS413-DHFR-Mod-02-Kan (Intervening DHFR 
module 02): Plasmid pRS413-DHFR-Mod-02 was made by assembling the vector 
backbone with four additional fragments using the DNA assembler method (Shao, Zhao 
and Zhao, 2009; Shao and Zhao, 2012). Fragment 5’-DHM2 (4.3 kb) and fragment 3’-
DHM2 (6.3 kb) with an overlap of 659 bp and were both PCR amplified from the DHFR 
BAC, using primer pair M2F12-AgeIfor/M2F1rev or DHM2-Seq2/M2F4-AgeIrev, 
respectively.  Two bridging oligomers, with a 125 bp homology to the pRS413 vector 
backbone, and a 125 bp homology to fragment 5’-DHM2 (oligo M2F1-pRS413) or 
fragment 3’-DHM2 (oligo M2F4-pRS413) were synthesized at Integrated DNA 
Technologies, Inc. The final Intervening DHFR module 02, plasmid pRS413-DHFR-
Mod-02-Kan, was created by ligating a 2.4 kb Kan/NeoR cassette derived from DraI 
digestion of plasmid pEGFP-C1, with the plasmid pRS413-DHFR-Module-02 linearized 
by DraIII and blunted by DNA Polymerase I, Large (Klenow) Fragment. 
For BAC recombineering an 11.7 kb of targeting construct was amplified from 
plasmid pRS413-DHFR-Mod-02-Kan using primer pair M2F12-AgeIFor/DH2-4rev and 
purified by gel extraction after DpnI digestion of the template plasmid. 
Construction of plasmid pRS413-DHFR-Mod-03-Kan (Intervening DHFR 
module 03): Plasmid pRS413-DHFR-Mod-03 was made by assembling the vector 
backbone with four additional fragments using the yeast DNA assembler method. 
Fragment 5’-DHM3 (6.5 kb) and fragment 3’-DHM3 (5.0 kb) with an overlap of 1553 bp 
were both PCR amplified from the DHFR BAC using primer pair M3F1-AgeIFor/M3F3-
BamHIrev or M3-F3For/M3F4-AgeIRev, respectively.  Two bridging oligomers, with a 
125 bp homology to the pRS413 vector backbone, and a 125 bp homology to fragment 
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5’-DHM3 (oligo M3F1-pRS413) or to fragment 3’-DHM3 (oligo M3F4-pRS413), 
respectively, were synthesized at Integrated DNA Technologies, Inc. The final 
Intervening DHFR module 03, plasmid pRS413-DHFR-Mod-03-Kan, was created by 
ligating a 2.4 kb Kan/NeoR cassette derived from DraI digestion of plasmid pEGFP-C1, 
with the plasmid pRS413-DHFR-Mod-03 linearized by SmaI. 
For BAC recombineering a 12.2 kb targeting construct was amplified from 
plasmid pRS413-DHFR-Mod-03-Kan using primer pair DH3-1for/DH3-4rev and purified 
by gel extraction after DpnI digestion of the template plasmid. 
Construction of plasmid pRS413-DHFR-Mod-04-Zeo (Intervening DHFR 
module 04): Plasmid pRS413-DHFR-Mod-04 was made by assembling the vector 
backbone plus 5 additional fragments using the yeast DNA assembler method (4). 
Fragment 5’-DHM4 (4.9 kb), fragment Mid-DHM4 (5.2 kb) and fragment 3’-DHM4 (5.2 
kb) with an overlap of 2663 bp in between 5’-DHM4 and Mid-DHM4, and an overlap of 
2542 bp in between Mid-DHM4 and 3’-DHM4, were PCR amplified from the DHFR 
BAC using primer pair M4F1-AgeIfor/DHM4F2-R, DHM4F2-Fw/DHM4F3-R, or Fw-
M4F2-BamHI/RevM4F5-MluI, respectively. Two bridging oligomers, with a 125 bp 
homology to pRS413 vector backbone, and a 125 bp homology to fragment 5’-DHM4 
(oligo M4F1-pRS413), or to fragment 3’-DHM4 (oligo M4F5-pRS413), were 
synthesized at Integrated DNA Technologies, Inc. The final Intervening DHFR module 
04, plasmid pRS413-DHFR-Mod-04-Zeo, was created by ligating a 1.1 kb ZeoR 
expression cassette PCR amplified from plasmid pSV40/Zeo2 (ThermoFisher Scientific) 
using 5’ phosphorylated primer pair ZeoMluIFor/ZeoMluIRev, with the plasmid pRS413-
DHFR-Module-04 linearized by BmgBI. 
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For BAC recombineering an 11.6 kb targeting construct was excised out from 
plasmid pRS413-DHFR-Mod-04-Zeo using KpnI/DrdI restriction enzymes and gel 
purified. 
Assembly of modules to create multi-reporter DHFR BAC: The six targeting 
constructs derived from the three reporter modules and the three intervening DHFR 
modules were incorporated into the DHFR BAC by BAC recombineering, with the 
following order: Reporter module 01, Intervening DHFR module 02, Reporter module 
02, Intervening DHFR module 03, Reporter module 03 and Intervening DHFR module 
04. E. coli strain SW102 was used for BAC recombineering. Each round of BAC 
recombineering used a corresponding antibiotic (50 µg/ml Kanamycin, 50 µg/ml 
Spectinomycin, or 25 µg/ml Zeocin) as positive selection for incorporation of the current 
targeting construct as described in section “Construction of dual reporter DHFR BACs”. 
In the second to the last round of BAC recombineering, colonies were further screened 
for loss of the antibiotic resistance gene incorporated in the previous round of BAC 
recombineering by streaking colonies onto a plate containing the corresponding 




The raw reads of the WGS data were deposited at the Sequence Read Archive 
(SRA) database (BioProject number: PRJNA553146) at the National Center for 
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Figure 2.1. Two-prong experimental approach. Left: Identification of promoters of 
different strengths- We measured relative promoter strengths by embedding EGFP and 
mRFP reporter genes into the DHFR BAC, using the CMV promoter to drive EGFP 
expression and the test promoter to drive mRFP. The ratio of mRFP and GFP expression, 
normalized by this same ratio for a CMV test promoter, defines promoter strength relative 
to CMV. Right: Surveying reporter gene expression in different BAC scaffolds- (Top) The 
UBC-GFP-ZeoR reporter gene was inserted into BACs carrying DNA from mouse or 
human genomic regions corresponding to either transcriptionally active or inactive 
genomic regions. (Bottom) Plotting reporter gene expression (y-axis) versus reporter gene 
copy number (x-axis) for multiple cell clones stably expressing BAC transgenes: a linear 
correlation would indicate copy-number dependent, position independent expression, 






Figure 2.2 Dual-reporter assay for promoter strength estimation. (a) Dual reporter 
DHFR BAC showing the two genes on the BAC, Dhfr and Msh3, and the insertion sites 
of the two reporter expression cassettes. Longer vertical bars- exons; shorter vertical 
bars- UTRs; arrows- direction of transcription; green arrowhead- EGFP expression 
cassette insertion site; red arrowhead- mRFP expression cassette insertion site. (b) The 
two reporter gene/selectable marker cassettes used in the assay. The EGFP cassette (top) 
contains an EGFP minigene, driven by a CMV promoter, and a Kanamycin/Neomycin 
resistance gene (Kan/NeoR), driven by a SV40 promoter for expression in mammalian 
cells, or by a AmpR promoter for expression in bacteria. The mRFP cassette (bottom) 
contains a mRFP minigene and a Zeocin resistance gene (ZeoR). Different endogenous 
promoters were inserted immediately upstream of mRFP. ZeoR is driven by a SV40 
promoter for expression in mammalian cells, or by a AmpR promoter for expression in 
bacteria. pA- poly(A) signal. (c) Scatter plots showing mRFP fluorescence (y-axis) vs 
EGFP fluorescence (x-axis) of cells from the mixed clonal populations stably transfected 
with dual reporter DHFR BACs. Promoters driving the mRFP and the ratio of 






Figure 2.3. Expression of reporter gene embedded in different BAC scaffolds. (a) 
UBC-GFP-ZeoR-FRT-GalK-FRT cassette showing the GFP-ZeoR minigene driven by 
the UBC promoter and the galK positive/negative selection marker flanked by 34 bp 
flippase recognition target (FRT) sites (arrowheads). (b) Maps of the BACs used in the 
study. Longer vertical bars- exons; shorter vertical bars- UTRs; black arrows or 
arrowheads- direction of transcription; green arrow heads- UBC-GFP-ZeoR insertion site. 
(c) GFP fluorescence histograms obtained by flow-cytometry for “uniform” (left, green, 
clone DHFR-UG-f3-15) versus “heterogeneous” (right, green, clone DHFR-UG-f1-6) 
expressing NIH 3T3 clones carrying the DHFR-UG BAC. x-axis- fluorescence value, y-
axis- cell number; gray- autofluorescence of untransfected cells. Fluorescence is 
measured in arbitrary units. (d) Scatter plots of mean normalized cellular GFP 
fluorescence (y-axis) vs reporter gene copy number (x-axis) for clonal populations 
transfected with the UBC-GFP-ZeoR cassette alone or with different BAC scaffolds 
carrying the UBC-GFP-ZeoR reporter gene. Linear regression fits (black lines, y-
intercepts set to 0) are shown with corresponding R-squared values and equations. Red 
circles- heterogeneous clones; Black circles- uniform clones; Bottom right of plots: 





Figure 2.4. UBC-GFP-ZeoR reporter gene expression over time. “Uniform” clones 
show stable expression with or without expression, while “heterogenous” clones show 
progressive loss of expression without selection. (a) Changes in GFP fluorescence of 
uniform versus heterogeneous clones, averaged over multiple clones (2-8), carrying 
indicated BAC transgenes during 96 days of continuous passaging with or without Zeocin 
selection. x-axis- number of days since removal of Zeocin; y-axis- mean fluorescence 
values of multiple clones divided by that at day zero; black- “uniform” expressing clones 
cultured with Zeocin; blue- “uniform” expressing clones cultured without Zeocin; red- 
“heterogeneous” expressing clones cultured with Zeocin; green- “heterogeneous” 
expressing clones cultured without Zeocin; (b) GFP fluorescence histogram of 
representative “uniform” and “heterogeneous” expressing NIH 3T3 clones at day 0, 24, 
60 and 96 without selection. Gray- autofluorescence of untransfected cells; Green- GFP 





Figure 2.5. BAC transgenes exist as episomes in heterogeneously expressing clones. 
(a-c) BAC copy number analysis of sub-populations of a heterogeneous clone, DHFR-
UG-s3, with different fluorescence levels. (a) GFP fluorescence histogram of DHFR-UG-
s3 cells during first sorting (y-axis- cell number; x-axis- GFP fluorescence level). Cells 
within a narrow peak-window (dotted lines) were sorted by FACS. (b) GFP fluorescence 
histogram of sorted DHFR-UG-s3 cells after one week of cell growth. Cells within the 
four colored windows (P1-4) were sorted by FACS and used for BAC copy number 
estimation by qPCR. (c) Mean GFP fluorescence (y-axis) vs copy number (x-axis) of the 
four cell sub-populations and the original unsorted population shows linear correlation  
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Figure 2.5. Cont. 
between fluorescence levels and copy number (R2=0.99). (d-e) DNA FISH over 
interphase nuclei of the heterogeneous clone DHFR-UG-s3 (d) and a uniform clone 
DHFR-UG-f3-15 (e) to visualize the BAC transgenes. Maximum-intensity projections are 
shown. Gamma=0.5 was applied to FISH channel after projection to better display low 
intensity FISH spots. (f-g) DNA FISH over mitotic spreads of the heterogeneous clone 
DHFR-UG-s3 (f) and the uniform clone DHFR-UG-f3-15 (g). (h) DAPI intensity over an 
episome with strong FISH signal and one with weak FISH signal. Top: enlarged view of 
the white square area in (f); bottom: DAPI (red) and FISH signal (green) intensity profile 
along the white arrow in the top panel. (i) A pair of telophase nuclei of the heterogeneous 
clone, DHFR-UG-s3, showing unequal segregation of episomal BAC transgenes during 





Figure 2.6. BAC episome size estimation and CNV analysis. (a) Estimation of average 
episome size in the DHFR-UG-s3 clone using mitotic FISH. Red- DNA DAPI stain; 
Green- BAC FISH signal; Red circles: regions of interest (ROIs) of FISH spots used for 
analysis; Yellow circles: ROI of the smallest chromosome in the field. Scale bars = 5 µm. 
This panel reuses the image in Figure 5f for analysis. (b) Southern hybridization using 
probes prepared from the DHFR BAC of cellular DNA without enzyme digestion, or 
digested with increasing amount of S1 Nuclease, separated by PFGE. Lane 1-4: uniform 
clone DHFR-UG-f3-1; Lane 5-8: heterogeneous clone DHFR-UG-s3; Lane 9-12: E. coli 
carrying the DHFR BAC. (c-g) CNV analysis of the DHFR-UG-s3 clone. (c) Flow chart 
of the CNV analysis. (d) Two FACS experiments for collecting cells with high (H1 and 
H2), and low (L) fluorescence subpopulation. x-axis- FITC channel intensity; y-axis-  
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Figure 2.6. Cont. 
forward scatter; H1, H2, and L- sorting windows. (e) Episome-localizing genomic 
regions (pink highlighted regions) are expected to have mean log2(ratio) (red line) equal 
to or greater than log2(estimated minimum copy number increase) (blue dashed line). (f) 
log2(ratio) of individual bins (dark gray dots) and the segment mean log2(ratio) (red lines) 
around the Dhfr-Msh3 locus belonging to the DHFR BAC (pink highlight) in the H1 and 
H2 subpopulations of the DHFR-UG-s3 clone. (g) Scatter plot of segment mean 
log2(ratio) vs segment mean log2(normalized reads) of all segments of the H1 and H2 
subpopulations of the DHFR-UG-s3 clone. Pink dots- segments belonging to the DHFR 
BAC, including the Dhfr-Msh3 locus, UBC-GFP-ZeoR and the BAC vector; Black dots- 






Figure 2.7. BAC-MAGIC and simultaneous multi-reporter expression. (a-b) 
Construction of the multi-reporter DHFR BAC by BAC-MAGIC. (a) Modular design of 
BAC-MAGIC. Reporter module 01, 02 and 03 contain reporter gene expression cassettes 
(X), DHFR BAC homologous sequences (dark gray), and Spectinomycin resistance 
markers (SpecR, yellow) near the 3’ ends for bacterial selection. Intervening DHFR 
module 02, 03 and 04 contain DHFR BAC homologous sequences (dark gray), and 
antibiotic resistance markers near the 3’ ends (Kanamycin/Neomycin resistance marker 
(Kan/NeoR, blue) in module 02 and 03 for bacterial selection, and Zeocin resistance 
marker (ZeoR, dark green) in module 04 for dual selection in bacterial or mammalian  
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Figure 2.7. Cont. 
cells). The dotted lines mark homologous regions between the reporter modules and the 
intervening DHFR modules. (b) Six sequential steps of BAC recombineering introduce 
three reporter expression cassettes, RPL32-driven SNAP-tagged Lamin B1 (RSLB1), 
PPIA-driven SNAP-tagged Fibrillarin (PSF), and PPIA-driven mCherry-Magoh, onto the 
DHFR BAC (light gray) with ~10 kb of intervening DHFR BAC sequences (dark gray). 
Homologous regions are indicated by crossed lines. (c) Relative expression of the SNAP-
tagged Lamin B1 and Fibrillarin to the mCherry-Magoh reporter in four representative 
NIH 3T3 cell clones (04, 08, 13 and 14) containing the multi-reporter BAC. Integrated 
fluorescence intensities per cell of SNAP--fluorescein (y-axis) and mCherry-Magoh (x-
axis) are plotted. Linear regression lines (y-intercepts set to 0) are shown with 
corresponding R-squared values. Number of nuclei of each clone analyzed range from 18 
to 27. Red- Clone 04; Blue- Clone 08, Black- Clone 13; Green- Clone 14. (d) 
Representative images (maximum intensity projections of 2-3 optical sections) from the 
four cell clones (Clone 04, 08, 13 and 14) showing expression of the three reporter genes. 
Nuclear lamina is labeled with SNAP-tagged Lamin B1 (green), nucleoli with SNAP-
tagged Fibrillarin (green), and speckles with mCherry-Magoh (red). One magnified 
nucleus from each representative field (top panel) is shown in the bottom panel. Scale 
bars = 5 μm. 
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Table 2.1. Percentage of heterogeneously expressing clones transfected with the UBC-
GFP-ZeoR cassette alone or with different BAC scaffolds carrying the UBC-GFP-
ZeoR reporter gene. 
 
Construct Heterogeneous clones% Number of clones 
UBC-GFP-ZeoR 0 58 
DHFR-UG 60% 30 
ROSA-UG 76% 38 
UBB-UG 58% 41 
2207K13-UG 69% 35 




Table 2.2. BAC copy number, episome copy number, and BAC DNA content per 




number per cell 
Episome copy 
number per cell 




BAC content per 
episome (kb) 
DHFR-UG-s3 15.4 6.2 (n=99) 2.5 178 445 




Table 2.3. BAC copy number, estimated episome copy number, and estimated 
minimum copy number increase of episome-localizing DNA in H1 and H2 





number per cell 
Estimated episome copy 
number per cell 
Minimum copy number increase of 
episome-localizing DNA relative to L 
DHFR-UG-s3_H1 49.4 19.8 5.8 
DHFR-UG-s3_H2 57.5 23.1 6.6 
DHFR-UG-s3_L 0.3 0.1 / 
HBB-UG-100d3_H1 48.5 14.7 4.6 
HBB-UG-100d3_H2 51.2 15.5 4.8 
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CHAPTER 3: BAC TRANSGENE ARRAYS AS A MODEL SYSTEM FOR 
DISSECTING LARGE-SCALE CHROMATIN ORGANIZATION 
 
ABSTRACT 
Dissecting mechanisms regulating large-scale chromatin organization in 
mammalian cells is difficult largely due to the complexity of the mammalian genome and 
the lack of efficient ways both to manipulate the sequence and then to visualize the 
consequences of these manipulations on chromatin folding and nuclear localization. Here 
we show how bacterial artificial chromosomes (BACs) may be a powerful tool to dissect 
determinants of large-scale chromatin organization. We first show distinctive chromatin 
structures formed by Mb sized BAC transgene arrays containing transcriptionally active 
versus inactive genomic inserts. Such BAC transgene arrays have much lower DNA 
complexity than endogenous genomic regions of comparable size. We then show 
interesting clues about determinants of large-scale chromatin organization. First, insertion 
of a reporter mini-gene into a BAC containing the human b-globin locus (HBB BAC) 
moved the BAC transgene away from the nuclear periphery, without opening up the 
condensed chromatin formed by the HBB BAC transgene. Second, a deletion DHFR 
BAC, derived from a BAC containing the mouse Dhfr-Msh3 locus (DHFR BAC) formed 
more condensed chromatin, but had higher transcriptional activities, compared to another 
deletion DHFR BAC. These results suggest separable pathways controlling large-scale 







In eukaryotes, DNA is packaged with histones and other proteins, as wells as 
RNAs, to form chromatin in interphase cells. Large-scale chromatin organization refers 
to the chromatin structure beyond the “beads-on-a-string” chromatin fiber (Olins and 
Olins, 1974), and the spatial organization of the chromatin. While the higher levels of 
chromatin folding has not been solved (Bian and Belmont, 2012; Ghirlando and 
Felsenfeld, 2013), it has long been observed that chromatin fibers in the interphase nuclei 
have various diameters, as shown by transmission electron microscopy (TEM) studies 
(Belmont et al., 1989; Bohrmann and Kellenberger, 1994; Bazett-Jones and Hendzel, 
1999) and recently ChromEMT (Ou et al., 2017). However, it is not clear whether such 
differential compaction of chromatin is sequence specific, and if so, what sequences, and 
how these sequences regulate chromatin compaction. 
The chromatin has highly ordered spatial organization. Each chromosome 
occupies a distinct territory (Cremer and Cremer, 2001; Parada et al., 2002). The 
interaction pattern of genomic regions on each chromosome form topologically 
associating domains (Dixon et al., 2012; Dixon, Gorkin and Ren, 2016). The positioning 
of the genomic regions in relative to the nuclear lamina and various nuclear bodies, such 
as nuclear speckles, nucleoli, Cajal bodies, etc., is also non-random, as shown by both 
microscopy (Shopland et al., 2003; Wang et al., 2016) and genomic mapping studies 
(Pickersgill et al., 2006; Guelen et al., 2008; Németh et al., 2010; Peric-Hupkes et al., 
2010; van Koningsbruggen et al., 2010; Chen et al., 2018; Quinodoz et al., 2018). 
However, like with large-scale chromatin structure, the sequences and mechanisms that 




Moreover, numerous studies have shown correlations between chromatin 
compaction, nuclear localization, epigenetic modifications, and transcriptional activities. 
The nuclear lamina and nucleoli are lined with condensed chromatin (Fawcett, 1966; 
Schöfer and Weipoltshammer, 2018). Lamina associated genomic regions (LADs) 
(Pickersgill et al., 2006; Guelen et al., 2008) are generally low in transcriptional activity, 
and are enriched with repressive histone modifications (Guelen et al., 2008; Peric-
Hupkes et al., 2010). Chromatin with different combinations of epigenetic marks forms 
distinctive structures (Boettiger et al., 2016; Xu et al., 2018). Genomic regions with 
higher transcriptional activities are less condensed and further away from the nuclear 
periphery than that with lower transcriptional activities (Chambeyron and Bickmore, 
2004; Gierman et al., 2007; Hu et al., 2009; Peric-Hupkes et al., 2010; Lund et al., 2013; 
Robson et al., 2016). However, whether these correlations are merely coincidence, or real 
cause-effect relationships needs further studying.  
A molecular dissection, where DNA sequences in a genomic region are disrupted 
to test their effects on large-scale chromatin organization, epigenetic modifications and 
transcriptional activities, would greatly advance our understandings of the regulation of 
large-scale chromatin organization and its functional roles. However, such molecular 
dissection is difficult in mammalian systems. First, the mammalian genome has too many 
functionally redundant cis-elements and long-range interactions that disrupting one or 
several cis-elements might not produce a significant phenotype. Second, manipulating 
sequences in mammalian cells is still non-trivial. Finally, to exceed the resolution limit of 
light microscopy, the genomic region for dissection needs to be long enough, which 




Alternatively, using BAC transgene arrays as a model system could circumvent 
these difficulties. BACs contain 100-300 kb mammalian genomic inserts and can 
integrate into the mammalian genome as tandem arrays of up to Mb in size (Hu et al., 
2009; Sinclair et al., 2010). These arrays have much lower DNA complexity than 
endogenous genomic regions of comparable size, yet they retain near normal levels of 
expression for the genes contained within the BAC genomic inserts (Hu et al., 2009; Li et 
al., 2009; Sinclair et al., 2010). Moreover, BAC DNA sequences can be efficiently 
manipulated by BAC recombineering within Escherichia coli (E. coli).  
Previously, our lab showed large scale chromatin structures of several BAC 
transgene arrays in several mammalian cell lines (Hu et al., 2009; Bian and Belmont, 
2010; Sinclair et al., 2010), as well as BAC transgene motion after transcription 
activation (Khanna, Hu and Belmont, 2014; Kim et al., 2019). We also dissected the 
HBB BAC for nuclear periphery targeting mechanisms (Bian et al., 2013). Interestingly, 
however, a recent study in our lab showed that a reporter mini-gene had similar 
expression levels, uniformness of expression and long-term expression stability 
embedded in BACs containing transcriptionally active vs inactive genomic inserts 
(Chapter 2), indicating that the BAC transgenes could not recapitulate all features of the 
corresponding genomic regions, or the reporter mini-gene is insensitive to large-scale 
chromatin environments, or both. 
Here we show distinctive chromatin structures formed by three BACs from that 
study (Chapter 2), demonstrating that BACs can reconstitute differential chromatin 
compaction, and that large-scale chromatin folding is regulated by DNA sequences. We 




HBB BAC without opening the condensed chromatin formed by the BAC transgene. 
Moreover, we show uncorrelated level of chromatin compaction and level of transcription 
from both reporter mini-gene and BAC transgens. These results suggest an experimental 
path to dissect the relationship between large-scale chromatin structure, nuclear 





Establishing BAC cell lines 
Previously our lab analyzed the expression of a human UBC promoter driven, 
CpG free, GFP-Zeocin resistance fusion mini-gene (UBC-GFP-ZeoR) embedded in 
BACs containing transcriptionally active vs inactive genomic regions in mouse NIH 3T3 
fibroblast cells (Chapter 2). Interestingly, this study found that the UBC-GFP-ZeoR 
reporter mini-gene had similar expression level, uniformness of expression and long-term 
expression stability in all the BACs tested (Chapter 2). To test whether BACs containing 
highly transcribed regions would form less condensed chromatin structure than BACs 
containing transcriptionally inactive regions, we chose three BACs from the previous 
study (Chapter 2) to study.  
The DHFR-UG BAC was derived from the CITB-057L22 BAC (DHFR BAC) 
containing a mouse Dhfr gene and a partial mouse Msh3 gene, both actively transcribed 
in NIH 3T3 cells (Figure 3.1a). The HBB-UG BAC was derived from the CTD-2643I7 




3.1b). The 2207K13-UG BAC was derived from the CTD-2207K13 BAC (2207K13 
BAC) containing a human genomic region with no known genes or regulatory elements 
(Figure 3.1c). All three BACs have the UBC-GFP-ZeoR mini-gene inserted (Figure 3.1a-
c). The UBC-GFP-ZeoR expression level/copy number in the three BACs was 1.9 in the 
DHFR-UG BAC, 1.5 in the HBB-UG BAC, and 1.2 in the 2207K13-UG BAC (Chapter 
2). 
To obtain more clones with large integrated BAC transgene arrays for easier 
chromatin structure analysis by light microscopy, we FACS sorted mixed clonal 
populations stably transfected with the BACs for high GFP expressing cells and isolated 
single clonal populations. As the previous study (Chapter 2) showed that in NIH 3T3 
cells, a large fraction of stably transfected clones contained episomal BAC transgenes 
rather than integrated BAC transgenes, and that BAC episome clones had variegated GFP 
expression, we screened the clones for uniform GFP expression by flow cytometry. 
We measured BAC copy number in the selected clones using qPCR (Table 3.1) 
and estimated BAC transgene array size by multiplying BAC copy number with BAC 
size (Table 3.1). We also calculated GFP fluorescence per BAC copy number and 
confirmed that the UBC-GFP-ZeoR expression is similar in all BAC clones (Table 3.1). 
 
BAC transgene arrays reconstitute distinctive large-scale chromatin structures  
We visualized the DHFR-UG, HBB-UG and 2207K13-UG BAC transgene arrays 
in the selected clones with 3D DNA FISH (Cremer et al., 2008; Solovei and Cremer, 
2010). Clones with more than one FISH spots per nucleus or with bad cell morphologies 




formed an “open” chromatin structure, with elongated and fiber like FISH spots (Figure 
3.2a). Moreover, with the increase of BAC transgene copy number, the DHFR-UG BAC 
transgene array FISH spots increased significantly in size, and became more and more 
fiber like (Figure 3.2a). Interestingly, the fiber like structure of the DHFR BAC transgene 
arrays, especially the large ones, were not uniform in diameter, but like a set of connected 
round or elongated blobs instead (Figure 3.2a). In contrast, both the HBB-UG and the 
2207K13-UG BAC transgene arrays formed round blob like structures which became 
slightly irregular and increased slightly in size with the increase of BAC copy number 
(Figure 3.2b-c). There was no significant differences between the HBB-UG and the 
2207K13-UG BAC transgene arrays (Figure 3.2b-c) as judged by eye. 
To confirm the visual observations of the BAC transgene arrays, we quantitated 
the maximum intensity z-projections of the FISH spots by two metrics: area and 
circularity (defined as 4p´area/perimeter^2). A perfect circle has a circularity equal to 1 
while a line has a circularity equal to 0. To objectively select the FISH spots, several 
segmentation methods were tested with a few FISH images and the accuracy was judged 
by eye. The multi-threshold maximum entropy thresholding method (Sacha, 1985) was 
selected for its accuracy and not requiring manual input. The whole analysis used Fiji 
(Schindelin et al., 2012) and was summarized in Figure 3.3a. To separate BAC 
transgenes from background fluorescent aggregates and endogenous Dhfr-Msh3 loci, 
areas containing individual nuclei were first cropped out from the z-projection images 
and the lowest thresholds produced by the 3-threshold maximum entropy thresholding 
function were used to further confine the areas containing the BAC transgene FISH spots. 




surrounding the FISH signals (Figure 3.3b). The selected FISH spots were verified by eye 
and the area and circularity were measured. This analysis pipeline worked well 
with >90% of the FISH images analyzed (Figure 3.3b). 
We plotted area or circularity against BAC transgene array size. Consistent with 
the visual observation, the area curve of the DHFR-UG BAC transgene array was always 
above that of the HBB-UG or 2207K13-UG BAC transgene arrays, while the circularity 
curve always below (Figure 3.3c). Moreover, with increasing BAC transgene array size, 
the area and the circularity of the DHFR-UG BAC transgene array changed much faster 
than the other two BAC transgene arrays (Figure 3.3c). Interestingly, the 2207K13-UG 
BAC transgene array had a slightly larger area than but similar circularity as the HBB-
UG BAC transgene array. More sensitive imaging method, such as TEM, is needed to 
confirm whether 2207K13-UG and HBB-UG BAC transgenes can form different 
chromatin structures. 
In conclusion, the DHFR-UG, HBB-UG and 2207K13-UG BACs can reconstitute 
differentially compacted chromatin in NIH 3T3 cells, indicating that the level of 
chromatin compaction is regulated by certain genomic sequences and that BAC transgene 
arrays are suitable for dissecting cis-elements regulating differential chromatin 
compaction. 
 
The UBC-GFP-ZeoR reporter mini-gene moved the HBB BAC transgene away from 
the nuclear periphery 
It is intriguing how the UBC-GFP-ZeoR mini-gene gets as highly expressed in a 




of such transcriptional insensitivity to large scale chromatin structure here, we report an 
interesting discovery about the UBC-GFP-ZeoR reporter mini-gene and the HBB BAC. 
A previous study in our lab showed that the HBB-LacO BAC (Figure 3.4a), 
derived by inserting a 10-kb, 256mer lac operator direct repeat (LacO) into the HBB 
BAC, localized at the nuclear periphery in NIH 3T3 cells (Bian et al., 2013). Three 
functionally redundant nuclear periphery targeting regions (PTR1-3) on the HBB BAC 
(Figure 3.4a) were identified (Bian et al., 2013). Deletion HBB BACs containing none of 
the PTRs, such as HBBD4, localized to chromocenters, which are clusters of 
pericentromeric heterochromatin, in NIH 3T3 cells, whereas deletion HBB BACs 
containing any of the PTRs, such as HBBD5 (Figure 3.4a), localized to the nuclear 
periphery (Bian et al., 2013). Moreover, reducing H3K9me3 by knocking down SuvH1 
and SuvH2 inhibited both the nuclear periphery and the chromocenter targeting of the 
HBB-LacO BAC transgene (Bian et al., 2013).  
Interestingly, the HBB-UG BAC has the UBC-GFP-ZeoR reporter mini-gene 
inserted in the PTR2 region (Figure 3.1b and Figure 3.4a). During our analysis of the 
HBB-UG BAC transgene chromatin structure, we found most of the DNA FISH spots 
were localized in the nuclear interior. 
To validate this observation, we analyzed the nuclear localization of the HBB-
LacO BAC transgene in clone HBB-LacO-C3, the HBBD4 BAC transgene in clone 
HBBD4-C40, the HBBD5 BAC transgene in clone HBBD5-C43, and the HBB-UG 
transgene in three clones: HBB-UG-fD2 (Chapter 2), HBB-UG-H3-50-4, and HBB-UG-
H4-100-16. We also included two clones containing the DHFR-UG BAC, DHFR-UG-P4-




Although the clones from the previous study (Bian et al., 2013) expressed an 
EGFP-dimer lac repressor-NLS (nuclear localization signal) fusion protein (EGFP-LacI), 
we visualized all the BAC transgenes by 3D DNA FISH. Optical sections where the 
FISH signals were in focus and was on the middle planes of the nuclei were used for 
analysis. FISH spots localized within 0.2 µm from the edge of the nuclei defined by 
DAPI staining was regarded as nuclear periphery localization. FISH spots completely or 
partially overlapping chromocenters was regarded as chromocenter localization.  
Consistent with the previous study (Bian et al., 2013), clone HBB-LacO-C3 and 
clone HBBD5-C43 had much higher rate of nuclear periphery localizing BAC transgenes 
than the two DHFR-UG BAC clones, whereas the HBBD4 clone had similar rate as the 
DHFR-UG BAC clones (Figure 3.4b). However, different form the previous study (Bian 
et al., 2013), increased chromocenter localization was not observed in the HBBD4 clone 
and the summed rate of periphery localization and chromocenter localization of the 
HBBD4 clone was similar to that of the two DHFR-UG clones, and much lower than that 
of the HBB-LacO clone or that of the HBBD5 clone. This difference in chromocenter 
localization could be due to physiological changes in the clone, or due to possible 
distortions of chromocenters during the FISH procedure. The three HBB-UG clones had 
similar rate of nuclear periphery localizing and chromocenter localizing BAC transgenes 
as the two DHFR-UG clones.  
In conclusion, insertion of the UBC-GFP-ZeoR mini-gene moved the HBB BAC 
transgene away from the nuclear periphery. However, whether the HBB-UG BAC 




confirmation, which would give a hint on whether H3K9me3 over the HBB BAC 
transgene was disrupted by the UBC-GFP-ZeoR mini-gene. 
 
Two deletion DHFR BACs reconstituted differentially compacted chromatin 
The observation that the UBC-GFP-ZeoR reporter gene expression was similar in 
“open” versus condensed chromatin formed by the DHFR-UG, HBB-UG and 2207K13-
UG BACs indicates that at least for some genes the level of chromatin compaction is not 
directly related to the level of transcription. While here we do not dissect the underlying 
mechanism, we provide another example of uncorrelated transcription and chromatin 
compaction. 
In an attempt to dissect the DHFR BAC for sequences responsible for the “open” 
chromatin structure formed by the BAC transgene array, we made two deletion DHFR 
BACs. The DHFR-c27d2 BAC contains a LacO, a CMV-mRFP-SV40-ZeoR expression 
cassette and a ~70 kb deletion of the 3’ part of the Msh3 gene (Figure 3.5a). The DHFR-
c27d3crz BAC contains a LacO, a CMV-mRFP-SV40-ZeoR expression cassette and a 
~80 kb deletion of the whole Dhfr gene and the 5’ part of the Msh3 gene (Figure 3.5a). 
An NIH 3T3 clone expressing an EGFP-LacI was used for making the BAC cell lines. 
We measured BAC copy number in individual clones by qPCR (Table 3.2) and estimated 
BAC transgene array size (Table 3.2). 
The BAC transgene arrays were visualized directly in formaldehyde fixed cells. A 
previous study (Sinclair et al., 2010) showed that in two NIH 3T3 clones stably 
transfected with a full length DHFR BAC containing LacO, the EGFP-LacI spots 




spot, and BAC and LacO DNA FISH signals were highly co-localized. Here we found 
that in a DHFR-c27d2 BAC clone (DHFR-c27d2-02) with high BAC copy number, the 
EGFP-LacI spots were tiny, well separated from each other, and arranged in fiber-like 
conformation (Figure 3.5b), similar to what was observed with the full-length DHFR 
BAC (Sinclair et al., 2010). In contrast, a DHFR-c27d3crz BAC clone (DHFR-c27d3crz-
65) with similar BAC copy number, the EGFP-LacI spots were frequently fused together, 
forming blob-like structures (Figure 3.5c). Such difference was less obvious in clones 
with low BAC copy numbers (DHFR-c27d2-17 vs DHFR-c27d3crz-33). However, we 
did find that clone DHFR-c27d2-17 had more EGFP-LacI spots than clone DHFR-
c27d3crz-33 (Figure 3.5 b-c) in general. However, the DHFR-c27d3crz transgene arrays 
looked less condensed than the HBB-UG and 2207K13-UG BAC transgenes. 
To validate the observed differences in the DHFR-c27d2 and the DHFRc27d3crz 
BAC transgene chromatin structures, we quantitated the maximum intensity z-projections 
of the EGFP-LacI spots. The whole analysis used Fiji (Schindelin et al., 2012) and was 
summarized in Figure 3.6a. To separate BAC transgenes from background fluorescent 
aggregates, areas containing individual nuclei were first cropped out from the z-
projection images and a maximum entropy thresholding method was used to further 
confine the areas containing the EGFP-LacI spots. We quantitated the EGFP-LacI spots 
in two aspects. First, the number, area and circularity of individual spots, segmented by 
an unsharp mask followed by maximum entropy or simple thresholding, were measured. 
Second, the contour of all the spots was identified by blurring the spots with a Gaussian 
mask followed by maximum entropy or simple thresholding, and the area and circularity 




Consistent with visual observation, the two DHFR-c27d2 clones had more EGFP-
LacI spots, with each spot having larger circularity and smaller area comparing to the two 
DHFR-c27d3crz clones. Moreover, DHFR-c27d2 clones had 9-16 BACs per EGFP-LacI 
spot (Table 3.2), which is around twice of the full length DHFR-c27 BAC (Sinclair et al., 
2010), while the DHFR-c27d3crz clones had 23-45 BACs per EGFP-LacI spot (Table 
3.2). Considering that the DHFR-c27d2 BAC is half in size of the full length DHFR BAC, 
the compaction level of the DHFR-c27d2 should be similar to that of the full DHFR BAC.  
 
Higher transcription level over the more condensed deletion DHFR BAC transgene 
array than the more “open” one 
As the DHFR-c27d2 BAC retains the divergent promoter driving the Dhfr and the 
Msh3 gene, whereas the DHFR-c27d3crz BAC does not contain any known promoters, 
we hypothesized that the divergent promoter and active transcription of the Dhfr and the 
Msh3 gene could be contributing to the more “open” chromatin structure of the DHFR-
c27d2 BAC transgene. Therefore, we measured transcription levels over the two deletion 
DHFR BACs and the full length DHFR BAC by qPCR, using cells without the BAC 
transgenes as reference samples. The transcription levels were further normalized by 
BAC copy number for easier comparison. As expected, the transcription levels of the 
DHFR-c27d2 BAC was similar to the corresponding regions on the full length DHFR 
BAC (Figure 3.7a). Surprisingly, the DHFR-c27d3crz BAC had even higher transcription 
than the full length DHFR BAC, in spite of the absence of the divergent promoter (Figure 
3.7a), indicating alternative promoters getting activated by the deletion of the divergent 




BACs had higher expression in the more condensed DHFR-c27d3crz BAC than in the 
more “open” DHFR-c27d2 BAC, as shown both by qPCR (Figure 3.7b) and by flow 
cytometry (Table 3.2). These results suggests that the differential chromatin compaction 
of the two deletion DHFR BACs is not directly related to level of transcription, and the 
expression of the CMV-mRFP mini-gene embedded in the BACs is not purely 




With accumulating studies showing correlations between large-scale chromatin 
organization and genome function, dissecting the determinants regulating large-scale 
chromatin organization becomes more and more important. However, the high density of 
regulatory elements and the frequent long-range interactions of the mammalian genome 
makes molecular dissection difficult. Here we show that BAC transgene arrays could be a 
powerful model system for dissecting the mechanisms regulating large-scale chromatin 
organization. 
Differential chromatin compaction has long been observed. Here we show that we 
can reproducibly reconstitute distinctive large-scale chromatin conformations with BAC 
transgene arrays by altering the genomic inserts contained within the BACs. Moreover, 
we show that we can manipulate the chromatin conformation of the BAC transgenes by 
manipulating the BAC sequences. 
It is not clear what the “default” chromatin conformation is, where neither 




has shown that genomic regions with active histone modifications have more “open” 
chromatin conformation than genomic regions with repressive histone modifications, and 
genomic regions with neither active or repressive histone modifications have chromatin 
conformation in between. While we have not analyzed the epigenetic marks over the 
BAC transgenes, genomic mapping studies in fibroblasts have shown that the genomic 
regions corresponding to the DHFR BAC has elevated active histone modifications, that 
corresponding to the HBB BAC has elevated H3K9me3, and that corresponding to the 
2207K13 BAC is low in both active and repressive histone modifications. Consistent 
with the previous study (Boettiger et al., 2016), the DHFR-UG BAC has the most “open” 
and the HBB-UG BAC most condensed large-scale chromatin conformation. 
Interestingly, the 2207K13-UG BAC forms similar chromatin conformation as the HBB-
UG BAC. Further studies comparing the epigenetic modifications over the BAC 
transgenes would yield helpful information about the relationship between epigenetic 
modifications and large-scale chromatin structures. 
Position effects and position effects variegation have been commonly seen in 
transgene expression (Robertson et al., 1995; Gierman et al., 2007; Ramunas et al., 2007; 
Akhtar et al., 2013; Tchasovnikarova et al., 2015). A previous study (Gierman et al., 
2007) has shown that a human PGK promoter driven GFP reporter gene integrated at 
different chromosomal positions has expression levels corresponding to the 
transcriptional activity of the regions of integration, and that transcriptionally active 
regions of integration have a more open chromatin structure than inactive regions. 
Interestingly, however, here we show that the UBC-GFP-ZeoR had similar expression 




large-scale chromatin structures and expression levels of the BAC transgenes, indicating 
position-independent expression of the UBC-GFP-ZeoR reporter gene. However, a 
previous study has shown that the UBC-GFP-ZeoR integrated into the chromosomes 
alone without the BACs has copy-number independent, position dependent expression 
(Chapter 2). A possible explanation is that the UBC-GFP-ZeoR reporter gene itself is 
insensitive to the chromatin environment of the integration site, but multi-copy plasmid 
repeats induced silencing in certain genomic regions. Alternatively, the BACs we 
selected happen to not contain the real repressive genomic regions, or the BAC 
transgenes cannot recapitulate certain features required for repressing reporter gene 
expression. Further studying the mechanism enabling the high expressing of the UBC-
GFP-ZeoR reporter gene in condensed BAC transgene arrays would reveal interesting 
clues about transcriptional regulation and large-scale chromatin structures. 
 
 
MATERIALS AND METHODS 
BAC modifications 
The DHFR-UG, HBB-UG and 2207K13-UG BACs were constructed in another 
study (Chapter 2). The DHFR-UG BAC was derived from the CITB-057L22 BAC 
(DHFR BAC) containing mouse chr13:92,992,156-93,161,185 (mm9). The HBB-UG 
BAC was derived from the CTD-2643I7 BAC (HBB BAC) containing human 
chr11:5,218,904-5,426,232 (hg19). The 2207K13-UG BAC was derived from the CTD-
2207K13 BAC (2207K13 BAC), containing human chr1:79,180,278-79,286,094. The 




inserted into these BACs at the following positions in relative to the mouse or human 
genome: chr13:93,099,101-93,099,102 (mm9) in the DHFR BAC, chr11:5,390,233-
5,390,244 (hg19) in the HBB BAC, and chr1:79,224,725-79,224,726 (hg19) in the 
2207K13 BAC. 
Construction of the two deletion DHFR BACs, DHFR-c27d2 and DHFR-
c27d3crz was described in another study (Chapter 2). The DHFR-c27 BAC (50) 
containing a 256-mer lac operator direct repeat (LacO) and a CMV-mRFP-SV40-ZeoR 
expression cassette was derived from the DHFR BAC. The DHFR-c27d2 and the DHFR-
c27d3crz BAC were derived from the DHFR-c27 BAC. The DHFR-c27d2 BAC contains 
a ~70 kb deletion of the 3’ part of the Msh3 gene (chr13:92,992,394-93,059,992, mm9). 
The DHFR-c27d3crz BAC contains a ~80 kb deletion of the whole Dhfr gene and the 5’ 
part of the Msh3 gene (chr13:93,075,639-93,160,310, mm9), and a new CMV-mRFP-
SV40-ZeoR expression cassette introduced at the remaining part of Msh3 gene 
(chr13:93,007,742-93,007,743, mm9). 
 
Cell culture and BAC cell line establishment 
NIH 3T3 cells were cultured with Dulbecco’s modified Eagle medium (DMEM, 
with 4.5 g/L D-glucose, 4 mM L-glutamine, 1 mM sodium pyruvate and 3.7 g/L 
NaHCO3) supplemented with 10% HyClone Bovine Growth Serum (GE Healthcare Life 
Sciences, Cat. # SH30541.03). 
Mixed clonal populations stably transfected with the DHFR-UG, HBB-UG or 
2207K13-UG BAC, respectively, obtained from another study (Chapter 2) were first 




The cells were either directly sorted into 96-well plates, at 1 cell/well, or sorted into tubes. 
The cells sorted into tubes were cultured for several days for them to recover and expand, 
and then diluted and plated in a 96-well plate at ~1 cell per well to obtain single 
populations. Both the mixed clonal and single clonal populations with the DHFR-UG, 
HBB-UG or 2207K13-UG BAC were maintained with 75 µg/ml Zeocin (Thermo Fisher 
Scientific). 
NIH 3T3 cell clone 3T3_LG_C29 stably expressing an EGFP-dimer lac repressor-
NLS (nuclear localization signal) fusion protein (EGFP-LacI) was obtained from another 
study (Bian et al., 2013) and was maintained with 200 μg/ml Hygromycin B (Thermo 
Fisher Scientific). Clone 3T3_LG_C29 was transfected with the DHFR-c27d2 or the 
DHFR-c27d3crz BAC using Lipofectamine 2000 (Thermo Fisher Scientific) according to 
the manufacturer’s instructions and selected with 200 μg/ml Hygromycin B and 75 µg/ml 
Zeocin for 1-2 weeks. Individual cell clones were obtained by serial dilution (Strukov and 
Belmont, 2008). Cells stably transfected with the DHFR-c27d2 or the DHFR-c27d3crz 
BAC were maintained with 200 μg/ml Hygromycin B and 75 µg/ml Zeocin. 
NIH 3T3 clones DHFR-UG-f3-1 and DHFR-UG-f3-15, stably transfected with 
the DHFR-UG BAC, and NIH 3T3 clone HBB-UG-fD2 stably transfected with the HBB-
UG BAC were created in another study (Chapter 2). 3T3_LG_C29 derived clones, HBB-
LacO-C3, HBBD4-C40 and HBBD5-C43 were created in another study (Bian et al., 
2013). NIH 3T3 clone DHFR-c27-4 stably transfected with the DHFR-c27 BAC was 







Flow cytometry used similar protocols as another study (Chapter 2). GFP 
expression from the UBC-GFP-ZeoR mini-gene was analyzed on a BD FACS Canto II 
Flow Cytometry Analyzer (BD Biosciences), using the FITC/Alexa Fluor-488 channel 
(488nm laser, 502 longpass dichroic mirror and 530/30 bandpass filter). mRFP 
expression from the CMV-mRFP-SV40-ZeoR mini-gene was analyzed on a BD LSR 
Fortessa (BD Biosciences), using the PE channel (561 nm laser and 582/15 nm bandpass 
filter). Rainbow fluorescent beads (Spherotech, Cat. # RFP-30-5A) were used as 
fluorescence intensity standards.  
Cell sorting used a BD FACS AriaII (BD Biosciences) and was assisted by the 
flow cytometry facility stuff at Roy J. Carver Biotechnology Center, University of Illinois 
at Urbana-Champaign (UIUC). Two sorting windows were set on the FITC channel (488 
nm laser, 505 longpass dichroic mirror and 530/30 nm bandpass filter), one over the 
highest GFP signals and one near the right half of the GFP peak, each took up ~10% of 
parent cells. 
 
Estimation of BAC transgene copy number 
BAC transgene copy number within individual cell clones was measured by real-
time quantitative PCR (qPCR), using relative quantitation methods as described in 
another study (Chapter 2). Mouse genes Sgk1 and Hprt1 were used as endogenous 
controls, assuming four copies of each gene per cell in NIH 3T3. Multiple primer pairs 
were used for estimating the copy numbers of the BAC transgenes: five for the DHFR-




DHFR-c27d2 and DHFR-c27d3crz. DCT method (Equation 3.1 and 3.2) was used to 
calculate the copy numbers of the PCR amplification regions on the UBC-GFP-ZeoR 
reporter gene, on the HBB BAC or on the 2207K13 BAC, and DDCT method (Equation 
3.3 and 3.4) was used to calculate the copy numbers of the PCR amplification regions on 
the DHFR BAC. The mean copy number of all PCR amplification regions was calculated 
as the copy number of that region. All primers are listed in Data A.1. 
 
  3.1 
   3.2 
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3D DNA FISH 
Biotin labeled DNA FISH probes were made from BAC DNA by end-labeling 
with Terminal Transferase, according to a published protocol (Dernburg, 2011). The 
following reagents were used: AluI, DpnI, HaeIII, MseI, MspI, RsaI (New England 
Biolabs) and CutSmart Buffer (comes with the enzymes); Terminal Deoxynucleotidyl 
Transferase and reaction buffer (Thermo Fisher Scientific, Cat. # EP0161); dATP (New 
England Biolabs, Cat. # N0446S) and Biotin-14-dATP (Thermo Fisher Scientific, Cat. # 
19524016). 
DNA FISH of interphase nuclei was performed according to published protocols 
(Cremer et al., 2008; Solovei and Cremer, 2010) with small modifications, and was 








Alex Fluor 488 conjugated Strepavidin (1:500; Jackson ImmunoResearch, Cat. # 016-
540-084), Alexa Fluor 647 conjugated Strepavidin (1:200; Jackson ImmunoResearch, Cat. 




For examining EGFP-LacI signals, cells were grown on coverslips and fixed with 
3-4% paraformaldehyde in DPBS before mounting. All samples- including fixed cells 
expressing EGFP-LacI and 3D DNA FISH sample- were mounted with a Mowiol-
DABCO anti-fade medium (‘Mowiol mounting medium’, 2006) containing ~3 μg/ml 
DAPI (MilliporeSigma). 3D z-stack images were acquired using a V4 OMX (GE 
healthcare) microscope, equipped with a 100X, 1.4 NA oil immersion objective 
(Olympus), and two Evolve EMCCDs (Photometrics). Images were deconvolved using 
the deconvolution algorithm (Agard et al., 1989) provided by the softWoRx software (GE 
Healthcare). Chromatic aberrations were measured using the alignment slide provided by 
GE Healthcare and the OMX Image registration function in the softWoRx was used to 
correct the chromatic aberrations in all DNA FISH images according to the 
manufacturer’s instructions. 
 
Analysis of DNA FISH images 
The area and circularity of z-projected DNA FISH signals were measured using 
Fiji (Schindelin et al., 2012). A macro was developed to semi-automate the analysis 




the “Z Project…” function with “projection=[Max Intensity]”. Next, individual nucleus 
was cropped out from the z-projection image to minimize the detection of background 
fluorescent aggregates by the computer program. An “Otsu” auto-thresholding function 
was applied to the DAPI channel of the z-projection to select individual nuclei. The 
selection was turned into a rectangle and enlarged by 1 µm. Next, a “Maximum Entropy 
Multi-Threshold” function with “number=3” from the IJ Plugins package (http://ij-
plugins.sourceforge.net/index.html) was applied to the FISH channel of the cropped 
nucleus image, generating three thresholds. To prevent endogenous Dhfr-Msh3 loci and 
background fluorescent aggregates from being identified, the area containing the FISH 
signal was first identified by applying the “Analyze Particles...” function with “size=0-
Infinity display exclude clear add" to the FISH channel masked with the lowest threshold 
and selecting the largest particle. The FISH signal was then identified by masking the 
area containing the FISH signal with the middle threshold. The selection of FISH signal 
was examined manually and any area not corresponding to the BAC transgene arrays 
were deselected. Finally, the area and circularity of the correctly selected FISH signals 
were measured by the “Set Measurements...” function with “area perimeter shape 
redirect=None decimal=3” and the “Measure” function.  
The following clones were used for Figure 3.3c: DHFR-UG-f3-1, -f3-15, -P4-14; 
HBB-UG-fD2, -H3-50-4, -H4-100-16; 2207K13-UG-K3-50-17, -K4-100-12. 
 
Analysis of BAC transgene nuclear localization 
The BAC transgenes were visualized by DNA FISH and images were analyzed 




examined manually and optical sections where he FISH spots were both in focus and 
were at the middle planes of the nuclei were used for analysis. To detect nuclear 
periphery localization, the edges of the nuclei was selected by applying a “Gaussian 
Blur…” function with “sigma=2.50” and subsequently a “Default dark” auto-thresholding 
function to the DAPI channel. The selection was then shrank by 0.2 µm. FISH spots 
overlapping the selection were regarded as localized at the nuclear periphery. FISH spots 
completely or partially overlapping a chromocenter were regarded as localized at 
chromocenters.  
95% confidence intervals of the proportions were calculated by Equation 3.5 and 
3.6 (N- total number of nuclei; Nd- number of nuclei with periphery or chromocenter 










Analysis of EGFP-LacI images 
The conformation and arrangement of z-projected EGFP-LacI spots were 
measured using Fiji (Schindelin et al., 2012). Macros were developed to semi-automate 
the analysis process. To prevent the computer program from identifying background 
fluorescent aggregates as EGFP-LacI spots, 100 pixel ´ 100 pixel areas containing the 






stack images were created and individual nucleus were cropped out from the z-projection 
images, using the same procedures as described in section “Analysis of DNA FISH 
images”. Incorrectly segmented individual nucleus images were then removed from 
analysis manually. Next, 100 pixel ´ 100 pixel areas containing EGFP-LacI spots were 
cropped out from the individual nucleus images, by applying a “MaxEntropy dark” auto-
thresholding function and subsequently a “Analyze Particles...” function with “size=20-
Infinity pixel exclude clear add” to the FITC channel, followed by turning the selection 
bounds of all identified particles into 100 pixel ´ 100 pixel square selections. Incorrectly 
segmented EGFP-LacI images were then removed from analysis manually.  
To make a selection contouring all of the EGFP-LacI spots, a “Gaussian Blur...” 
function with “sigma=2.5” was applied to the FITC channel, followed by a “MaxEntropy 
dark” auto-thresholding function (clone DHFR-c27d2-17 and clone DHFR-c27d3crz-33) 
or by setting threshold at 25% of the maximum intensity (clone DHFR-c27d2-02 and 
clone DHFR-c27d3crz-65). To segment individual EGFP-LacI spots, an “Unsharp 
Mask...” function with “radius=1 mask=0.90” was applied to the FITC channel, followed 
by a “MaxEntropy dark” auto-thresholding function (clone DHFR-c27d2-17 and clone 
DHFR-c27d3crz-33) or by setting threshold at 25% of the maximum intensity (clone 
DHFR-c27d2-02 and clone DHFR-c27d3crz-65). The area and circularity of the 
selections were measured by “Set Measurements...” with “area mean standard modal min 
centroid center perimeter bounding shape limit add redirect=None decimal=3” and 
“Analyze Particles...” with “show=Overlay display exclude include”. Finally, for clone 
DHFR-c27d2-17 and clone DHFR-c27d3crz-33, each segmented images were examined 




The number of individual spots in each nucleus were calculated by counting the number 
of entries for the individual spots for the nucleus. 
 
Estimation of transcription level of the full length DHFR BAC and the two deletion 
DHFR BACs 
Transcription levels over the DHFR-c27d2 and the DHFR-c27d3crz BAC were 
measured by real-time quantitative PCR (qPCR), using relative quantitation. Cellular 
RNA was extracted using RNeasy Mini Kit (QIAGEN) with in-solution DNase 
digestions, according to the manufacturer’s instructions. RNA was reverse transcribed 
with random hexamers using qScript Flex cDNA Kit (Qaunta Biosciences). Mouse gene 
Hprt1 were used as endogenous control. Multiple primer pairs were used for measuring 
the transcription over the BAC transgenes. DCT method (Equation 3.7 and 3.8) was used 
to calculate the transcription level of the CMV-mRFP reporter gene, and DDCT method 
(Equation 3.9 and 3.10) was used to calculate the transcription level of regions on the 
DHFR BAC. All primers are listed in Data A.1. 
 
  3.7 
   3.8 
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Transcription level over the DHFR-c27 BAC was measured similar as the 
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Figure 3.1. Maps of the DHFR-UG, HBB-UG and 2207K13-UG BAC. Longer vertical 
bars- exons; shorter vertical bars- UTRs; black arrows or arrowheads- direction of 






Figure 3.2. Representative 3D DNA FISH images showing distinctive chromatin 
conformation formed by the DHFR-UG, HBB-UG and 2207K13-UG clones. 
Maximum intensity z-projections of three DHFR-UG clones (a), three HBB-UG clones 
(b), and two 2207K13-UG clones (c) are shown. Insets are enlarged FISH signals. Clone 
numbers are shown on the bottom right of each image. Estimated sizes of the BAC 






Figure 3.3. Quantitative analysis of the FISH images confirms differences in large-
scale chromatin folding. (a) Work flow of the analysis. (b) Example images showing the 
results of segmentation of FISH signals in a DHFR-UG clone and a HBB-UG clone. (c) 
Median area (left, y-axis, unit = µm2) or median circularity (right, y-axis) of the FISH 
signals are plotted against estimated BAC transgene array size (Mb). Error bars represent 






Figure 3.4. The UBC-GFP-ZeoR reporter mini-gene moved the HBB BAC transgene 
away from the nuclear periphery. (a) Maps of the HBB-LacO, HBBD4 and HBBD5 
BACs. Dashed lines- deleted regions; PTR1-3: periphery targeting regions identified in 
another study (Bian et al., 2013); Longer vertical bars- exons; shorter vertical bars- UTRs; 
black arrows or arrowheads- direction of transcription; purple arrow heads- LacO 




Figure 3.4. Cont. 
localization (right) of the BAC transgenes in the corresponding clones. Error bars 
represent 95% confidence intervals. Number of images analyzed: 43 for HBB-LacO-C3, 
61 for HBBD4-C40, 36 for HBBD5-C43, 41 for HBB-UG-fD2, 40 for HBB-UG-H3-50-4, 






Figure 3.5. The DHFR-c27d2 deletion DHFR BAC formed more “open” chromatin 
conformation than the DHFR-c27d3crz deletion DHFR BAC. (a) Maps of the DHFR-
c27d2 and the DHFR-c27d3crz BACs. Dashed lines- deleted regions; Longer vertical 
bars- exons; shorter vertical bars- UTRs; black arrows or arrowheads- direction of 
transcription; green arrow heads- LacO insertion site; red arrow heads- CMV-mRFP-
SV40-ZeoR expression cassette insertion site; (b) Representative images of a large 
insertion and a small insertion DHFR-c27d2 clones. (c) Representative images of a large 
insertion and a small insertion DHFR-c27d3crz clones. (b-c) Maximum intensity z-
projections are shown. Insets are enlarged EGFP-LacI spots. Estimated sizes of the BAC 
transgene arrays are behind the clone names. Red- DAPI; Green- EGFP-LacI; Scale bars 







Figure 3.6. Quantitative analysis of the EGFP-LacI images confirms differences in 
large-scale chromatin folding. (a) Work flow of the analysis. (b) Comparison of two 
large insertion clones, DHFR-c27d2-02 vs DHFR-c27d3crz-65. (c) Comparison of two 






Figure 3.7. Transcription over the DHFR-c27d3crz BAC is higher than DHFR-
c27d2 BAC. (a) Transcription level over the DHFR BAC normalized by BAC copy 
number in two DHFR-27d2 clones and two DHFR-27d3crz clones, with comparison of 
clone DHFR-c27-4. (b) Transcription level of the mRFP reporter gene in the same clones 
as in (a). x-axis- locations on the DHFR BAC; y-axis- transcription level normalized by 




Table 3.1. Information of the DHFR-UG, HBB-UG and 2207K13-UG clones. 
 
 




array size (Mb) GFP/beads 
GFP/beads/BAC 
copy # GFP CV% 
DHFR-UG f3-1 37 179 6.6 94.3 2.5 43.2 
DHFR-UG f3-15 52 179 9.3 80.6 1.6 46.2 
DHFR-UG P4-14 24 179 4.3 52.1 2.2 26.6 
HBB-UG fD2 17 218 3.7 30.0 1.8 38 
HBB-UG H3-50-4 28 218 6.1 54.5 1.9 33.4 
HBB-UG H4-100-16 45 218 9.8 120.4 2.7 37.7 
2207K13-UG K3-50-17 33 116 3.9 / / / 




Table 3.2. Information of the DHFR-c27d2 and DHFR-c27d3crz clones. 
 





















c27d2 02 123 124 15.1 4.39 0.036 112.8 7.7 16.0 
DHFR-
c27d2 17 29 124 3.6 1.36 0.047 194.9 3.1 9.4 
DHFR-
c27d3crz 65 216 107 23.1 17.69 0.082 123 4.8 45.0 
DHFR-
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Figure A.1. GFP fluorescence histogram of representative “uniform” and 
“heterogeneous” expressing NIH 3T3 clones at day 0, 24, 60 and 96 without selection 
obtained by flow-cytometry. Gray- autofluorescence of untransfected cells; Green- GFP 





Figure A.2. DNA FISH over heterogeneously expressing clones transfected with 
DHFR-UG or HBB-UG BAC. (a-f) 3D DNA FISH over interphase nuclei from three 
DHFR-UG BAC (a-c) and three HBB-UG BAC (d-f) heterogeneous clones using BAC 
probes. Maximum-intensity projections are shown. (g-i) DNA FISH over mitotic spreads 
of one DHFR heterogeneous clone (g) and two HBB heterogeneous clones (h-i) using 





Figure A.3. Southern blot hybridization - using probes prepared from BAC DNA- of 
cellular DNA without enzyme digestion, or digested with increasing amount of S1 
Nuclease, separated by PFGE. (a) Lane 1-2: NIH 3T3 cellular DNA; Lane 3-7: uniform 
clone HBB-UG-fD2; Lane 8-12: heterogenous clone HBB-UG-100d3; (b) E. coli 





Figure A.4. CNV analysis of the HBB-UG-100d3 clone. (a) Two FACS experiments 
for collecting cells with high (H1 and H2), and low (L) fluorescence subpopulations. x-
axis- FITC channel intensity; y-axis- forward scatter; H1, H2, and L- sorting windows. 
(b) log2(ratio) of individual bins (dark gray dots) and the segment mean log2(ratio) (red 
lines) over the HBB BAC (pink highlight) in the H1 and H2 subpopulations of the HBB-
UG-100d3 clone. (c) Scatter plot of segment mean log2(ratio) vs segment mean 
log2(normalized reads) of all segments of the H1 and H2 subpopulations of the HBB-UG-
100d3 clone. Pink dots- segments belonging to the HBB BAC, including the HBB locus, 
UBC-GFP-ZeoR and the BAC vector; Black dots- genomic segments. (b-c) Blue dashed 





Figure A.5. Comparison of copy number fold increases of BAC regions (y-axis) in 






Figure A.6. log2(ratio) of individual bins (dark gray dots) and the segment mean 
log2(ratio) (red lines) over the UBC-GFP-ZeoR and the pBeloBAC11 BAC 
backbone, in the H1 and H2 subpopulations of the DHFR-UG-s3 and the HBB-UG-





Figure A.7. Promoter strength and BAC episome formation. (a) Summary of 
percentages of heterogeneously expressing clones and relative promoter strengths for 
different reporter constructs embedded in the DHFR BAC. (b) Average normalized RFP 
fluorescence of individual cell clones (y-axis) are plotted versus transgene copy number 
(x-axis) for EEF1α-mRFP-SV40-ZeoR (left) or RPL32-mRFP-SV40-ZeoR (right) 
reporter constructs embedded in the DHFR BAC. Linear regression fits (black line) with 
y-intercepts set at 0 are shown with corresponding R-squared values and equations. Red 
circles- heterogeneous clones; Black circles- uniform clones. Bottom right: Number of 
clones analyzed and percentage of uniform clones. (c) Chromosomal locations of BAC 
transgene arrays within metaphase chromosomes of indicated clones as visualized by 





Figure A.8. Episome formation of DHFR BACs with CMV-mRFP-SV40-ZeoR 
reporter gene insertions. (a) Schematics of the intact DHFR BAC (DHFR-c27) and 
three DHFR BAC deletions (DHFR-c27d2, -c27d3crz and -c27d4). Longer vertical bars- 
exons; shorter vertical bars- UTRs; arrows- direction of transcription; black dashed lines- 
deleted regions; green arrowhead- Lac operator repeats (LacO) insertion site; red 
arrowhead- CMV-mRFP-SV40-ZeoR insertion site. (b) Representative maximum-
intensity projection images of clones with integrated BACs (c27d2_17, c27d3crz_65) and 
clones with episomal BACs (remaining clones). Red- DNA DAPI staining; Green- 
EGFP-LacI. Gamma = 0.5 was applied to the green channels of all images, and to the red 
channels of clone c27d2-17 and c27d3crz-52 images after projection. Scale bars = 5 μm. 
(c) mRFP fluorescence histogram of the clones in (b) obtained by flow-cytometry. x-axis- 





Figure A.9. GFP fluorescence histograms of HCT116 derived clones stably 
transfected with the 2207K13-UG BAC obtained by flow-cytometry. x-axis- signal 




Figure A.10. 3D DNA FISH over HCT116 derived clones stably transfected with the 
2207K13-UG BAC using BAC probes. (a) Four clones with broad GFP-reporter 
fluorescence histograms (Figure A.9) show integrated BAC arrays (top 3 panels, left  
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Figure A.10. Cont. 
bottom panel), similar to clones with narrow GFP-reporter fluorescence histograms 
(middle and right bottom panels). (b-c) One clone with a narrow GFP-reporter 
fluorescence histogram showed a subpopulation of cells within the clonal population 
showing episomal BAC transgenes (b). Subcloning this clone identified a subclones 
which also contained a similar mixture of clones with integrated versus episomal forms 
of the the BAC transgenes (c). (a-c): Maximum intensity projections are shown. Gamma 
= 0.5 was applied to the green channels after projection. Red- DAPI staining; Green- 




Figure A.11. Maps of Reporter and DHFR modules used for BAC-MAGIC. (a-c) 
reporter expression cassettes subcloned in the respective reporter recipient modules 
harboring SpecR selection marker (gray). (d-e) Schematics of the intervening DHFR 
modules harboring Kan/NeoR or ZeoR selection markers (gray). (a-e) Longer vertical 
bars represent the indicated restriction endonucleases used to generate recombineering 
fragments and arrows show the binding sites of primers used for amplification of 
recombineering fragments. See Methods for details of terminal regions corresponding to 
DHFR BAC homology regions. Scale bar = 2 kb.  
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Table A.1. Synthetic DNA fragment “RCS” sequence. 
 
Name Sequence Notes 
RCS 
   
NotI overhang 
NheI overhang 
5’ GGCCGCGGCGCGCCTTAATTAACCGGTG 3’ 
3’ CCGGCGCCGCGCGGAATTAATTGGCCACGATC 5’ 




Data A.1. List of primers and oligos used for Chapter 2 and Chapter 3. Primer/oligo 










Figure B.1. GAPDH BAC did not form episomes in mouse ES cells. (a) Broad 
distribution of GFP histograms of two mouse ES cell clones containing GAPDH BAC 
(green).  The GAPDH BAC and the clones were described in a previous study 
(Chaturvedi et al., 2018). Gray: untransfected mouse ES cells. (b) z-projections of DNA 
FISH images of the two clones in panel a. GAPDH BAC probes were used for DNA 





Chaturvedi, P. et al. (2018) ‘Stable and reproducible transgene expression independent of 










In order to study chromatin large-scale structure and spatial organization, specific 
genomic regions need to be visualized. Ideally, the visualization method should work in 
both fixed and living cells, so as to study the dynamics of the chromatin during various 
physiological activities. The ideal visualization method should also be able to label any 
genomic region of any size, without disturbing chromatin structure of the labeled region.  
Robust DNA Fluorescence in situ Hybridization (FISH) protocols have been 
developed to label both small genomic loci ~100s kb in size, and large genomic regions 
several Mbs in size or even the whole chromatin (Cremer et al., 2008; Boyle et al., 2011). 
However, DNA FISH has several disadvantages: the procedure is long, spanning several 
days; cells must be fixed; chromatin structure is not well preserved after DNA FISH 
procedure, due to multiple hash treatments to ensure successfully hybridization of FISH 
probes to the genomic DNA, including HCl extraction, freeze-thaw cycles and heat 
denaturation.   
Alternative visualization methods using a fluorescent repressor-operator system 
(Belmont and Straight, 1998; Tasan et al., 2018) can visualize genomic loci both in fixed 
and living cells with minimal disruption of the chromatin.  However, such systems only 
mark the genomic insertion sites of the tandem operator repeats, and do not light up long 




operator repeats stably integrated at the desired genomic loci while expressing an optimal 
level of fluorescent repressors. 
The revolutionary genome editing tool, type II clustered regularly interspaced 
short palindromic repeats (CRISPR)/CRISPR-associated caspase 9 (Cas9) system  
derived from Streptococcus pyogenes (Doudna and Charpentier, 2014; Hsu, Lander and 
Zhang, 2014) has also been used for visualization of genomic loci, where a fluorescently 
tagged nuclease-deficient Cas9 (dCas9) is used instead of Cas9. While most studies 
visualize genomic loci by establishing cell lines simultaneously expressing fluorescently 
tagged dCas9 and single-guide RNAs (sgRNAs) (Chen et al., 2013; Tanenbaum et al., 
2014; B. Chen et al., 2018; Gu et al., 2018; Ma et al., 2018), one study showed efficient 
labeling of genomic loci by incubating methanol-acidic acid fixed cells with in-vitro 
assembled dCas9/sgRNA complexes (Deng et al., 2015). This so-called CASFISH 
method is rapid and robust, and thus has the potential to substitute traditional DNA FISH 
if it has similar or even better chromatin preservation comparing to DNA FISH. 
Currently, highly repetitive sequences consisting of hundreds of repeats have been 
visualized efficiently both by expressing dCas9/sgRNA and by CASFISH. However, 
visualizing non-repetitive regions with CRISPR/CAS systems remains challenging (Chen 
et al., 2013; Deng et al., 2015), as it requires a large number of different sgRNAs, 
depending on the fluorescent tag of the system and the length of the genomic region to be 
visualized, to achieve a sufficient signal-to-noise ratio for microscopy detection. Current 
strategies to circumvent the need of large quantities of different sgRNAs include 




inserting tandem repeats of CRISPR targetable DNA sequences into the genomic loci to 
be visualized (Gu et al., 2018; Y. Chen et al., 2018). 
Here I show successful visualization of a large BAC transgene array ~20 Mb in 
size with pooled 13 sgRNAs using the CASFISH protocol.  Each of these sgRNAs is 
specific to a naturally occurring, low-copy number tandem repetitive sequence unique to 
the BAC constituting the transgene array. The total copy number of these tandem repeats 
is ~100 copies per BAC. While the endogenous loci corresponding to the region 
contained within the BAC could not be visualized by these sgRNAs, this method could 





Efficiency of CASFISH 
As CASFISH (Deng et al., 2015) is a newly developed method, I first tested the 
published protocol with three repetitive sequences, mouse major satellite repeats (MSR), 
human MUC4 gene exon 2 (E2) and intron 1 (I1) repeats, which were used as 
demonstrations in the paper (Deng et al., 2015).  
The standard CASFISH protocol from the paper (Deng et al., 2015) was used 
with BSA removed from the blocking/reaction buffer (Deng et al., 2015) and with no 
blocking step. As expected, MSR CASFISH generated strong signals over the 
chromocenters of the nuclei of mouse NIH 3T3 cells (Figure C.1a). Both E2 and I1 




good signal-to-noise ratio, while the I1 puncta were weaker than E2 and resembled 
background puncta (Figure C.1b-c). Increasing concentration of dCas9/sgRNA in the 
incubation step could not improve signal-to-noise ratio, indicating limited binding of 
dCas9/sgRNA to the genomic DNA (data not shown).  
Although it is claimed that the E2 repeats have ~400 copies of repeats, while the 
I1 repeats ~90 copies (Chen et al., 2013), CasFinder (Aach, Mali and Church, 2014), a 
software for identifying specific Cas9 targets in genomes, identified 125 (97% of all 
binding sites over the whole hg19 genome) and 127 (99% of all binding sites over the 
whole hg19 genome) binding sites over MUC4 gene for E2 and I1 sgRNA, respectively. 
However, there is a significant difference in the spacing of the E2 and I1 sgRNA binding 
sites over the MUC4 gene. The median distances of adjacent binding sites (5’ to 5’) were 
48 bp and 15 bp for E2 and I1, respectively. Thus it is likely that both the number of 
sgRNA binding sites and the spacing of the sgRNA binding sites contributes to the 
efficiency of CASFISH. 
CASFISH with formaldehyde fixation was tested using MSR sgRNA, as 
formaldehyde fixation could potentially preserve the chromatin better than 
methanol/acetic acid fixation. A low concentration of formaldehyde and short incubation 
time, and a 15 min HCl treatment were required to detect the signal (Figure C.2).  
 
CASFISH of DHFR BAC transgene array with 12 pooled sgRNAs 
Previous studies have successfully visualized a 5-kb nonrepetitive region of 
MUC4 gene both by CASFISH using 73 sgRNAs (Deng et al., 2015) and by expressing 




nonrepetitive region, CASFISH requires an additional stringent wash step. Here I show 
an alternative way to visualize large non-repetitive genomic regions by CASFISH, by 
designing sgRNAs targeting naturally occurring low-copy tandem repetitive sequences 
scattered in non-repetitive genomic regions. 
While the number of high copy number tandem repetitive sequences is limited in 
the genome, low copy tandem repeats are abundant. 12 tandem repeats over a BAC 
containing the mouse Dhfr-Msh3 locus (DHFR BAC) were identified using Tandem 
Repeat Finder (Benson, 1999). 13 sgRNAs targeting these tandem repeats were then 
designed using CasFinder (Aach, Mali and Church, 2014). These sgRNAs have a total of 
100 binding sites over the DHFR BAC and 104 over the whole mm9 genome.  
The sgRNAs were tested on an NIH 3T3 clone containing a large lac operator 
repeats (LacO) tagged DHFR BAC transgene array (~20 Mb) and expressing EGFP-
dimer lac repressor-NLS (nuclear localization signal) fusion protein (EGFP-LacI). As 
expected, CASFISH using the pooled sgRNA targeting the tandem repeats successfully 
visualized the trajectory of the DHFR BAC transgene array (Figure C.3).  
 
 
MATERIALS AND METHODS 
Cell culture and DHFR BAC 
Mouse NIH 3T3 cells and human U2OS cells were cultured with Dulbecco’s 
modified Eagle medium (DMEM, with 4.5 g/L D-glucose, 4 mM L-glutamine, 1 mM 
sodium pyruvate and 3.7 g/L NaHCO3) supplemented with 10% HyClone Bovine Growth 




The DHFR-c27 BAC (Bian and Belmont, 2010) containing a 256-mer lac 
operator direct repeat (LacO) and a CMV-mRFP-SV40-ZeoR expression cassette was 
derived from the CITB-057L22 BAC (DHFR BAC) containing mouse chr13:92,992,156-
93,161,185 (mm9). NIH 3T3 cell clone DHFR-c27-13 FULGW containing ~117 copies 
of the DHFR-c27 BAC and expressing an EGFP-dimer lac repressor-NLS (nuclear 
localization signal) fusion protein (EGFP-LacI) from lentivirus FULGW was established 
in previous studies (Bian and Belmont, 2010; Sinclair et al., 2010). The cell clone was 
maintained with 75 μg/ml Zeocin (Thermo Fisher Scientific). 
 
dCas9 constructs and purification 
Purified dCas9-tdTomato and dCas9-mNeonGreen (Lane et al., 2015) were a gift 
from Dr. Rebecca Heald (University of California at Berkeley, Berkeley, CA, USA).  
Plasmid pBZ03-NLS-dCas9-Halo-NLS-6xHis was derived from plasmid pET302-
6His-dCas9-Halo, a gift from Timothée Lionnet (Addgene plasmid # 72269 ; 
http://n2t.net/addgene:72269 ; RRID:Addgene_72269) using NEBuilder HiFi DNA 
Assembly (New England Biolabs). All oligos used for construction were listed in Table 
C.1.  
To construct the intermediate plasmid pBZ02-NLS-dCas9-Halo, the following 
fragments were used: a 1.5 kb PCR products amplified from plasmid pET302-6His-
dCas9-Halo using primer pair BZ#327/328, a connecting oligo BZ#335, and a 9248 bp 
vector backbone derived from digesting plasmid pET302-6His-dCas9-Halo with NcoI-
HF and PmeI (New England Biolabs). To construct plasmid pBZ03-NLS-dCas9-Halo-




plasmid pET302-6His-dCas9-Halo using primer pair BZ#329/330, a connecting oligo 
BZ#336 and a 10621 bp vector backbone derived from digesting plasmid pBZ02-NLS-
dCas9-Halo with XmaI and XhoI (New England Biolabs). 
NLS-dCas9-Halo-NLS-6xHis protein was expressed in Rosetta (DE3) 
(MilliporeSigma), grown in LB medium at ~18°C for ~18 h following induction with 0.2 
mM IPTG. Cells were lysed in Buffer A (20 mM Tris-Cl, pH=8.0; 500 mM NaCl) by 
sonication. Clarified lysate was applied to a HisTrap HP column (GE Healthcare). The 
bound protein was washed by increasing concentration of imidazole up to 50 mM and 
eluted by increasing imidazole up to 100 mM. The eluted protein was concentrated using 
an Ultra-15 100K centrifugal filter (Amicon), exchanged into Buffer C (20mM Tris-Cl 
pH=8.0; 200 mM KCl; 10 mM MgCl2; 10% glycerol) using a PD-10 column (GE 
Healthcare) x2, and concentrated again using an Ultra-4 3K centrifugal filter (Amicon). 
Protein concentration was measured using A280 (molecular weight = 195.5 kDa, 
extinction coefficient = 169600 M-¹cm-¹). 
NLS-dCas9-Halo-NLS-6xHis protein was fluorescently labeled by incubating 10-
40 µM protein with Janelia Fluor 549-Halo tag ligands (a gift from Janelia Research 
Campus) or with Alexa Fluor 660-Halo tag ligands (Promega) in Buffer C at 4°C for ~16 
h, with protein/dye molar ratio = 1:4 – 1:8. Free dyes were removed by 50K centrifugal 
filter (Amicon). 
 
Synthesis of MSR, E1 and E2 sgRNA templates 
The targeting sequences of MSR, E1 and E2 sgRNA and the sgRNA scaffold 




template was synthesized by PCR using two overlapping oligos synthesized by Integrated 
DNA Technologies (Table C.2). One oligo contains a T7 promoter, a sgRNA targeting 
sequence and a partial sgRNA scaffold (MSR-sgRNA-forward, MUC4-E2-sgRNA-
forward, or MUC4-I1-sgRNA-forward). The other oligo contains a partial sgRNA 
scaffold (Linker3-bottom). PCR used the following recipe: 1x Q5 reaction buffer, 200 
µM dNTPs (New England Biolabs), 0.5 µM each oligo, and 0.02 U/µl Q5 Hot Start 
High-Fidelity DNA Polymerase (New England Biolabs), and the following running 
protocol: 98°C 30 s; 35 cycles of 98°C 10 s, 71°C 30 s, and 72°C 5 s; 72°C 2 min; and 
4°C HOLD.   
 
Design of DHFR BAC sgRNA targeting sequences 
Tandem repeats over the DHFR BAC were searched by Tandem Repeat Finder 
(Benson, 1999) (version 4.09, Sequence: mm9_dna range=chr13:92992156-93161185 
5'pad=0 3'pad=0 strand=+ repeatMasking=none; Parameters: 2 7 7 80 10 50 500). 
Repeats with consensus size > 20 and period size ³ 30 were merged into repetitive 
regions. 12 repetitive regions with length ³ 120 bp were selected and named DHFRt1, 
DHFRt2, …, DHFRt12 (Table C.3). The summed length of the 12 repetitive regions was 
~5 kb. 
20 nt and 23 nt candidate sgRNA targeting sequences over DHFRt1, DHFRt2, …, 
DHFRt12 were searched by CasFinder (Aach, Mali and Church, 2014) (distribution: 
05122014, options: -D -A 200 -R -g mm9). Total numbers of binding sites of each 
candidate targeting sequences over the DHFR BAC regions and over the whole mm9 




from the output files of CasFinder. 13 candidate targeting sequences were manually 
selected according to the following conditions: 5’ end starting with “G”; maximum 
binding sites over the DHFR BAC; minimum binding sites over the rest of the genome; 
maximum spacing. DHFRt3 has two candidate targeting sequences and each of the rest 
repetitive regions has one. Next, to create the final oligos BZ-lib-01, -02, …, -26, PAM 
sequences were removed from the 13 candidate targeting sequences; a single “G” was 
added to candidate targeting sequences that did not begin with “GG”; a reverse 
complimentary sequence of each candidate targeting sequence was created; and finally 
overhangs compatible to the BsaI sites of plasmid pBZ01 were added to each sequence. 
Sequences of BZ-lib-01, -02, …, -26 were listed in Table C.4. 
 
Construction of DHFR BAC sgRNA template plasmids 
The strategy for constructing sgRNA template plasmids was similar to previous 
studies (Hwang et al., 2013; Zhou et al., 2017). A 147 bp sequence containing a T7 
promoter positioned upstream of an optimized sgRNA scaffold sequence (Chen et al., 
2013) was synthesized and cloned into plasmid pIDTSMART-KAN by Integrated DNA 
Technologies, yielding plasmid pBZ01 (Figure C.4 and Data C.1). Two BsaI sites were 
positioned in between the T7 promoter and the sgRNA scaffold sequence, where sgRNA 
targeting sequences could be cloned into to make a complete sgRNA template. A BstBI 
and a HindIII sites were positioned immediately downstream of sgRNA scaffold 
sequence for linearization of the plasmid for in vitro transcription. 
Two oligos were designed for each sgRNA targeting sequence so that the 




oligos (BZ-lib-01, -02, …, -26) were synthesized by Integrated DNA Technologies, 
phosphorylated using T4 Polynucleotide Kinase (New England Biolabs) and annealed in 
a thermocycler using the following protocol: 98°C 2 min; 20°C 2 min (Ramp = 0.02°/s); 
4°C pause. Plasmid pBZ01 was digested by BsaI-HF (New England Biolabs), gel 
purified using QIAquick Gel Extraction Kit (Qiagen) and ligated with the annealed oligos 
using Quick Ligation Kit (New England Biolabs), yielding plasmid pBZ01-1/2, pBZ01-
3/4, …, pBZ01-25/26. 
 
Synthesis of sgRNAs 
sgRNAs were synthesized by in vitro transcription using MEGAscript T7 
Transcription Kit (Thermo Fisher Scientific) according to manufacturer’s instructions, 
with ~150 ng PCR products or ~450 ng linearized plasmids per 10 µl reaction as 
templates and ~16 h incubation time. The sgRNAs were purified using MEGAclear 
Transcription Clean-up Kit (Thermo Fisher Scientific) according to manufacturer’s 
instructions. The yield was ~50 µg purified sgRNA per 10 µl reaction. 
 
CASFISH 
CASFISH used the standard protocol (Deng et al., 2015) with small 
modifications. Cells grown on coverslips were fixed with methanol/acetic acid (1v:1v) at 
-20°C for ~20 min and washed with DPBS (Chapter 2) x3. Fluorescently labeled dCas9 
(1-25 nM) and sgRNA (dCas9:sgRNA = 1:2 to 1:4 molar ratio) were incubated in B/R 
Buffer (20 mM HEPES, pH 7.5; 100 mM KCl; 5 mM MgCl2; 5% glycerol; 0.1% 




next step. The fixed cells were incubated with the dCas9/sgRNA mixture for 30 min at 
37°C, washed with B/R Buffer for 5 min x3, and mounted.  
Fixation with formaldehyde was tested using MSR sgRNA. Cells were fixed with 
0.5% paraformaldehyde/DPBS for 5 min at RT, permeabilized with 0.5% Triton X-
100/DPBS and incubated in 0.1 N HCl for 15 min. Rest steps were the same as above. 
 
Code Availability 
All computational scripts used for designing sgRNA targeting sequences are 








Figure C.1. CASFISH of MSR, E2 and I1. (a) CASFISH using MSR sgRNA over NIH 
3T3 cells. Gamma = 0.5 was applied to green channels. (b-c): CASFISH using E2 (b) or 
I1 (c) sgRNA over U2OS cells. Red- DNA DAPI staining; Green- CASFISH signal; 






Figure C.2. CASFISH of MSR using formaldehyde fixation (top panel) and 
methanol/acetic acids fixation (bottom panel). NIH 3T3 cells were used. Bottom panel 
reuses the image for Figure C.1. Red and Middle panel- DNA DAPI staining; Green and 






Figure C.3. DHFR BAC transgene array in a NIH 3T3 clone DHFR-c27-13 
visualized by CASFISH (left) vs by EGFP-LacI (right). Maximum intensity 























Table C.1. Oligo sequences for constructing pBZ03-NLS-dCas9-Halo-NLS-6xHis. 
 











Table C.2. Oligo sequences for synthesizing MSR, E2 and I1 sgRNA templates. 
 
Oligo name Oligo sequence (5’-3’) 


















Table C.3. Tandem repetitive regions over the DHFR BAC. 
 
Repeat name Repeat length Repeat mm9 coordinate 
DHFRt1 869bp  chr13:92999581-93000449 
DHFRt2 156bp  chr13:93018743-93018898 
DHFRt3 404bp  chr13:93028764-93029167 
DHFRt4 150bp  chr13:93029976-93030125 
DHFRt5 193bp  chr13:93070622-93070814 
DHFRt6 343bp  chr13:93081847-93082189 
DHFRt7 1378bp  chr13:93085813-93087190 
DHFRt8 298bp  chr13:93097220-93097517 
DHFRt9 275bp  chr13:93106886-93107160 
DHFRt10 165bp  chr13:93124956-93125120 
DHFRt11 494bp  chr13:93134619-93135112 







Table C.4. Oligo sequences used to synthesize the targeting sites of DHFR sgRNA 
templates. 
 












































Data C.1. Plasmid pBZ01 sequence. Sequence and annotations of plasmid pBZ01 saved 
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APPENDIX D: DESIGN OF OLIGO LIBRARIES FOR VISUALIZING LARGE 
GENOMIC REGIONS WITH CRISPR/CAS9 SYSTEM 
 
To visualize large non-repetitive mammalian genomic regions, pooled sgRNAs 
tiling the genomic regions need to be synthesized. Here I represent a strategy for 
synthesizing such sgRNA libraries. First, a pool of oligos containing the sgRNA targeting 
sequences is synthesized. Next, the oligos were PCR amplified and cloned into plasmid 
pBZ01 (Appendix C), which contains a T7 promoter upstream of an sgRNA scaffold, 
with two BsaI sites positioned in between the T7 promoter and the sgRNA scaffold for 
cloning. Finally, the plasmid libraries are used for synthesis of sgRNA libraries by in 
vitro transcription. This strategy is similar to published studies (Bao et al., 2018), except 
here multiple libraries are synthesized within one oligo pool. 
A pool of 12461 oligos was designed for visualizing 30 different mouse and 
human genomic regions (Table D.1). Each oligo has the following structures: 
FFFFFFFFFFFFFFFFFFggtctcataggNNNNNNNNNNNNNNNNNNgtttagagaccRRRRR
RRRRRRRRRRRRR. 
The FFFFFFFFFFFFFFFFFF and RRRRRRRRRRRRRRRRRR represent 18 nt 
PCR primer binding sites for amplifying each sgRNA targeting sequence library. The 
ggNNNNNNNNNNNNNNNNNN represents 20 nt sgRNA targeting sequence. The 
small letters are BsaI sites. 
sgRNAs candidate targeting sites were searched by CasFinder (Aach, Mali and 
Church, 2014). The candidate targeting sites were then selected with the following steps: 
1) targeting sites starting with "GN" or "NG" were selected; 2) targeting sites containing 
 178 
BsaI sites (GGTCTC|GAGACC) were removed; 3) targeting sites with 35%~ 65% GC% 
were selected; 4) targeting sites containing 'TTTT..' were removed; 5) targeting sites were 
selected so that distance to adjacent targeting sites (5’-5’) >= 46.  
This targeting sites selection did not check HindIII or BstBI sites, which are used 
to linearize the final plasmid library for in vitro transcription. The percentage of bad 
oligos that will be cut by HindIII or BstBI is listed in Table D.2.  
Primers for amplifying each library are designed by the following steps: 1) 
18mers were derived from a library of orthogonal 25mers (Xu et al., 2009) with the 
following conditions: GC content in between 40% and 60%, not containing BsaI sites, Tm 
³57°C and £ 63°C, hairpin Tm £ 0°C, homodimer Tm £ 0°C, homodimer dG >= -3500, no 
XXXX…, no XYXYXY…; 2) mis-priming of the 18mers against the sgRNA targeting 
sequences were checked by primer3-2.3.7 (Untergasser et al., 2012), oligos with mis-
priming scores £ 10 were selected; 3) mis-priming of the 18mers against the sgRNA 
targeting sequences were checked again by blast 2.6.0; 4) mis-priming of the 18mers 
among themselves were checked by blast 2.6.0; 5) oligos were filtered by Sequence 
Manipulation Suite: PCR Primer Stats 
(http://www.bioinformatics.org/sms2/pcr_primer_stats.html); 6) oligos with minimum 
heterodimer formation and similar Tm (calculated by NEB Tm Calculator 
(https://tmcalculator.neb.com/#!/main) using Q5 polymerase) were paired. 
Detailed information of each oligo is in Data D.1. Detailed information of the 
primers for library amplification is in Data D.2. Computational scripts for designing the 
oligo sequences are available at https://bitbucket.org/Binhui/sgrna-design/src. 
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Table D.1. Information of the libraries in the oligo pool. 
 
 Library name Number 
of oligos 
Targeting sequence  Description Specificity 
1 Chr12_A2_peak-h-lib_1 34 RP11-154B14 (BAC) A2 peak of TSA seq, human 
2 Chr18_A2_pInv-h-lib_1 97 
RP11-650D13 (BAC) A2 peak in valley of TSA seq human 3 Chr18_A2_pInv-h-lib_2 97 
4 Chr2_A1_pTos-h-lib_1 2520 chr2:22925891-27325691 (hg19) periphery to speckle trajectory human 
5 Chr2_A1_sTop-h-lib_1 4398 chr2:27325671-34336642 (hg19) speckle to periphery trajectory human 
6 Chr2_A2_peak-h-lib_1 119 RP11-598F14 (BAC) A2 peak of TSA seq human 
7 Chr2_A2_v1-h-lib_1 1749 
chr2:36000000- 40950032 (hg19) A2 valley of TSA seq human 
8 Chr2_A2_v2-h-lib_1 1130 
9 Chr3_A2_peak-h-lib_1 156 RP11-922N10 (BAC) A2 peak of TSA seq human 
10 Chr4_R_lib1 239 chr4:144965603- 147315930 (mm9) 
mouse naturally repetitive 
region mouse 
11 Chr6_A2_pInv-h-lib_1 90 
RP11-20H19 (BAC) A2 peak in valley of TSA seq human 12 Chr6_A2_pInv-h-lib_2 90 
13 COL1A1_BAC-h-lib_1 120 
RP11-267M22 (BAC) COL1A1 BAC 
human 
14 COL1A1_BAC-h&m-lib_1 95 human and 
mouse 15 COL1A1_BAC-h&m-lib_2 94 
16 DHFR_BAC-m-lib_1 116 
CITB-057L22 (BAC) DHFR BAC mouse 
17 DHFR_BAC-m-lib_2 116 
18 GAPDH_BAC-h-lib_1 125 
RP11-369N23 (BAC) GAPDH BAC 
human 
19 GAPDH_BAC-h&m-lib_1 126 human and 
mouse 20 GAPDH_BAC-h&m-lib_2 125 
21 HBB_BAC-h-lib_1 76 
CTD-2643I7 (BAC) HBB BAC 
human 
22 HBB_BAC-h&m-lib_1 59 human and mouse 
23 HBB_BAC-m-lib_1 103 
mouse 24 HBB_BAC-m-lib_2 102 
25 HBB_BAC-m-lib-3 102 
26 HSPH1_BAC-h-lib_1 130 
RP11-173P16 (BAC) Heat shock BAC human 
27 HSPH1_BAC-h-lib_2 130 
28 K13_BAC-h-lib_1 11 
CTD-2207K13 (BAC) 2207K13 BAC 
human 
29 K13_BAC-h&m-lib_1 17 human and mouse 













Oligos with HindIII 
or BstBI sites 
Bad oligos% 
Chr12_A2_peak-h-lib-1 34 0 0 0 0.00% 
Chr18_A2_pInv-h-lib-1 97 0 0 0 0.00% 
Chr18_A2_pInv-h-lib-2 97 1 0 1 1.03% 
Chr2_A1_pTos-h-lib-1 2520 15 3 18 0.71% 
Chr2_A1_sTop-h-lib-1 4398 20 10 30 0.68% 
Chr2_A2_peak-h-lib-1 119 1 0 1 0.84% 
Chr2_A2_v1-h-lib-1 1749 6 3 9 0.51% 
Chr2_A2_v2-h-lib-1 1130 4 4 8 0.71% 
Chr3_A2_peak-h-lib-1 156 0 0 0 0.00% 
Chr4_R_lib1 239 0 0 0 0.00% 
Chr6_A2_pInv-h-lib-1 90 0 0 0 0.00% 
Chr6_A2_pInv-h-lib-2 90 0 0 0 0.00% 
COL1A1_BAC-h-lib-1 120 0 1 1 0.83% 
COL1A1_BAC-h&m-lib-1 95 0 1 1 1.05% 
COL1A1_BAC-h&m-lib-2 94 0 0 0 0.00% 
DHFR_BAC-m-lib-1 116 0 0 0 0.00% 
DHFR_BAC-m-lib-2 116 2 0 2 1.72% 
GAPDH_BAC-h-lib-1 125 1 0 1 0.80% 
GAPDH_BAC-h&m-lib-1 126 0 0 0 0.00% 
GAPDH_BAC-h&m-lib-2 125 2 1 3 2.40% 
HBB_BAC-h-lib-1 76 0 0 0 0.00% 
HBB_BAC-h&m-lib-1 59 1 0 1 1.69% 
HBB_BAC-m-lib-1 103 1 0 1 0.97% 
HBB_BAC-m-lib-2 102 1 0 1 0.98% 
HBB_BAC-m-lib-3 102 2 0 2 1.96% 
HSPH1_BAC-h-lib-1 130 2 0 2 1.54% 
HSPH1_BAC-h-lib-2 130 2 0 2 1.54% 
K13_BAC-h-lib-1 11 0 0 0 0.00% 
K13_BAC-h&m-lib-1 17 0 0 0 0.00% 




Data D.1. Information of each oligo. A tab delimited text file (Data_D.1.txt) providing 
the following information: library name, sequence name, oligo sequence without primer 
binding sites, amplification primer ID, forward primer name, alternative forward primer 
name, forward primer sequence,  reverse primer name, alternative reverse primer name, 
reverse primer sequence, reverse complementary sequence of reverse primer, and 
complete oligo sequence of each oligo. 
 
Data D.2. Primers for amplifying the libraries in the oligo pool. A tab delimited text 
file (Data_D.2.txt)  providing the following information: amplification primer ID, 
forward primer name, alternative forward primer name, forward primer sequence,  
reverse primer name, alternative reverse primer name, reverse primer sequence, and 
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